AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON JANUARY 10, 1997
REGISTRATION NO. 333-16451

U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549


AMENDMENT NO. 1
TO
FORM SB-2
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933


SAC TECHNOLOGIES, INC.

(Name of small business issuer as specified in its charter)

         MINNESOTA                       3577                   41-1741861
State or other jurisdiction   (Primary Standard Industrial   (I.R.S. Employer
    of incorporation or        Classification Code Number)   Identification No.)
      organization

4444 WEST 76TH STREET, SUITE 600, EDINA, MINNESOTA 55435
(612) 835-7080
(Address and telephone number of principal executive offices)

(Address of principal place of business or intended principal place of business)

MR. BARRY M. WENDT
CHIEF EXECUTIVE OFFICER
SAC TECHNOLOGIES, INC.
4444 WEST 76TH STREET, SUITE 600
EDINA, MINNESOTA 55435

TELEPHONE: (612) 835-7080 FACSIMILE: (612) 835-6620

(Name, address and telephone number of agent for service)


COPIES TO:

        STEPHEN E. SMITH, ESQ.                        MICHAEL L. BERDE, ESQ.
       DANIEL R. TENENBAUM, ESQ.                       KEVIN S. SPRENG, ESQ.
DOHERTY, RUMBLE & BUTLER, PROFESSIONAL               MERRITT, FURBER & TIMMER
             ASSOCIATION                             2100 METROPOLITAN CENTRE
       3500 FIFTH STREET TOWERS                      333 SOUTH SEVENTH STREET
        150 SOUTH FIFTH STREET                     MINNEAPOLIS, MINNESOTA 55402
   MINNEAPOLIS, MINNESOTA 55402-4235                 TELEPHONE: (612) 338-3965
       TELEPHONE: (612) 340-5555                     FACSIMILE: (612) 330-0959
       FACSIMILE: (612) 340-5584

                       ----------------------------------

Approximate date of commencement of proposed sale to the public: As soon as practicable after this Registration Statement becomes effective.

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. [ ]

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. [ ]

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. [ ]

If delivery of the prospectus is expected to be made pursuant to Rule 434, please check the following box. [ ]




                                           CALCULATION OF REGISTRATION FEE

                                                               PROPOSED
                                                           MAXIMUM OFFERING     PROPOSED MAXIMUM
          TITLE OF EACH CLASS OF           AMOUNT TO BE        PRICE PER       AGGREGATE OFFERING      AMOUNT OF
        SECURITIES TO BE REGISTERED         REGISTERED         SHARE(1)             PRICE(1)        REGISTRATION FEE
        ---------------------------         ----------         --------             --------        ----------------
                                            1,210,000
Common Stock, $0.01 par value.............  shares(2)            $6.00             $7,260,000            $2,200

Underwriters Warrant to purchase shares
of Common Stock(3)........................      1                                  $      100            $  0(4)

(1) Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(a).
(2) Includes the Underwriter's over-allotment option to purchase up to 110,000 shares.
(3) Represents a warrant to be issued by the Company to the Underwriter at the time of delivery and acceptance of the Shares to be sold by the Company to the public hereunder.
(4) None, pursuant to Rule 457(g).

THE SMALL BUSINESS ISSUER HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE OR DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL THE SMALL BUSINESS ISSUER SHALL FILE A FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THIS REGISTRATION STATEMENT SHALL THEREAFTER BECOME EFFECTIVE IN ACCORDANCE WITH
SECTION 8(a) OF THE SECURITIES ACT OF 1933 OR UNTIL THE REGISTRATION STATEMENT SHALL BECOME EFFECTIVE ON SUCH DATE AS THE COMMISSION, ACTING PURSUANT TO SAID
SECTION 8(a), MAY DETERMINE.

SAC TECHNOLOGIES, INC.

CROSS REFERENCE SHEET

PURSUANT TO ITEM 502(f) OF REGULATION S-B

SHOWING LOCATION IN PROSPECTUS OF PART I ITEMS OF FORM SB-2

ITEM NUMBER AND CAPTION                                        LOCATION IN PROSPECTUS
- -----------------------                                        ----------------------
    1.    Front of Registration Statement and
          Outside Front Cover of Prospectus ................   Outside Front Cover Page of Prospectus

    2.    Inside Front and Outside Back Cover Pages
          of Prospectus ....................................   Inside Front and Outside Back Cover Pages of
                                                               Prospectus

    3.    Summary Information and Risk Factors .............   Summary; Risk Factors

    4.    Use of Proceeds ..................................   Summary; Use of Proceeds

    5.    Determination of Offering Price ..................   Outside Front Cover Page; Risk Factors;
                                                               Underwriting

    6.    Dilution .........................................   Risk Factors; Dilution

    7.    Selling Security Holders .........................   Not Applicable

    8.    Plan of Distribution .............................   Outside Front Cover Page; Underwriting and Plan
                                                               of Distribution

    9.    Legal Proceedings ................................   Business

   10.    Directors, Executive Officers, Promoters,
          and Control Persons ..............................   Risk Factors; Management; Principal Shareholders

   11.    Security Ownership of Certain Beneficial
          Owners and Management ............................   Principal Shareholders

   12.    Description of Securities ........................   Summary; Description of Securities

   13.    Interest of Named Experts and Counsel ............   Experts; Legal Matters

   14.    Disclosure of Commission Position on
          Indemnification for Securities Act Liabilities ...   Description of Securities; Underwriting

   15.    Organization Within Last Five Years ..............   Summary; Business

   16.    Description of Business ..........................   Summary; Risk Factors; Business

   17.    Management's Discussion and Analysis or
          Plan of Operation ................................   Management's Discussion and Analysis of Financial
                                                               Condition and Results of Operations

   18.    Description of Property ..........................   Business

   19.    Certain Relationships and Related Transactions ...   Certain Transactions

   20.    Market for Common Equity and Related
          Stockholder Matters ..............................   Divided Policy; Shares Available for Future Sale;
                                                               and Description of Securities

   21.    Executive Compensation ...........................   Management

   22.    Financial Statements .............................   Summary; Capitalization; Selected Historical and
                                                               Pro Forma Financial Data; Index to Financial
                                                               Statements

   23.    Changes In and Disagreements With Accountants on
          Accounting and Financial Disclosure ..............   Not Applicable

INFORMATION CONTAINED HEREIN IS SUBJECT TO COMPLETION OR AMENDMENT. A REGISTRATION STATEMENT RELATING TO THESE SECURITIES HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE COMMISSION. THESE SECURITIES MAY NOT BE SOLD NOR MAY OFFERS TO BUY BE ACCEPTED PRIOR TO THE TIME THE REGISTRATION STATEMENT BECOMES EFFECTIVE. THIS PROSPECTUS SHALL NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY NOR SHALL THERE BE ANY SALE OF THESE SECURITIES IN ANY STATE IN WHICH SUCH OFFER, SOLICITATION OR SALE WOULD BE UNLAWFUL PRIOR TO REGISTRATION OR QUALIFICATION UNDER THE SECURITIES LAWS OF ANY SUCH STATE.

SUBJECT TO COMPLETION, DATED JANUARY 10, 1997

1,100,000 SHARES

[LOGO]

SAC TECHNOLOGIES, INC.

COMMON STOCK

SAC Technologies, Inc. (the "Company") is offering hereby 1,100,000 shares (the "Shares") of the Company's $0.01 par value common stock. The Price to Public is expected to be $6.00 per share. See "Risk Factors--Arbitrary Offering Price; No Prior Public Market; Possible Volatility of Stock Price."

Prior to this offering, there has been no public market for the Shares, and no assurance can be given that any such market will exist or develop upon completion of this offering or, if developed, will be maintained. The initial offering price of the Shares offered hereby has been arbitrarily determined by negotiations between the Company and Tuschner & Company, Inc. (the "Underwriter"). See "Underwriting." The Company has applied for listing of the Shares on the Nasdaq SmallCap Market under the symbol "SACM."

THE SECURITIES OFFERED HEREBY ARE SPECULATIVE AND INVOLVE A HIGH DEGREE OF RISK AND IMMEDIATE SUBSTANTIAL DILUTION AND SHOULD NOT BE PURCHASED BY INVESTORS WHO CANNOT AFFORD THE LOSS OF THEIR ENTIRE INVESTMENT. SEE "RISK FACTORS" COMMENCING ON PAGE 3 AND "DILUTION" ON PAGE 10.

THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES AND
EXCHANGE COMMISSION OR ANY STATE SECURITIES COMMISSION NOR HAS THE
COMMISSION OR ANY STATE SECURITIES COMMISSION PASSED UPON THE
ACCURACY OR ADEQUACY OF THIS PROSPECTUS. ANY REPRESENTATION TO
THE CONTRARY IS A CRIMINAL OFFENSE.

                             PRICE TO      UNDERWRITING      PROCEEDS TO
                              PUBLIC         DISCOUNT       COMPANY(1)(2)

Per Share .............       $6.00            $0.51           $5.49
Total(3) ..............     $6,600,000       $561,000        $6,039,000

(1) The Company has agreed to pay the Underwriter a nonaccountable expense allowance equal to 2% of the gross proceeds of this offering, and has agreed to issue to the Underwriter a five-year warrant to purchase up to 44,496 shares of common stock at 120% of the Price to Public. The Company has also agreed to indemnify the Underwriter against certain liabilities, including liabilities under the Securities Act of 1933. See "Underwriting."

(2) Before deducting offering expenses payable by the Company, estimated at $367,000 (including the nonaccountable expense allowance referenced in Note 1 above).

(3) The Company has granted the Underwriter a 30-day option to purchase up to an aggregate of 110,000 additional shares of common stock solely to cover over-allotments, if any, at the per share Price to Public less the Underwriting Discount. If the Underwriter exercises this option in full, the total Price to Public, Underwriting Discount and Proceeds to Company in the aggregate will be $7,260,000, $617,100 and $6,642,900, respectively. See "Underwriting."

The Shares are offered by the Underwriter subject to prior sale when, as and if delivered to and accepted by the Underwriter and subject to the approval of certain legal matters by counsel and to certain other conditions. The Underwriter reserves the right to withdraw, correct or modify the offering and to reject an order in whole or in part. It is expected that delivery of the certificates representing shares of common stock will be made at the offices of the Underwriter in Minneapolis, Minnesota on , 1997.

TUSCHNER & COMPANY, INC.

The date of this Prospectus is , 1997

[PHOTO OF SACMAN UNIT WHICH IS A RECTANGULAR-SHAPED BOX APPROXIMATELY 3" H X 3" W X 5.75" L AND RESEMBLES A COMPUTER MOUSE WITH A FINGERPRINT-SIZED WINDOW IN THE CENTER FOR PLACING AND VERIFYING A FINGERPRINT.]

PROSPECTUS SUMMARY

THE FOLLOWING SUMMARY IS QUALIFIED IN ITS ENTIRETY BY THE MORE DETAILED INFORMATION AND FINANCIAL STATEMENTS AND NOTES THERETO APPEARING ELSEWHERE IN THIS PROSPECTUS, INCLUDING INFORMATION UNDER "RISK FACTORS." UNLESS OTHERWISE INDICATED, ALL INFORMATION IN THIS PROSPECTUS (I) ASSUMES NO EXERCISE OF THE UNDERWRITER'S OVER-ALLOTMENT OPTION AND (II) REFLECTS THE COMPANY'S NINE-FOR-TWO

STOCK SPLIT IN APRIL, 1996. SEE "DESCRIPTION OF SECURITIES" AND "UNDERWRITING." THE COMMON STOCK OFFERED HEREBY IS SPECULATIVE AND INVOLVES A HIGH DEGREE OF RISK. SEE "RISK FACTORS" FOR INFORMATION PROSPECTIVE INVESTORS SHOULD CONSIDER.

THE COMPANY

SAC Technologies, Inc. (the "Company") develops, markets, and distributes fingerprint identification products for use in general commercial and consumer market applications. The Company is a development stage enterprise that was formed in 1993 and has yet to generate any commercial sales, significant revenues, or profits. See "Business--General."

It is generally recognized that fingerprint patterns are unique to each individual. However, manual fingerprint analysis is time-consuming, tedious, and potentially unreliable. The Company's focus has been to develop automated fingerprint identification products for the access control market which are portable, easily integrated with existing applications, and affordable for mass commercial uses. See "Business--General."

The Company has completed the development and testing of its initial automated fingerprint identification product called SACMan(tm). SACMan and related products are designed to provide controlled access to information, resources, and facilities. The Company plans to market its products for a variety of different applications including information access control, computer network access control, and facility access control. The Company's technology also has potential application in other markets including law enforcement and financial credit transaction markets which belong to Jasper Consulting, Inc. ("Jasper") by agreement. Furthermore, the Company plans to develop some limited manufacturing and assembly capability and to contract for outside manufacturing and assembly of its products, as needed. See "Business--General," "--Technology License," and "--Market."

SACMan is principally intended to control access to information resources, allowing only those individuals whose fingerprints are included in a fingerprint database access to computers, computer networks, and/or specific applications. The Company's SACMan(tm) and SAC_App products have undergone extensive internal and external testing and are believed to be ready for commercial scale production, sale and use. The Company has not yet completed final development or commenced testing of its SAC_Remote product, developed principally for use in restricting door entry access to a specific set of individuals, or SAC_Encrypt products; however, the initial hardware design of these products has been completed. It is anticipated that development and testing of the SAC_Remote and SAC_Encrypt products will be completed in early to mid 1997, at which time the product is expected to be made available for commercial release. See "Business--Products."

The Company believes its principal competition will come from existing methods of restricting access to facilities, such as pass cards, personal identification numbers, password access, locks and keys, as well as from other companies involved in the development, manufacture, and marketing of fingerprint biometric products. The Company's products will also be competing for market share with other biometric technologies including hand geometry, facial recognition, iris scanning, retinal scanning, signature verification, and voice analysis. Many of these competitors have substantially greater resources and experience in developing and marketing access control products. The Company has yet to manufacture, market, or sell any of its products on a commercial basis. Based on field testing, available pricing information of product components, and its current sales price, the Company believes its products are reliable and will be affordable in its targeted markets.

The Company's underlying technology consists of: (i) optic technology which captures the image of a fingerprint ("Optic Technology"); (ii) hardware and software which translates and standardizes the image of the fingerprint for computer analysis ("Biometric Solution"); (iii) a license to certain software which classifies the fingerprint and matches it to an existing database ("FIDS Technology"); and (iv) SAC_App application database development software which can be used to enter, sort, structure, manipulate, and manage a database of fingerprint models. See "Business--Technology License."

The Company began operations and was incorporated under the laws of the State of Minnesota in January, 1993. The Company's principal office is located at Suite 600, 4444 West 76th Street, Edina, Minnesota 55435 and its telephone number is (612) 835-7080. The Company also leases space at 4620 South Valley View Road, Suite A1, Las Vegas, Nevada 89103, which it plans to use for marketing and showroom purposes. The Company's fiscal year ends December 31. See "Business--Property."

THE OFFERING

COMMON STOCK OFFERED.....................  1,100,000 Shares

COMMON STOCK OUTSTANDING(1)

  BEFORE THE OFFERING....................  2,508,750 shares

  AFTER THE OFFERING (PRO FORMA)(2)......  3,608,750 shares

USE OF PROCEEDS .........................  For sales and marketing activities,
                                           research and development and working
                                           capital. See "Use of Proceeds."


Proposed Nasdaq SmallCap market symbol...  SACM

CUSIP Number.............................  78386P 10 4

                                                  SUMMARY FINANCIAL DATA

                                                         JANUARY 7,                                        JANUARY 7,
                                                        1993 (DATE                                         1993 (DATE
                                                       OF INCEPTION)           NINE MONTHS ENDED          OF INCEPTION)
                            YEAR ENDED DECEMBER 31        THROUGH                 SEPTEMBER 30               THROUGH
                            ----------------------      DECEMBER 31,      ---------------------------     SEPTEMBER 30,
                               1994         1995           1995             1995            1996              1996
                            ---------     --------     ------------      -----------     -----------      -------------
                                                                         (UNAUDITED)     (UNAUDITED)       (UNAUDITED)
SELECTED STATEMENT OF
 OPERATIONS DATA
  Revenues  ................ $107,000     $229,070       $ 353,057        $ 153,374       $      --        $ 353,057
  Costs and Other
   Expenses ................  118,285      315,456         481,324          276,169         490,488          971,812
  Loss From Operations .....  (11,285)     (86,386)       (128,267)        (122,795)       (490,488)        (618,755)
  Net Loss .................  (11,285)     (86,386)       (128,267)        (122,795)       (517,399)        (645,666)
  Loss Per Share ...........       --         (.03)           (.05)            (.05)           (.20)            (.24)

                                        DECEMBER 31,                 SEPTEMBER 30, 1996
                                   -----------------------    --------------------------------
                                     1994          1995         ACTUAL      PRO FORMA(1)(2)(3)
                                   -------      ----------    -----------   ------------------
                                                              (UNAUDITED)        (UNAUDITED)
SELECTED BALANCE SHEET DATE
  Working capital (deficit)        $(5,628)     $(133,836)      $ 90,369         $5,562,369
  Total assets                       6,598         24,139        325,577          5,880,577
  Stockholders' equity
   (deficit)                        (5,628)      (125,188)       136,918          5,808,918


(1) Does not include (a) 50,000 shares of Common Stock which may be issued upon exercise of warrants issued to the investors in connection with bridge financing arrangements at an exercise price of $2.00 per share; (b) 41,639 shares of Common Stock which may be issued upon exercise of warrants issued to the Underwriter in connection with a private placement and bridge financing arrangements at an adjusted exercise price of $6.00 per share; (c) 375,000 shares of Common Stock reserved for issuance under the Company's 1996 Stock Option Plan, 173,000 shares of which are currently issued at a weighted average exercise price of $2.23 per share and none of which are exercisable within 60 days from the date hereof; and (d) up to 44,496 shares of Common Stock issuable upon exercise of warrants which may be issued to the Underwriter in connection with the sale of the Shares included in this offering.

(2) Adjusted to give effect to the sale of the 1,100,000 shares offered hereby at an assumed initial public offering price of $6.00 per share, net of anticipated Underwriter discounts and offering expenses. Assumes no exercise of the Underwriter's option to purchase 110,000 shares of common stock to cover overallotments. See "Use of Proceeds."

(3) Adjusted to give effect to the anticipated application of the net proceeds from this offering, including the repayment of certain liabilities.

RISK FACTORS

THE SHARES OFFERED HEREBY ARE SPECULATIVE AND INVOLVE A HIGH DEGREE OF RISK AND SHOULD ONLY BE CONSIDERED BY INVESTORS WHO CAN AFFORD THE LOSS OF THEIR ENTIRE INVESTMENT. PROSPECTIVE PURCHASERS OF THE SHARES SHOULD ALSO CONSIDER THE RISK FACTORS SET FORTH BELOW IN CONNECTION WITH THE OTHER INFORMATION FURNISHED HEREIN.

DEVELOPMENT STAGE COMPANY, LIMITED OPERATING HISTORY AND GOING CONCERN. The Company is a development stage enterprise, formed in 1993 which has yet to generate any significant revenues. The Company had net losses of $86,386 and $517,399 during the year ended December 31, 1995 and nine months ended September 30, 1996, respectively. Since inception through September 30, 1996, the Company has had accumulated losses of $645,666 and negative cash flow from operations of $718,566. All of the Company's revenues to date were derived from the reimbursement of development costs and other services provided to Jasper. In addition, the Company has yet to make any commercial sales of its products and has never successfully marketed a product. Furthermore, its officers have limited experience in the operation and development of a business like the Company's. The Company anticipates net losses will continue for the foreseeable future. There can be no assurance that the Company will be able to generate significant revenues or operate successfully. The report of the Company's independent certified public accountants on the Company's financial statements contains an explanatory paragraph concerning the Company's ability to continue as a going concern. See "Management's Discussion and Analysis of Financial Condition and Results of Operations," and "Financial Statements."

RIGHTS TO CERTAIN TECHNOLOGY NOT OWNED BY COMPANY. The FIDS Technology used in the Company's principal product offerings is owned by Jasper and licensed by the Company. The Company's Biometric Solution and Optic Technology are owned by it, subject to an exclusive worldwide license which has been granted to Jasper Consulting, Inc. ("Jasper") to use and sell products in certain markets. Therefore, the Company does not exclusively own all of the technology incorporated into its products, including SACMan. In addition, pursuant to its agreement with Jasper, the Company only has rights to use and sell the FIDS Technology in industrial, commercial, and consumer "access control" applications including, without limitation, access to buildings, apartments, offices, and other facilities, appliances, information, resources, computers, and computer networks. In all other markets, sale and use of the FIDS Technology belongs to Jasper. The success of the Company, therefore, will depend on its ability to exploit each of these technologies in its limited market areas. Furthermore, if the Company fails to perform its obligations under the license agreement with Jasper, it could lose a critical portion of the technology necessary for the manufacture of its products. While the Company believes it may be able to utilize other currently available software to classify and match a fingerprint, or may be able to develop such software with its own internal resources, there can be no assurance that such other software will be available to the Company on favorable terms, if at all, that the Company will have the technical ability to develop its own software, or that such software will ultimately serve as an adequate substitute for the FIDS technology in the Company's products. See "Business--Technology License."

LIMITED INTELLECTUAL PROPERTY PROTECTION. The Company has applied for a patent directed to the Optic Technology and Biometric Solution; however, none of the mentioned technologies are patented by the Company. There can be no assurances given that any patents will ever issue, or that, if issued, the Company would have the resources to protect any such issued patent. The Company believes that its technology described does not infringe upon patents held by others, but the Company cannot give any assurances that such infringements do not exist. See "Business--Technology Rights."

While the Company believes it will not be necessary to acquire additional technologies in order to market its current planned products, there is no assurance that the person or organization owning any additionally required technologies will grant licenses to the Company at all, or, if licenses are available, that the terms and conditions of such licenses will be acceptable to the Company.

LIMITED SALES AND MARKETING EXPERIENCE; NO MARKET ACCEPTANCE. The Company has recently begun marketing its SACMan(tm) product and has yet to make any commercial sales of SACMan or other products. The Company's employees have limited experience in marketing such a product and no distribution system has been developed. While the Company has plans for developing a significant marketing and sales effort, along with accessing various distribution channels, there can be no assurance that such efforts will be successful or that the Company will be able to attract and retain qualified individuals with marketing and sales expertise. The Company's future success will depend, among other factors, upon whether the Company's products can be sold at a profitable price and the extent to which consumers acquire, adopt, and continue to use them. There can be no assurance that the Company's products will gain wide acceptance in its targeted markets or that the Company will be able to effectively market its products. See "Business--Marketing and Sales."

LIMITED MANUFACTURING EXPERIENCE. To date, the Company's SACMan and SAC_App products have only been manufactured in limited quantities and have not been manufactured on a commercial scale. As a result, there can be no assurance that the Company will not encounter difficulties in obtaining reliable and affordable contract manufacturing assistance and/or in scaling up its manufacturing capabilities, including problems involving production yields, per-unit manufacturing costs, quality control, component supply, and shortages of qualified manufacturing personnel. Any such difficulties could also result in the inability of the Company to satisfy any customer demand for its products in a cost-effective manner and would likely have a material adverse effect on the Company.

PRODUCTS ARE CURRENTLY UNDER DEVELOPMENT; NO COMMERCIAL SALES OR USES TO DATE. The Company has only recently begun to focus on marketing and selling its SACMan and SAC_App products. In addition, the Company has not yet completed final development of its other products. Therefore, no commercial sales or uses of the Company's products have been made. Given this absence of sales and need for additional development on many of its products, there can be no assurance that the Company will be able to complete the development of and/or successfully introduce its products to the Company's markets. See "Business--Products" "--Market," and "--Marketing and Sales."

POTENTIAL INABILITY TO ADAPT TO CHANGES IN TECHNOLOGY. The access control market is subject to rapid technological change and intense competition. There can be no assurance that the Company will be able to keep pace with this change. The Company's products could become subject to technological obsolescence and there can be no assurance that the Company will be able to adapt to rapidly changing technology. If the Company is unable for technological or other reasons to develop products on a timely basis in response to technological changes, or if the Company's products or product enhancements do not achieve market acceptance, the Company's business would be materially and adversely affected.

LIMITED SOURCES OF SUPPLY. The Company has only limited agreements with vendors to supply components and subassemblies on a continuing basis. Should production requirements increase, the need for additional components and subassemblies will increase. In the future, the Company will attempt to (i) consummate formal supply agreement relationships, although there can be no assurance that it will be able to do so, and (ii) obtain multiple sources of supply for most of its components, although it may be necessary to have limited sources of supply for certain components. Should a key supplier be unwilling or unable to supply any such components or subassemblies in a timely manner, the Company would be materially adversely affected. See "Business--Marketing and Sales."

DISCRETIONARY USE OF PROCEEDS. The manner in which the proceeds of this offering will be used is based upon the current state of the Company's business operations, its current plans, and current economic and industry conditions. These estimates are subject to change based upon material factors such as unanticipated levels and types of competition, adverse market trends, and new business opportunities. A significant portion of the net proceeds of this offering have not been designated for any specific use other than as working capital. Such proceeds may be utilized for one or more purposes at the Company's discretion. There can be no assurance that the Company will ultimately use the proceeds as described or will adequately find the most efficient use of the proceeds raised hereby. See "Use of Proceeds."

NEED FOR ADDITIONAL FUNDS. The Company expects that, subsequent to this offering, it may need to raise substantial additional capital to fund the ongoing development and expansion of its business, including its research, development, marketing and sales efforts, and to attain profitability. There is no assurance that any additional funds needed will be available to the Company on favorable terms, or at all. Although based on assumptions that the Company considers reasonable, there is also no assurance that the Company's estimate of its anticipated liquidity needs is accurate or that new business developments or other unforeseen events will not occur, resulting in the need to raise additional funds. In addition, it is probable that raising additional funds will result in a substantial additional dilution and reduction in returns, if any, to investors. See "Dilution, "Use of Proceeds," and "Management's Discussion and Analysis of Financial Condition and Results of Operations."

SIGNIFICANT COMPETITION. The Company is engaged in a rapidly evolving field. Competition from other companies is intense and expected to increase. Many of the Company's competitors have substantially greater resources, research and development staffs, sales and marketing staffs, and facilities than does the Company. In addition, other recently developed technologies are, or may in the future be, the basis of competitive products. There can be no assurance that the Company's competitors will not develop technologies and products that are more effective than those being developed by the Company or that would render the Company's technology and products obsolete or noncompetitive. See "Business--Competition."

POTENTIAL PRODUCT LIABILITY CLAIMS. The Company faces an inherent business risk of exposure to product liability claims in the event that the use of its products are alleged to have resulted in injuries or losses related to their manufacture and use. Although the Company hopes to employ provisions limiting liability in contractual relationships with customers, there can be no assurance that the Company will be able to effectively avoid significant liability exposure. The Company does not currently maintain any product liability insurance. The Company may attempt to obtain insurance to minimize the impact of any potential product liability; however, there can be no assurance that the Company will be able to obtain such insurance on acceptable terms, or at all. Consequently, a product liability claim or recall or other claims with respect to any uninsured liabilities could have a material adverse effect on the business or financial condition of the Company.

IMMEDIATE AND SUBSTANTIAL DILUTION TO PURCHASERS. Purchasers of the Shares offered hereby will experience immediate and substantial dilution of $4.39 per share in the net tangible book value of the Shares based on the anticipated Price to Public. See "Dilution."

DILUTION FROM OUTSTANDING WARRANTS AND OPTIONS. The Company currently has outstanding warrants and options to purchase 264,639 shares of the Common Stock (excluding the Underwriter's Warrants issued in connection with this offering), all of which are exercisable at prices significantly below the Price to Public of the Shares in this offering. Exercise in the future of such warrants and options may result in additional dilution to purchasers in this offering. See "Dilution" and "Description of Securities."

ABSENCE OF DIVIDENDS. The Company has never declared or paid a cash dividend on its common stock. The Company intends to retain any earnings for use in the operation and expansion of its business and, therefore, does not anticipate paying any cash dividends in the foreseeable future, including on the Shares offered hereby. See "Dividend Policy."

DEPENDENCE ON KEY PERSONNEL. The Company's operations are materially dependent upon the services of Mr. Barry M. Wendt, the Chief Executive Officer of the Company and the co-inventor of SACMan(tm) and its underlying components, Mr. Richard T. Fiskum, the President of the Company and the co-inventor of the Optic Technology, Mr. Gary E. Wendt, the Chief Financial Officer of the Company, and Mr. Benedict A. Wittig, Director of Systems Software and co-inventor of SACMan(tm) and the Biometric Solution. The loss of the services of any of these individuals would materially and adversely affect the Company's business. The Company has agreements with these individuals prohibiting competition with the Company for a period of three years if the Company terminates an individual's employment for "cause" (as defined in the agreements), and a period of two years if an individual voluntarily terminates employment. There can be no assurance that the Company will retain the four individuals in its employ, or that it will successfully attract and retain additional or replacement personnel with the requisite experience and capabilities to enable the Company to profitably and effectively evaluate, develop, and market the Company's product line. The Company does not currently maintain any key man insurance on any of its officers. See "Management."

POTENTIAL INABILITY TO MANAGE GROWTH EFFECTIVELY. The Company hopes to significantly expand its business, in part with the proceeds of this offering. Such anticipated expansion will likely place further demands on the Company's existing management and operations. The Company's future growth and profitability will depend, in part, on its ability to successfully manage a growing sales force and implement management and operating systems which react efficiently and timely to short and long-term trends or changes in its business. There can be no assurance that the Company will be able to effectively manage any expansion of its business. See "Use of Proceeds" and "Management."

CONTROL BY EXISTING MANAGEMENT. The Company's directors and officers will own, after this offering, approximately 57% of the Company's outstanding capital stock and will be able to control the Company's business and affairs, including electing directors, appointing officers and determining officers' compensation. See "Management;" "Principal Shareholders;" and "Description of Securities."

LIMITATIONS OF LIABILITY. The Company's Articles of Incorporation provide, as permitted by Minnesota law, that a director of the Company shall not be personally liable to its shareholders for monetary damages for breach of his or her fiduciary duty of care as a director, with certain exceptions. In addition, the Company's bylaws provide for mandatory indemnification of directors and officers to the fullest extent permitted by Minnesota law. See "Description of Securities--Indemnification."

MINNESOTA ANTI-TAKEOVER LAW. Certain provisions of the Minnesota Business Corporation Act restrict the voting rights of a shareholder who acquired the Company's shares in a "control share acquisition," and limit the Company's ability to engage in a "business combination" with an "interested shareholder." The effect of these provisions could be to impede or deter a bidder for the Company's shares. See "Description of Securities--Minnesota Anti-Takeover Law."

ARBITRARY DETERMINATION OF OFFERING PRICE; NO PRIOR PUBLIC MARKET FOR SHARES; POSSIBLE VOLATILITY OF STOCK PRICE. The Price to Public of the Shares in this offering has been arbitrarily determined by negotiation between the Company and the Underwriter. Such offering price should not be considered an indication of the actual value of the Company, as it bears no relationship to the Company's assets, book value, earnings, net worth or other financial statement criteria of value. There is presently no market, private or public, for the Company's securities and there can be no assurance that a trading market will ever develop, or if developed, that it will be maintained. There can be no assurance that purchasers will be able to resell Shares at the offering price or at any price. Following this offering, the market price for the Common Stock may be highly volatile, and may therefore decrease significantly, depending on a number of factors including operating results and competitive forces, as well as market acceptance in the Company's market areas. The stock market generally has experienced extreme price and volume fluctuations that have particularly affected the market price of many companies for reasons unrelated to the operating performance of or announcements by the companies, and these broad market fluctuations and other general market conditions may adversely affect the market price of the Company's Common Stock, including the Shares offered hereby. See "Underwriting."

POSSIBLE INABILITY TO MAINTAIN QUOTATION BY NASDAQ; POTENTIAL APPLICABILITY OF "PENNY STOCK RULES;" POSSIBLE IMPACT ON LIQUIDITY OF STOCK. The Common Stock has been approved for quotation on the National Association of Securities Dealers Automated Quotation System ("Nasdaq") SmallCap Market. There can be no assurance that such approval will be maintained. To maintain its listing after its initial inclusion on Nasdaq, the Company must, in addition to other requirements, have total assets of at least $2 million, capital and surplus of at least $1 million, a minimum bid price of at least $1.00 and a market value for its publicly held shares of at least $200,000. If the Company fails to satisfy the Nasdaq requirements to maintain listing on Nasdaq in the future, the Common Stock will likely be quoted only in the local over-the-counter "pink sheets" and may also be reported on the Nasdaq OTC Bulletin Board. In the event of delisting of the Common Stock, the public trading market for the Common Stock could be adversely affected. If the Common Stock is subsequently delisted for failure to meet the Nasdaq maintenance requirements, the Common Stock would be subject to the rules promulgated under the Securities Exchange Act of 1934 relating to "penny stocks." These rules require brokers who sell securities subject to such rules to persons other than established customers and "institutional accredited investors" to complete certain documentation, make suitability inquiries of investors and provide investors with certain information concerning the risks of trading in the security. These rules may restrict the ability of brokers to sell the Common Stock and may affect the ability of purchasers in this offering to sell their Shares in the secondary market.

EFFECT ON MARKET PRICE OF SHARES ELIGIBLE FOR FUTURE SALE. Sales of significant amounts of Common Stock in the public market or the perception that such sales will occur could adversely affect the market price of the Common Stock or the future ability of the Company to raise capital through an offering of its equity securities. Of the 3,608,750 shares of Common Stock to be outstanding upon completion of this offering, only the 1,100,000 shares offered hereby will be eligible for immediate sale in the public market without restriction with the exception of shares held by "affiliates" of the Company within the meaning of Rule 144 under the Securities Act. The remaining 2,508,750 shares of Common Stock held by existing stockholders upon completion of this offering will be "restricted securities" as that term is defined in Rule 144 under the Securities Act. Of these shares, 2,058,750 are currently held by affiliates, 1,440,000 of which would be eligible for resale in the open market pursuant to Rules 144 and 701 under the Securities Act beginning 90 days after the date of this Prospectus. An additional 618,750 shares will become eligible for resale under Rule 144 on or prior to December 31, 1997 and an additional 450,000 shares will become eligible for resale under Rule 144 between January 1, 1998 and December 31, 1999. The 50,000 shares of Common Stock underlying warrants issued in conjunction with bridge financing will be eligible for sale under Rule 144 two years after exercise of the warrants. The 41,639 shares of Common Stock issued to the Underwriter in connection with a private placement and bridge financing arrangement will be eligible for sale under Rule 144 the earlier of: (i) two years after the exercise of the warrants, or (ii) two years after issuance of such warrant, if a cashless exercise is effected by the Underwriter pursuant to the terms of such warrant. The Company and certain of its stockholders (representing 2,058,750 of such restricted shares) have agreed that they will not sell, directly or indirectly, any Common Stock, without the prior written consent of the Underwriter, for a period of one year from the date of this Prospectus. In addition, certain stockholders and warrant holders have the right, subject to certain conditions, to participate in future Company registrations and to cause the Company to register certain shares of Common Stock owned by them upon exercise of currently outstanding options and warrants. See "Shares Eligible for Future Sale."

LIMITED EXPERIENCE OF THE UNDERWRITER. The Underwriter commenced business in May 1994, and has completed only one public offering to date. The Underwriter's relative inexperience in conducting public offerings could have an adverse effect on the "due diligence" investigation of the Company which the Underwriter has conducted, although the Underwriter believes that such investigation has been thorough on its part. Moreover, although the Underwriter believes it has exercised care in establishing the Price to Public of the Shares offered hereby, the Underwriter's inexperience in establishing the price of the Shares in this offering, and possibly in acting as a market-maker after the effective date of this offering, could have an adverse effect on the market value of the Shares offered hereby following the completion of this offering. See "Underwriting."

USE OF PROCEEDS

The net proceeds to the Company from the sale of the Shares offered hereby are estimated to be $5,507,000 after deduction of the Underwriting discount, the Underwriter's nonaccountable expense allowance and estimated expenses of this offering payable by the Company. This would increase to approximately $6,081,200 if the Underwriter's over-allotment option is exercised in full. There is no assurance that such over-allotment option will be exercised. The Company intends to use the net proceeds from this offering, assuming no exercise of the Underwriter's over-allotment option, in the following approximate amounts:

                                       APPROXIMATE      PERCENTAGE OF
                                        AMOUNT OF        APPROXIMATE
                                       NET PROCEEDS     NET PROCEEDS
                                       ------------     ------------

Selling, General and
 Administrative .....................   $2,500,000            44%
Research and Product Development ....    1,300,000            23
Repayment of Notes Payable ..........      367,000             6
Capital Expenditures ................      200,000             4
Working Capital .....................    1,305,000            23
                                        ----------           ---
  Total .............................   $5,672,000           100%
                                        ==========           ===

SELLING, GENERAL AND ADMINISTRATIVE. The Company plans to expand its customer support staff to meet the demands of an increasing number of customers actively developing markets based on the Company's products. In addition, the Company plans to increase its press relations and trade show activities as it broadens its market focus, and also plans to engage a controller.

RESEARCH AND PRODUCT DEVELOPMENT. Due to increased requirements for product enhancements options and development of new products, the Company plans to hire four to seven software developers, technical writers, and similar personnel.

REPAYMENT OF NOTES PAYABLE. The Company intends to use a portion of the proceeds to repay amounts expected to be outstanding under its line of credit agreement with a bank of $250,000. The line of credit agreement bears interest at 1% above the prime rate of interest and expires January 1998.

The Company also intends to use a portion of the proceeds to repay a $117,000 noninterest bearing note to Richard T. Fiskum, the President, Chief Operating Officer, and a Director of the Company. This note payable originated in connection with an August 1995 purchase of optics technology from Mr. Fiskum and is collateralized by a $117,000 account receivable from Jasper. See "Certain Transactions."

CAPITAL EXPENDITURES. The Company intends to use approximately $200,000 of the proceeds to purchase "pick and place" semi-automated assembly line components to meet additional prototype/pre-production test requirements in 1997 and 1998, as well as other general capital expenditures.

WORKING CAPITAL. The remaining net proceeds will be used for general working capital purposes, including the purchase of inventory, contract manufacturing, financing of accounts receivable and the payment of salaries and increased overhead expenses related to the anticipated expansion of the Company's operations.

The foregoing represents the Company's best estimate of its allocation of the net proceeds of this offering, based upon the current state of its business operations, its current plans and current economic and industry conditions. These estimates are subject to change based upon material factors such as unanticipated levels and types of competition, adverse market trends and new business opportunities. Any material revisions in the allocation of proceeds will be made at the discretion of the Board of Directors. The Company believes the net proceeds from this offering will be sufficient to meet the Company's capital needs through approximately mid-1998. Pending the use of the proceeds of this offering, the Company intends to invest the proceeds in short-term, high quality, interest-bearing instruments. If the Underwriter exercises the over-allotment option in full, the Company will realize additional net proceeds of $590,700. Such additional net proceeds will be added to the Company's working capital.

DILUTION

The net tangible book value of the Company as of September 30, 1996 was $118,176 or approximately $0.05 per share. "Net tangible book value" represents the amount of tangible assets less all liabilities. After giving effect to the sale of 1,100,000 shares of Common Stock included in this offering (assuming an offering price of $6.00 per share) and the application of the estimated net proceeds therefrom, the net tangible book value of the Company as of September 30, 1996 would have been $5,804,404, or $1.61 per share. This represents an immediate increase in net tangible book value of $1.56 per share to existing stockholders and an immediate dilution in net tangible book value of $1.61 per share to new investors of Common Stock in this offering, as illustrated by the following table:

Initial public offering price per share(1)                               $6.00
  Net tangible book value per share at September 30, 1996       $0.05
  Increase per share attributable to new investors               1.56
                                                                -----

  Pro forma net tangible book value after offering                        1.61
                                                                         -----
  Dilution to new investors                                              $4.39
                                                                         =====


(1) Before deducting estimated underwriting discounts and commissions and offering expenses payable by the Company.

The following table sets forth the number of shares of Common Stock purchased from the Company through September 30, 1996, the total consideration paid and the average price per share paid by the existing stockholders and to be paid by the purchasers of shares in this offering:

                                                             TOTAL CASH
                              SHARES PURCHASED(1)        CONSIDERATION PAID        AVERAGE
                              --------------------       --------------------       PRICE
                              NUMBER       PERCENT       AMOUNT       PERCENT     PER SHARE
                              ------       -------       ------       -------     ---------
Existing Stockholders ....   2,508,750       69.5%     $1,176,844       15.1%       $0.47
New Investors ............   1,100,000       30.5       6,600,000       84.9        $6.00
  Total ..................   3,608,750      100.0%     $7,776,844      100.0%


(1) Does not include (a) 50,000 shares of Common Stock which may be issued upon exercise of warrants issued to the investors in connection with bridge financing arrangements at an exercise price of $2.00 per share; (b) 41,639 shares of Common Stock which may be issued upon exercise of warrants issued to the Underwriter in connection with a private placement and bridge financing arrangements at an adjusted exercise price of $6.00 per share;
(c) 375,000 shares of Common Stock reserved for issuance under the Company's 1996 Stock Option Plan, 173,000 shares of which are currently issued at a weighted average exercise price of $2.23 per share and none of which are exercisable within 60 days from the date hereof; and (d) up to 44,496 shares of Common Stock issuable upon exercise of warrants which may be issued to the Underwriter in connection with the sale of the Shares included in this offering.

DIVIDEND POLICY

For the foreseeable future, the Company does not intend to pay any cash dividends. The Company presently expects to retain its earnings, if any, to finance the development and expansion of its business. The payment by the Company of cash dividends, if any, on its common stock in the future is subject to the discretion of the Board.

CAPITALIZATION

The following table sets forth the actual shareholders' equity (deficit) at September 30, 1996 and pro forma capitalization of the Company at September 30, 1996, as adjusted to reflect the net proceeds from the sale of the Shares assuming a $6.00 per Share price. See "Use of Proceeds," "Management's Discussion and Analysis of Financial Condition and Results of Operations."

                                                                      SEPTEMBER 30, 1996
                                                                  ---------------------------
                                                                   ACTUAL        PRO FORMA(1)
                                                                  ----------     ------------
                                                                  (UNAUDITED)
Stockholders' equity (deficit):
  Common stock, $.01 par value: 20,000,000 shares
   authorized; 2,508,750 shares issued and outstanding
   (actual); and 3,608,750 shares issued and outstanding
   (pro forma); ................................................  $  25,088       $   36,088
  Additional contributed capital ...............................    775,005        6,436,005
  Deficit accumulated during the development stage .............   (663,175)        (663,175)
                                                                  ---------       ----------
     Total Stockholder's Equity and Capitalization .............  $ 136,918       $5,808,918
                                                                  =========       ==========

(1) Does not include (a) 50,000 shares of Common Stock which may be issued upon exercise of warrants issued to the investors in connection with bridge financing arrangements at an exercise price of $2.00 per share; (b) 41,639 shares of Common Stock which may be issued upon exercise of warrants issued to the Underwriter in connection with a private placement and bridge financing arrangements at an adjusted exercise price of $6.00 per share;
(c) 375,000 shares of Common Stock reserved for issuance under the Company's 1996 Stock Option Plan, 173,000 shares of which are currently issued at a weighted average exercise price of $2.23 per share and none of which are exercisable within 60 days from the date hereof; and (d) up to 44,496 shares of Common Stock issuable upon exercise of warrants which may be issued to the Underwriter in connection with the sale of the Shares included in this offering.

SELECTED FINANCIAL DATA

The following selected financial data of the Company have been derived from its financial statements. The financial statements at December 31, 1994 and 1995 have been audited by Divine, Scherzer & Brody, Ltd. The data set forth below should be read in conjunction with the financial statements and notes thereto and "Management's Discussion and Analysis of Financial Condition and Results of Operations" included elsewhere in this Prospectus.

                                                                      JANUARY 7,                                     JANUARY 7,
                                                                      1993 (DATE                                     1993 (DATE
                                                                     OF INCEPTION)        NINE MONTHS ENDED         OF INCEPTION)
                                          YEARS ENDED DECEMBER 31       THROUGH             SEPTEMBER 30,              THROUGH
                                          -----------------------     DECEMBER 31,    -------------------------     SEPTEMBER 30,
                                            1994          1995            1995           1995           1996            1996
                                          --------      ---------    -------------    ----------     ----------     -------------
                                                                                      (UNAUDITED)    (UNAUDITED)     (UNAUDITED)
SELECTED STATEMENT OF OPERATIONS DATA
  Revenues ............................   $107,000      $229,070       $ 353,057       $ 153,374      $      --       $ 353,057
  Costs and other expenses.............
    Costs of Other Services ...........     33,154        28,799          61,953          28,799             --          61,953
    Selling, General and
     Administrative ...................     12,932        35,849          73,806          18,787        164,437         238,243
    Research and development ..........     72,199       250,808         345,565         228,583        326,051         671,616
                                          --------      --------       ---------       ---------      ---------       ---------
                                           118,285       315,456         481,324         276,169        490,488         971,812
                                          --------      --------       ---------       ---------      ---------       ---------
  Loss from Operations ................    (11,285)      (86,386)       (128,267)       (122,795)      (490,488)       (618,755)
  Interest Expense, Net ...............         --            --              --              --        (26,911)        (26,911)
                                          --------      --------       ---------       ---------      ---------       ---------
  Net Loss ............................   $(11,285)     $(86,386)      $(128,267)      $(122,795)     $(517,399)      $(645,666)
                                          ========      ========       =========       =========      =========       =========
  Loss Per Share ......................   $     --      $   (.03)      $    (.05)      $    (.05)     $    (.20)      $    (.24)
                                          ========      ========       =========       =========      =========       =========

DECEMBER 31,
------------------ SEPTEMBER 30,

                                    1994          1995            1996
                                    ----          ----        -------------
                                                               (UNAUDITED)
SELECTED BALANCE SHEET DATA
  Working capital (deficit) ....  $(5,628)     $(133,836)       $ 90,369
  Total assets .................    6,598         24,139         325,577
  Stockholders' equity
   (deficit) ...................   (5,628)      (125,188)        136,918

MANAGEMENT'S DISCUSSION AND ANALYSIS
OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

THE FOLLOWING DISCUSSION CONTAINS FORWARD LOOKING STATEMENTS. FUTURE OPERATING RESULTS ARE SUBJECT TO FLUCTUATIONS NOT WITHIN THE CONTROL OF THE COMPANY. THE FOLLOWING DISCUSSION AND ANALYSIS SHOULD BE READ IN CONJUNCTION WITH, AND IS QUALIFIED IN ITS ENTIRETY BY, THE COMPANY'S FINANCIAL STATEMENTS AND NOTES THERETO INCLUDED ELSEWHERE IN THE PROSPECTUS, THE RISK FACTORS SECTION OF THIS PROSPECTUS, AND THE OTHER INFORMATION CONTAINED IN THE PROSPECTUS.

OVERVIEW

The Company was incorporated in 1993 to develop real-time, stand-alone systems capable of identifying individuals through automated fingerprint analysis for use in controlling access to resources, information and facilities. From inception through most of 1996 the Company's development efforts, which by agreement were to be funded by Jasper Consulting, Inc. ("Jasper"), were principally focused on the development of its fingerprint identification and analysis products. In the second half of 1996, the Company shifted its principal focus from development to marketing and sales of its products. However, there have been no commercial product sales to date and the Company's revenues to date have been derived exclusively through its development arrangement with Jasper or from other services provided to Jasper.

The Company's more significant current product offerings incorporate FIDS Technology, a technology developed by the Company for Jasper, with other technologies developed by the Company. The Company has a world-wide license agreement with Jasper for use of the FIDS Technology in all access control markets. Jasper has the right to exploit FIDS technology in all other markets including specifically financial services, law enforcement, national identification systems, and personal identification systems for government and medical applications. If the Company fails to perform its obligations under the license agreement with Jasper, it could lose a critical portion of the technology necessary for the manufacture of its products. While the Company believes it may be able to utilize other currently available software to classify and match the fingerprint or may be required to develop such software with its own internal resources, there can be no assurance that such other software will be available to the Company on favorable terms, if at all, that the Company will have the technical ability to develop its own software, or that such software will ultimately serve as an adequate substitute for the Company's products. See "Business--Company History" and "--Technology License."

The Company also has completed development of a Set Top Box, which provides for basic personal computer functions and Internet access via a wireless keyboard and a conventional television set. However, the Company does not believe that the promotion and marketing of the Set Top Box is within its focus and, accordingly, conveyed the technology in exchange for a 50% ownership interest in the initial equity of Inter-Con/PC, Inc. ("Inter-Con") a development stage Company. See "Business--Set Top Box Technology."

The Company's focus in the near term is to market its products primarily in the following application areas: controlled access to appliances, information, resources, computers, computer networks, as well as apartments, offices and other facilities. The Company anticipates adding approximately 14 employees through 1998. The Company anticipates ongoing research and development expenses during 1997 at a level greater than that experienced for the nine months ended September 30, 1996. The Company anticipates selling, general and administrative expenses will increase significantly in connection with its transition to marketing and selling its products.

The Company is considered a development stage enterprise for accounting purposes. Results achieved to date are not indicative of future results primarily because the Company has shifted its focus from the development of its products to the marketing and selling of its products. The Company may continue to sustain operating losses for the foreseeable future. Management believes existing cash reserves and availability under its line of credit agreement with a bank will not be adequate to last beyond early 1997. The Company believes that if the Shares offered hereby are sold at the $6.00 offering price, the proceeds from this offering will be sufficient to fund operations through approximately mid-1998. See "Use of Proceeds" for discussion of anticipated use of proceeds related to this offering. There can be no assurance this offering will be successful.

By agreement, Jasper is obligated to pay a royalty to the Company for sales of certain products and the Company has the exclusive right to manufacture products sold by Jasper, subject to a predetermined pricing structure. However, the Company is not relying on these potential sources of revenue or its interest in Inter-Con previously described to significantly impact its results of operations.

DEVELOPMENT STAGE RESULTS OF OPERATIONS

Revenues of $353,057 from inception (January 7, 1993) through September 30, 1996 were from reimbursement of development costs and other services provided to Jasper. Jasper agreed to fund development of SACMan(tm) and related products through April 1996. As more fully discussed in the Company's notes to financial statements for the years ended December 31, 1994 and 1995, the Company has recognized revenue from Jasper on the cash method, as collectibility of amounts billed is not assured.

As of September 30, 1996, there were $407,000 of billings outstanding from Jasper which have not yet been recognized for financial reporting purposes. Jasper has agreed to allow the Company to offset future product royalties due to Jasper, if any, against these unrecognized receivables. In addition, the Company may also charge an additional $800 for each product manufactured by the Company for Jasper in order to accelerate payment of the outstanding balance. The Company has sold no products which would require payment of royalties to Jasper. The Company has no orders to manufacture products on behalf of Jasper. No assurance can be given that future sales subject to payment of royalty to Jasper or orders to manufacture products on behalf of Jasper will occur in amounts sufficient to offset the uncollected billings above, if at all.

NINE MONTHS ENDED SEPTEMBER 30, 1995 COMPARED TO NINE MONTHS ENDED SEPTEMBER 30,
1996:

Revenues were $153,374 during the nine months ended September 30, 1995 as compared to no revenues recognized during the same period in 1996. The decline is attributable to the timing of collection of fees received under its development arrangement with Jasper. There were $117,000 and $290,000 of billings to Jasper during the nine months ended September 30, 1995 and 1996, respectively, which remain outstanding and which have not yet been recognized for financial reporting purposes as of such dates.

Selling, general and administrative expense increased $145,650 to $164,437 during the nine months ended September 30, 1996, as compared to $18,787 for the same period in 1995. The increase is principally due to additional salaries and wages for marketing and administrative personnel, the development of certain promotional materials, and increased attendance at trade shows.

Research and development expense increased $97,468 to $326,051 during the nine months ended September 30, 1996 as compared to $228,583 for 1995. The increase is attributable to increased development activity to commercialize certain of its products.

No interest expense was incurred for the nine months ended September 30, 1995 and interest expense was $30,591 during the same period in 1996. The increase was attributable to borrowings under the Company's line of credit agreement with a bank and borrowings under convertible bridge notes issued during 1996, which were subsequently converted to common stock.

YEAR ENDED DECEMBER 31, 1994 AS COMPARED TO YEAR ENDED DECEMBER 31, 1995:

Revenues increased $122,070 to $229,070 during 1995 as compared to $107,000 for 1994. The increase is attributable to fees collected from increased development activity of the Company's products under its development arrangement with Jasper. There were $15,421 and $117,000 of billings to Jasper during 1994 and 1995, respectively, which remain outstanding and which have not yet been recognized for financial statement purposes as of such dates.

Research and development expense increased $178,609 to $250,808 during 1995 as compared to $72,199 for 1994. The increase is attributable to increased development activity to commercialize certain of its products.

LIQUIDITY AND CAPITAL RESOURCES

Total cash used in operating activities from inception (January 7, 1993) through September 30, 1996 was $718,566 and is principally due to operating losses. Working capital increased $224,205 during the nine months ended September 30, 1996 to $90,369, as compared to a deficit of $133,836 as of December 31, 1995. This increase is primarily attributable to cash received from sales of common stock discussed below, offset by operating losses during the nine months ended September 30, 1996.

The Company's capital requirements have been principally met through the issuance of 2,508,750 shares (after effect of a nine-for-two stock split during April 1996) of common stock for gross proceeds of $1,201,844 (includes issuance of $200,000 of convertible bridge notes during 1996 subsequently converted into common stock), net of a buyout of all of Jasper's common stock during August and December 1995 for total cash consideration of $138,000 plus non-cash consideration of $170,174.

The Company has a $250,000 revolving credit agreement with a bank. Interest is at 1% above the prime rate of interest. The agreement is collateralized by substantially all assets of the Company and guaranteed by three stockholders. The agreement expires in January, 1998.

In connection with the Company's contribution of the "Set Top Box" technology to Inter-Con in November 1996, the Company agreed to complete development of certain "Set Top Box" related products at an estimated future cost to the Company of approximately $30,000. The Company has also entered into a technical support agreement with Inter-Con for which the Company will provide technical support to Inter-Con for a fee of up to $20,000 per month. See "Business--Set Top Box Technology."

During July 1996 the Company issued stock options to employees and consultants to purchase an aggregate of 173,000 shares of common stock at weighted average exercise prices of $2.23 per share. Also, during July and August 1996, in connection with a private offering of common stock and issuance of convertible bridge notes (which were subsequently converted to common stock), warrants to purchase 91,639 shares of common stock at adjusted weighted average exercise prices of $3.82 per share were issued.

RECENTLY ISSUED ACCOUNTING STANDARD

The Company accounts for stock options and other equity instruments in accordance with APB Opinion No. 25, "Accounting for Stock Issued to Employees." Effective in fiscal 1996, the Company will account for stock options in accordance with Statement of Financial Accounting Standards ("SFAS") No. 123, "Accounting for Stock Based Compensation." SFAS No. 123 establishes accounting standards for organizations that have stock based employee compensation plans. Generally, the statement defines a fair value based method of accounting for these plans which requires the measurement of compensation costs at the grant date and recognition of such costs over the service period, which is usually the vesting period. The Company will continue to value its options under APB Opinion No. 25 and will comply with the disclosure requirements of SFAS No. 123.

BUSINESS

GENERAL

Incorporated in 1993, SAC Technologies, Inc. (the "Company") develops and distributes fingerprint identification products for use in general commercial and consumer market applications. It has been generally recognized since the late nineteenth century that fingerprint patterns are unique to each individual. However, manual fingerprint analysis is time-consuming, tedious, and potentially unreliable. The Company's goal has been to develop automated fingerprint identification products which are portable, easily integrated with existing applications, and affordable for mass commercialization.

The Company's underlying technology consists of (i) optic technology which captures the image of a fingerprint ("Optic Technology"); (ii) hardware and software which translates and standardizes the image of the fingerprint for computer analysis ("Biometric Solution"); (iii) a license to certain software which classifies the fingerprint and matches it to an existing database ("FIDS Technology"); and (iv) SAC_App, an application generator development package which facilitates integration of the Company's products for vertical market applications. Utilizing these technologies, the Company has continued the development of its initial automated fingerprint identification products. Its initial product, SACMan(tm), is principally targeted to control access to information resources such that only individuals comprising an approved fingerprint database are allowed access to computers, computer networks, and/or specific applications. SACMan(tm) is the fifth generation of product based on the Company's technologies, each generation of which has undergone both internal and external testing. The Company's SAC_Remote product, currently scheduled for release in early 1997, is designed principally for use in restricting door entry access to a specific set of individuals.

The Company's more significant anticipated product offerings incorporate FIDS Technology, a technology developed by the Company for Jasper Consulting, Inc. ("Jasper"), with other technologies developed by the Company. The Company has a world-wide license agreement with Jasper for use of the FIDS Technology in all access control markets. Jasper has the right to exploit FIDS technology in all other markets including specifically financial services, law enforcement, national identification systems, and personal identification systems for government and medical applications, which market rights belong to Jasper. The Company believes it has, to date, performed all of its material obligations under its license agreement with Jasper. These obligations include product research and development, payment and reporting of royalties, and payment of specified amounts upon a transfer of the technology, as well as certain indemnification and confidentiality obligations. Were the Company to fail to perform these obligations, it could lose a critical portion of the technology necessary for the manufacture of its products. While the Company believes it may be able to utilize other currently available software to classify and match a fingerprint or may be able to develop such software with its own internal resources, there can be no assurance that such other software will be available to the Company on favorable terms, if at all, that the Company will have the technical ability to develop such software on its own, or that such software will ultimately serve as an adequate substitute for the FIDS technology in the Company's products. See "Business--Technology License."

The Company has not yet developed any mass commercial manufacturing and assembly capacity; however, the Company has acquired a semi-automated assembly line to meet anticipated initial product demand. The Company currently intends to qualify and use outside manufacturing contractors to satisfy production requirements as they exceed its internal capacities.

As indicated above, the Company's technology also has potential application in both the law enforcement and financial credit transaction markets, which belong to Jasper by agreement, subject to the payment of a royalty to the Company. Law enforcement application users could use the Company's products to compare a live scan or latent fingerprint to an on-line database of fingerprints. In financial credit transaction applications, a live scan would be compared to either an on-line database or to a fingerprint stored on a card (magnetic stripe or smart card) for real-time verification of the consumer and concurrent approval or disapproval of the transaction.

COMPANY HISTORY

In 1992 Jasper engaged North Country Business Products, an office supply company located in Bemidji, Minnesota, in discussions about the possibility of developing an automated fingerprint identification device. North Country Business Products began a search for someone who could engineer and develop such a product. Barry M. Wendt, the Company's CEO, was contacted and determined that the automation of such a process was within his abilities. Consequently, in 1993, a new company, BBG Engineering, Inc. ("BBG") was formed by Jasper and Mr. Wendt, along with Benedict A. Wittig and Gary E. Wendt for the purpose of developing an automated fingerprint identification systems (BBG subsequently changed its name to SAC Technologies, Inc.). Jasper agreed, in consideration of an assignment of the patent rights to the FIDS technology, to fund the development of a fingerprint identification system.

By mid-summer of 1993, BBG completed the development of the initial concepts for electronic analysis of fingerprints. Pursuant to the Company's agreement with Jasper, initial patent applications were filed by Jasper in the fall of 1993. Also, in the fall of 1993 the Company acquired the Optic Technology from Richard Fiskum to be used in conjunction with and as an integral part of the fingerprint analysis system. Subsequently, the Company redeemed all of the shares of the Company owned by Jasper. It was also at this time that the Company finalized the original intention of its underlying understandings with Jasper with respect to a licensing agreement (the "Jasper Agreement"). From inception through most of 1996 the Company's development efforts, which by agreement were to be funded by Jasper, were principally focused on the development of its fingerprint identification and analysis products. See "Business--Technology License," and "Certain Transactions."

TECHNOLOGY LICENSE

The Company's technology consists of knowledge and information relating to computer hardware and software which is used to create an automated process of imaging a fingerprint, formatting the fingerprint for computer analysis, and identifying and verifying the print relative to an existing database of fingerprint information. The Optic Technology and the Company's Biometric Solution are owned by the Company, subject to an exclusive worldwide license which has been granted to Jasper to use and sell products in certain markets. The FIDS Technology used for fingerprint analysis is owned by Jasper, subject to an exclusive worldwide license which has been granted to the Company to make products for all markets and to use and sell products in certain markets.

For products utilizing FIDS Technology the Jasper Agreement provides that the Company will be paid a royalty of $30.00 for each product sold by Jasper, that Jasper will be paid a royalty of $30.50 for each product sold by the Company, and that all of Jasper's product requirements may be made by the Company at a gross margin of twenty percent, pursuant to the provisions of a separate OEM agreement between Jasper and the Company. The Jasper Agreement exclusively reserves to the Company the access control market and applications including, but not limited to, the control of access to buildings, apartments, offices and other facilities, appliances, information, resources, computers, and computer networks. The Jasper Agreement exclusively reserves to Jasper all other market areas including, but not limited to, credit card clearing, check clearing and other such financial applications, law enforcement, national identification systems, immigration control, automobiles, medical patient identification systems, and personnel identification systems for federal and state government applications.

Pursuant to the Jasper Agreement, either Jasper or the Company may transfer or license its rights to FIDS Technology, with the consent of the other party. Any consideration received with respect to a transfer of FIDS Technology within Jasper's field of use, will be divided as follows: (i) 10% to Jasper for purposes of funding any legal fees and costs incurred with respect to the transfer or claims; (ii) 10% to the Company for purposes of funding ongoing research and development expenses with respect to the FIDS Technology, Optic Technology, or Biometric Solution; (iii) 48% to Jasper without restriction; and
(iv) 32% to the Company without restriction. Any consideration received with respect to a transfer of FIDS Technology within the Company's field of use, will be divided as follows: (i) 10% to Jasper for purposes of funding any legal fees and costs incurred with respect to the transfer or claims; (ii) 10% to the Company for purposes of funding ongoing research and development expenses with respect to the FIDS Technology, Optic Technology, or Biometric Solution; (iii) 48% to the Company without restriction; and (iv) 32% to Jasper without restriction.

PRODUCTS

The Company's current plan is to develop and market several products which address industry-specific security applications. The Company also plans to develop some limited manufacturing and product assembly capability and to contract for outside manufacturing and assembly of its products, as needed. The products are intended to provide controlled access to information, resources, and facilities. The company's SACMan(tm) and SAC_App products have undergone extensive internal and external testing and are believed to be ready for commercial scale production, sale and use. The Company has not yet completed final development or commenced testing of its SAC_Remote and SAC_Encrypt products; however, the initial hardware design of these products has been completed. These products are intended for use with software based upon the software used in the SACMan(tm). It is anticipated that development and testing of the SAC_Remote and SAC_Encrypt products will be completed in early to mid 1997, at which time the product is expected to be made available for commercial release. Although the Company does not expect to derive any significant short-term revenue from the markets serviced by Jasper, the Company also plans to package its products for sale by Jasper to the consumer credit verification and validation, law enforcement applications, and national identification systems markets.

The Company's products use a camera to take a visual image of an approximately one-half inch by one-half inch area of a fingerprint. The image is produced at an effective resolution of approximately 1000 dots per inch (DPI). The products then make several passes on the image to optimize and clarify it. Subsequently the products identify distinguishing characteristics of a fingerprint; these characteristics include ridges, valleys, loops, double loops, spirals, ovals/circles, bifurcations, rods, arches, deltas, and core locations. These distinguishing characteristics are mapped by the Company's technology such that the product can verify whether the characteristics match those of a known fingerprint. The technology is designed to perform, in a consistent and efficient manner, either one to one (1:1) verification to detect and match the fingerprint information to a single fingerprint or one to many (1:N) verification to match a fingerprint to any of a number of fingerprints in a database.

PRINCIPAL PRODUCTS

Each SACMan(tm) unit scans and analyzes a fingerprint in approximately three seconds and generates an identification code which can be used to identify the owner of the print from an online database located on an attached personal computer. The SACMan(tm) can verify the identity of a computer user desiring access and allow or stop the user from accessing a computer, computer network, or specific application. SACMan(tm) incorporates most functions of existing logic cards into a peripheral system believed by the Company to be both simple and able to be priced for broad consumer use. The Company currently plans to make this product available in desk-top and wall-mount enclosures created for cost-effective uses in existing mass marketplaces.

The Company hopes to complete development in the near term of its SAC_Remote product, currently scheduled for release in early 1997. SAC_Remote is designed to restrict door access through fingerprint identification by incorporating local processing capability to the basic unit to allow for analysis and database comparison without the necessity of an attached personal computer. These units will include a communication port for complex facility access control configurations, such as hotels, apartment buildings, and office complexes which have many access points and a continually changing database of users.

OTHER PRODUCTS

The Company has also developed its SAC_App application database development software which can be used to enter, sort, structure, manipulate, and manage a database of fingerprint models. The product has been designed to facilitate the rapid integration of the Company's technology into a wide variety of markets and to provide for simple application definition through a menu selection process.

Finally, the SAC_Encrypt computer data security system, scheduled for release in early to mid 1997, will provide for the encryption/de-encryption of local applications programs by controlling all access to data files and networks according to a user's unique fingerprint key, thereby controlling all data movement and peripherals (e.g. disk drives, network cards and printers) within a computer system.

INTELLECTUAL PROPERTY PROTECTION

While the Company has filed a patent application relating to both the Optic Technology and Biometric Solution components of its technology, no patents have yet been issued or indicated as allowable. In addition, although Jasper has filed certain patent applications with the United States Patent & Trademark Office with respect to FIDS Technology, no patent has yet issued and, accordingly, none of the technologies described herein are currently patented by the Company. Part of the Company's technology consists of software or hardware implementations of software ("firmware"). The Company intends to take measures to ensure copyright protection for its software and firmware releases prior to distribution. Also, the firmware/software is serialized to ensure that only matched sets will function together. This provides both a mechanism to combat cloning of the Company's products and a method for standardizing products. The Company believes it has developed common law trademark rights in the term SACMan(tm) but has not filed a state or federal trademark application. The Company does not claim any additional trademarks.

MARKET

The Company believes that its products will have a broad range of possible applications relating to high technology security solutions. The potential applications for secure access control include the following:

i. General access control--Every doorway presently utilizing any form of controlled access represents a possible sale opportunity for the Company. Secure access control was estimated by Security Management Magazine (January, 1996) to be a $1 billion market in the United States during 1994.

ii. Information resource and network access control--Every existing computer network and stand-alone computer system represents an opportunity for use of the Company's technology, which could provide a cost effective method for securing information resources.

In addition, the Company may derive revenue from the efforts of Jasper in those longer-term, markets reserved for Jasper under the Jasper Agreement. For example, credit card companies currently have approximately 39 million participating merchants, each of whom could benefit from units at retail check out counters for verification of credit card users' identities. However, the Company is not relying on these potential sources of revenue to significantly impact its results of operations.

MARKETING AND SALES

The Company currently plans to market its products through various distributors, original equipment manufacturers ("OEMS"), dealers, value added resellers, as well as directly to end users. Marketing plans include direct mailing, telemarketing, trade show presentations, advertising in trade publications, and catalog sales. The Company plans to develop an effective strategy for identifying the major purchasing entities in each of its target markets and determining the appropriate medium for reaching such entities.

The Company has developed marketing literature for its SACMan product and has displayed its SACMan product at the American Society for Industrial Security (ASIS) conference in September 1996 and at COMDEX (an annual computer products convention) in November 1996. The Company has also displayed its product at the Internet Firewalls Conference in October 1996 and plans to participate in the Consumer Electronic Show (CES) in January 1997. The Company believes it has generated significant interest of prospective dealers for its products and has maintained an extensive inquiry list of interested parties.

A majority of the Company's sales are expected to be made through qualified volume resellers, consisting primarily of distributors, OEMS, and system integrators. Sales to end users are likely to be made through existing retail electronics distribution channels so that the Company can attempt to optimally allocate its technical support resources to volume users. The Company currently plans to develop support teams for each product with each team consisting of a sales/marketing individual, a software engineer, and a hardware engineer. These teams are to be developed early in the product cycle to provide for active involvement in all the development and marketing of a particular product including market research, product definition, user documentation, and subsequent support and evaluation.

COMPETITION

In addition to existing commonplace methods of restricting access to facilities such as pass cards, personal identification numbers, password access, and locks and keys, there are numerous companies involved in the development, manufacture, and marketing of fingerprint biometric products to government, law enforcement, prison, and consumer markets. Some of these companies include Computer Research Labs, Digital Biometrics, Inc., Printrak International, Identicator, Identix, Fingermatrix, Inc., Mytec Technologies, Inc., The National Registry, Sandia Labs, Fujitsu, Biometric Identification, Inc., and Ultrascan, Inc. Many of these competitors have substantially greater resources and experience in developing and marketing biometric products.

There are currently two types of biometric products on the market, verification and identification. In verification, the user supplies a personal identification number or password coupled with some form of biometric characteristic which is then verified against the user's "Model-Template." In identification, the user supplies a biometric characteristic only which is then verified against an on-line database to determine the users's identity. Identification products can eliminate ALIAS's (multiple IDs for one user) and as such are much more difficult to develop. The Company's believes its products are true identity products which are designed to be used in real time operation.

Most current automated fingerprint product offerings are primarily targeted to government and law enforcement applications at a price level higher than that anticipated for SACMan(tm). In part, this may be attributable to the fact that several of its competitors are integrating other manufacturers' hardware and/or software and, as such, may be forced to bear higher component costs and technology licensing fees, as well as greater selling expenses. Of the companies specifically targeting consumer application markets, many are projecting product availability during 1997 or 1998. While the Company has yet to manufacture, market, or sell any of its products on a commercial basis, based on field testing, available pricing information of product components, and its current sales price, the Company believes its products are reliable and will be affordable in its targeted markets.

With current non-biometric technologies the user must typically posses a key, card, or bit of information such as an personal identification number or password. These systems are easily defeated by obtaining possession of the key, card, or password, or by counterfeiting the key or card. The Company's products will also be competing for market share with other biometric technologies including hand geometry, facial recognition, iris scanning, retinal scanning, signature verification, and voice analysis, as well as existing lock/security/card technology. Some of the perceived disadvantages of these technologies are as follows:

* Hand geometry devices are subject to physical changes which makes them less than ideal for large database sizes, where identification versus verification is required. The devices are also typically large and, therefore, difficult to integrate into many applications.

* Facial recognition technology can be fooled by photographs and is typically cost prohibitive, thereby limiting its application in mass-market applications.

* Iris scanning has remained costly, subject to user motion, and requires large "Model Template" sizes for data storage.

* Retinal scanning has also remained expensive and is subject to user health concerns over laser scanning of the retina.

* Signature verification is subject to user physical changes over time and is susceptible to forgery.

* Voice analysis is subject to user physical changes and can be forged through the use of devices capable of recording and altering individual voices.

SET TOP BOX TECHNOLOGY

The Company also has developed a computer technology which consists of a small box which can be placed on top of a television set (the "Set Top Box") which performs basic personal computer functions, including word processor, spreadsheet, and database functions, as well as Internet access. With simple connections to a phone line for communications and a television for display purposes, the Set Top Box provides for low-cost home computing. The user communicates with the unit via an infra-red keyboard and track-ball mouse.

The Company does not believe that the promotion and marketing of the Set Top Box is within its primary focus and, accordingly, conveyed the technology to another company, Inter-Con/PC, Inc. ("Inter-Con") in exchange for fifty percent (50%) of the initial equity of Inter-Con. The Company also negotiated a short-term royalty of two percent (2%) of net revenues from Inter-Con. The royalty obligation of Inter-Con will terminate on the earlier of November 1, 2002, or the completion by Inter-Con of a public offering of its common stock. It is not currently anticipated that any member of the Company's board of directors or executive officer of the Company will be a member of the board of directors or an executive officer of Inter-Con. The Company does, however, pursuant to a shareholder control agreement, have a short-term right to elect two members to a five-person board of directors of Inter-Con.

The Company has also executed a technical support agreement with Inter-Con wherein the Company agrees to advise and consult for three years with the technical staff of Inter-Con in exchange for payment of technical support fees. Because Inter-Con is a development stage company, faces significant competition in its market, and has yet to raise the capital required to execute its business plan, or even to pay the aforesaid technical support fees to the Company, the Company is not expecting that its partial ownership of Inter-Con, or its contractual relationships with Inter-Con, will result in any major benefit to the Company, and the success of the Company is not viewed as a function of the success of Inter-Con.

EMPLOYEES

The Company currently employs nine individuals on a full-time basis. Four are primarily involved in research, development, and technical support, two are principally involved in research, development, and administrative matters, two are principally involved in administrative and finance matters, and one is principally involved in sales and marketing efforts. The Company also employs a part-time employee who is principally involved in administrative and finance matters.

LEGAL PROCEEDINGS

The Company is not a party to any material litigation and is not aware of any threatened litigation that would have a material adverse effect on its business.

PROPERTY

The Company leases approximately 2,000 square feet of space at 4444 West 76th Street, Suite 600, Edina, Minnesota 55435. The Company plans to use this space for ongoing research and development. The lease is a three-year lease terminating on August 31, 1998. During the term of the lease, the monthly rental increases from $1,792 to $1,875. The Company also leases approximately 1,200 square feet of space at 4620 South Valley View Road, Suite A1, Las Vegas, Nevada 89103. The Company currently plans to use this space for marketing and showroom facilities. The lease is a one-year lease terminating on May 31, 1997, with a monthly rent of approximately $1,200. In addition, the Company leases an apartment in Minnesota, for use by the Company's officers, directors, and sales staff as needed. The Company plans to locate additional facilities for both marketing and manufacturing efforts.

MANAGEMENT

Certain information about the Company's executive management and members of the Board of Directors is presented in the table below.

DIRECTORS, EXECUTIVE OFFICERS AND KEY EMPLOYEES

                                                                                  DIRECTOR
NAME                     AGE                       POSITION                        SINCE
- ----                     ---                       --------                        -----
Barry M. Wendt(1)        49    Chief Executive Officer, Chairman of the Board       1993
Richard T. Fiskum(1)     46    President, Chief Operating Officer, Director         1995
Gary E. Wendt(1)         55    Chief Financial Officer, Director                    1993
Benedict A. Wittig(1)    54    Secretary, Director                                  1993


(1) Member of the Committee for the 1996 Stock Option Plan

BARRY M. WENDT, Chief Executive Officer and Chairman of the Board since inception of the Company, manages engineering and marketing. From 1993 to 1994 Mr. Wendt also acted as the part-time and temporary Chief Executive Officer of Esprit Technologies, Inc., a computer manufacturer which produced high speed PCs marketed primarily to government and industry in the midwest. From 1988 to 1995 Mr. Wendt worked for (and was the CEO from 1992 to 1995 of) The Technology Congress, Ltd., a service bureau which supported primarily Fortune 500 companies in CAD/CAM/CAE laser plotting, scanning, and electrical testing with emphasis on photo-tooling for the fabrication industry. The Technology Congress, Ltd. filed for protection under Chapter 11 of the United States Bankruptcy Code in August, 1994 and was ultimately liquidated under Chapter 7 of the Bankruptcy Code in July, 1995. From 1985 to 1988 Mr. Wendt was the President and owner of BMW Research, a sole proprietorship specializing in the independent research and development of contract design of electronic products. Mr. Wendt was President of Custom Computer Systems, Inc., a company specializing in the design, manufacture, and sale of small business computer systems. Mr. Wendt received a Bachelor of Science degree in Electronic Engineering from Florida International University, a diploma in RF and Consumer Electronic systems from the De Vry Institute of Technology, and an Associate of Science in Electronic Engineering from Gulf Coast Community College. Mr. Wendt is the brother of Gary E. Wendt, Chief Financial Officer and a Director of the Company.

RICHARD T. FISKUM, President, Chief Operating Officer, and a Director since August, 1995, manages and has an active role in the development of imaging systems and oversees and directs all manufacturing operations. From 1980 to 1996, Mr. Fiskum was Chief Executive Officer of Industrial Research and Development, Inc., an enterprise wholly owned by Mr. Fiskum specializing in prototype to production process development and manufacturing of precision glass, ceramic, and plastic components and assemblies for industrial and medical applications. From 1975 to 1980 he was a Vice President of Litchfield Precision Components, Inc., a manufacturer of chemically milled glass and metal components. Mr. Fiskum attended Moorhead State University where he studied physics, chemistry, mathematics, and computer science.

GARY E. WENDT, Chief Financial Officer and a Director of the Company since inception, prepares the Company's financial reports and administers accounting operations. From 1993 to 1994 Mr. Wendt was Treasurer and Chief Financial Officer of Esprit Technologies, Inc., a computer manufacturer which produced high speed PCs and marketed primarily to government and industry in the midwest. From 1988 to 1995 he was Secretary-Treasurer and Chief Financial Officer of The Technology Congress, Ltd. The Technology Congress, Ltd. filed for protection under Chapter 11 of the United States Bankruptcy Code in August, 1994, and was ultimately liquidated under Chapter 7 of the Bankruptcy Code in July, 1995. From 1979-1985 Mr. Wendt was a systems analyst for Custom Computer Systems, Inc. Mr. Wendt attended Metropolitan State University, North Hennepin Community College, and the Academy of Accountancy where he was certified in public accounting. Mr. Wendt is not a Certified Public Accountant. Mr. Wendt is the brother of Barry M. Wendt, Chief Executive Officer and Chairman of the Board of the Company.

BENEDICT A. WITTIG, Director of Systems Software, Secretary and a member of the Company's Board of Directors since inception, manages all software projects and is actively involved in software development. From 1993 to 1994 Mr. Wittig was a Systems Software Manager for Esprit Technologies, Inc., a computer manufacturer which produced high speed PCs and marketed primarily to government and industry in the midwest. From 1983 to 1993, Mr. Wittig was an independent software developer specializing in software systems for processor controlled hardware. Prior to 1983, he worked as Staff Systems Programmer for Northern Telecom, Inc. and as Diagnostic Programmer for Control Data Corporation. Mr. Wittig received both a Master of Science in Electronic Engineering and a Bachelor of Science in Electronic Engineering from the University of Missouri.

All of the foregoing individuals have executed employment agreements and noncompetition letters containing nondisclosure obligations and, except as prohibited by law, the obligation to assign to the Company all ideas and inventions which relate indirectly or directly to the Company's business.

COMMITTEES OF THE BOARD OF DIRECTORS

The Board has a Committee for administration of its 1996 Stock Option Plan (the "Plan"), composed of all four of the current officers and directors which
(i) administers the Plan; (ii) determines the purchase price of the common stock covered by each option; (iii) determines the persons to whom and the time or times at which options or stock awards shall be granted pursuant to the Plan;
(iv) determines the number of shares subject to each option or stock award granted under the Plan; and (v) authorizes and directs the issuance of the common shares upon stock awards and the exercise of options granted pursuant to the Plan. See "Management--1996 Stock Option Plan."

EXECUTIVE COMPENSATION

The following table provides certain summary information for the past three years ended December 31, 1994, 1995, and 1996, concerning executive compensation paid or accrued by the Company to the Company's Chief Executive Officer. Other than as listed below, no executive officers salary and bonus compensation for 1995 exceeded $100,000.

SUMMARY COMPENSATION TABLE

SUMMARY COMPENSATION TABLE

                                                                               LONG TERM
                                              ANNUAL COMPENSATION         COMPENSATION AWARDS
                                          ----------------------------    -------------------
                               FISCAL                                         SECURITIES
NAME AND PRINCIPAL POSITION     YEAR      SALARY    BONUS     OTHER(1)    UNDERLYING OPTIONS
- ---------------------------    ------     ------    -----     --------    ------------------
Barry M. Wendt ..............   1996     $97,672     $--       $7,614            None
 (Chief Executive Officer)      1995      40,584      --        1,621            None
                                1994      17,533      --           --            None


(1) Includes group health insurance premiums and a vehicle allowance.

Additional columns required by Securities and Exchange Commission rules to be included in the foregoing table, and certain additional tables required by such rules, have been omitted because no compensation required to be disclosed therein was paid or awarded to the Named Executive Officers.

EMPLOYMENT AND CONSULTING AGREEMENTS

On May 10, 1996, the Company entered into Employment Agreements (which expire on December 31, 2001) with each of the Company's officers: Barry M. Wendt, Chief Executive Officer; Richard T. Fiskum, President; Benedict A. Wittig, Director of Systems Software; and Gary E. Wendt, Chief Financial Officer. The terms of the Employment Agreements for each of the above individuals are substantially the same, with differences only as to base salary. Each officer and director may be terminated only for "cause" as that term is defined in the Employment Agreements. In the event of "constructive termination" as defined in the Employment Agreements, including such matters as an adverse change in an employee's status or position in the Company, a reduction of such employee's base salary other than for austerity purposes, or the breach by the Company of any of its other contractual obligations for other than austerity reasons, the employee's noncompetition obligations lapse, and the employee's salary will be continued for up to five years and three months salary (as of September 30, 1996) reduced by one month each month thereafter until December 31, 2001, at which time the amount of severance is two years. The Employment Agreements also contain confidentiality obligations and incorporate a Non-Competition Letter. The Non-Competition Letter prohibits each of the four individuals from competing with the Company for a period of three years if the Company terminates the employment of any one of the said individuals for cause, and a period of two years if any individual voluntarily terminates employment. Except as may be prohibited by law, during the term of the Employment Agreements, each of the said employees are obligated to disclose and assign to the Company all ideas, inventions and business plans developed by each of them which relate directly or indirectly to the Company's business.

OUTSIDE DIRECTOR COMPENSATION

Members of the Board have received no cash compensation for serving on the Board. Pursuant to the Company's 1996 Stock Option Plan, each future non-employee Director will receive options to purchase 25,000 shares of common stock which will vest 20% annually over five years. Five years after the initial grant of an option to a non-employee director, and every fifth year thereafter, non-employee directors who remain on the Board shall automatically be granted additional options to purchase 25,000 shares of Common Stock which shall vest 20% on May 1 of each year over a period of five years. All options granted to non-employee directors shall have an exercise price equal to 100% of the fair market value of a share of the Company's Common stock which, if the stock is traded on the NASDAQ National Market System or an over-the-counter market price is reported, shall be equal to the average of the reported bid and asked prices as of the date of valuation determination.

1996 STOCK OPTION PLAN

The Company's Board of Directors and shareholders adopted the 1996 Stock Option Plan on May 1, 1996 (the "Stock Option Plan"). The Stock Option Plan provides for the reservation of 375,000 shares of Common Stock for issuance pursuant to the exercise of stock options which may be granted to employees, officers, directors and consultants of the Company, and permits granting both incentive stock options (as defined under Section 422 of the Code) and options which do not qualify as incentive stock options ("nonqualified stock options").

The Plan is administered by a committee appointed by the Board of Directors of the Company (the "Committee"). The Committee, by action of a majority of its members, has the authority to establish rules for administering and interpreting the Plan. The Committee has the authority to select individuals to whom awards are granted and the timing of such awards; to adopt, amend, and rescind administrative and interpretive rules and regulations relating to the Plan; and to make all other determinations necessary or advisable for administering the Plan. The committee shall be under no duty to provide terms of like duration for options granted under the Plan, but the term of an incentive stock option may not extend more than ten (10) years from the date of granting of such option.

The Stock Option Plan also provides for the acceleration of the vesting of unvested options upon a "Change of Control" of the Company. A Change of Control is defined in the Stock Option Plan to include (i) a sale or transfer of substantially all of the Company's assets; (ii) the dissolution or liquidation of the Company; (iii) a merger or consolidation to which the Company is a party and after which the prior shareholders of the Company hold less than 50% of the shares of the surviving entity; (iv) if any person becomes a "beneficial owner" of more than 50% of the combined voting power of the Company's outstanding securities; (v) the incumbent directors cease to constitute at least a majority of the Board; or (vi) a change in control of the Company which would otherwise be reportable under Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended.

The exercise price per share of stock purchasable under any incentive stock option granted pursuant to the Stock Option Plan will be determined by the Committee, but shall not be less than 100% of the fair market value of the stock on the date of the grant of such option (110% of the fair market value, in the case of grants to Shareholders beneficially owning more than 10% of the voting control of the Company). The option price for options granted under the Stock Option Plan which do not qualify as incentive stock options shall also be determined by the Committee, but may not be less than 50% of the fair market value of the Common Stock at the date of granting of such option.

No option granted under the Plan is transferable by an optionee, other than by will or the laws of descent or distribution. With few exceptions, during the lifetime of an optionee the option shall be exercisable only by such optionee.

The foregoing is a brief summary of the provisions of the Plan and does not purport to be a complete statement of its respective terms and conditions.

OTHER EMPLOYEE BENEFITS

Each officer and director of the Company receives a vehicle allowance of approximately $300 per month. The Company provides standard health insurance coverage to its officers, directors and employees.

CERTAIN TRANSACTIONS

In January 1993 the then existing shareholders of the Company and the Company entered into a Stock Purchase Agreement which requires each shareholder desiring to sell his shares in the Company to a non-shareholder to first offer such shares to the Company. The Company was granted a sixty-day option to acquire the shares at the price determined by the selling shareholder. If the Company did not exercise its option, then the other shareholders, pro rata, had a subsequent thirty-day option to acquire the same. If neither option was exercised, then the selling shareholder could sell his shares to any third party. The parties to this Agreement have agreed that its provisions will terminate upon the effective date of this Offering.

On August 4, 1995, Barry M. Wendt and Benedict A. Wittig, officers and directors of the Company, each received 618,750 shares (137,500 shares prior to the stock split) of the Company's Class A and Class B common stock in a recapitalization of their previous equity interests in the Company. Concurrently, Gary E. Wendt, a third officer and director, received 202,500 shares (45,000 shares prior to the stock split) of the Company's Class A and Class B common stock in a recapitalization of his previous interests in the Company. Each of these individuals had previously paid $1.00 for their interests in the Company. On April 24, 1996, all of these shares were converted into shares of common stock of one class.

On August 4, 1995, Richard T. Fiskum, an officer and director of the Company, purchased 472,500 shares (105,000 shares prior to the split) of the Company's Class A and Class B common stock for $225,000. Also, on December 22, 1995 Mr. Fiskum purchased an additional 146,250 shares (32,500 shares prior to the split) of the Company's Class A and Class B common stock for $50,000. On April 24, 1996, all of these shares were converted into shares of common stock of one class.

In August 1995 the Company purchased certain optics technology from Richard T. Fiskum pursuant to a non-interest bearing note issued to Mr. Fiskum by the Company. The note is collateralized by a $117,000 receivable from Jasper. The Company currently intends to use a portion of the proceeds from this offering to repay the amounts owing to Mr. Fiskum under this note.

During August and December, 1995 the Company repurchased all of the shares of common stock held by Jasper for a total price of $308,174, of which $138,000 was paid in cash. This price was commensurate with the then aforementioned most recent sales price of the Company's Common Stock to Mr. Fiskum. See "Business--Company History."

On May 10, 1996, Barry M. Wendt, Richard T. Fiskum, Benedict A. Wittig and Gary E. Wendt each executed Employment Agreements with the Company (terminating on December 31, 2001), each of which may be terminated for "cause" as that term is defined in the Employment Agreements. In the event of a "constructive termination" as defined in the Employment Agreements, including such matters as an adverse change in an employee's status or position in the Company, a reduction of such employee's base salary other than for austerity purposes, or the breach by the Company of any of its other contractual obligations for other than austerity reasons, the employee's noncompetition obligations lapse, and the employee's salary will be continued for up to five years and three months salary (as of September 30, 1996) reduced by one month each month thereafter until December 31, 2001, at which time the amount of severance is two years. The Employment Agreements also contain confidentiality obligations and incorporate a Non-Competition Letter. The Non-Competition Letter prohibits each of the four individuals from competing with the Company for a period of three years if the Company terminates his employment for cause, and a period of two years if said individual voluntarily terminates his employment. Finally, except as may be prohibited by law, during the term of the Employment Agreements, each of the said employees are obligated to disclose and assign to the Company all ideas, inventions and business plans developed by each of them which relate directly or indirectly to the Company's business.

On May 17, 1996, the Company, with the Underwriter as its selling agent, completed the Bridge Loan pursuant to which it raised a total of approximately $200,000, less a commission and expense allowance to the Underwriter in this offering, then acting as the Company's selling agent, of $8,660. Investors in the Bridge Loan received a promissory note bearing interest at a rate of eight percent (8%) (the "Convertible Note"). Each Convertible Note converted into shares of the Company's Common Stock at a price of $2.00 per share on June 28, 1996 as part of the private placement described below. The lenders in the Bridge Loan also received warrants to purchase (at a price of $2.00 per share) a number of shares of the Company's Common Stock equal to one-half the principle amount of each Convertible Note divided by $2.00.

On July 17, 1996, the Company, with the Underwriter as its selling agent, completed a $900,000 private placement of its Common Stock at a per share price of $2.00. Of this $900,000, approximately $200,000 was represented by the conversion of the Bridge Loans described immediately above. The Underwriter received a commission and expense allowance in an approximate amount of $110,279 and a warrant to purchase 41,639 shares of common stock which has an adjusted exercise price of $6.00 per share.

The Company intends to contract with Industrial Research & Development, Inc. ("IR-D"), a company wholly owned by Richard T. Fiskum, to manufacture initial prototypes and pre-production optics assemblies. The arrangement with IR-D is not intended to be a long-term or exclusive relationship and will be structured on a competitive basis.

During Richard T. Fiskum's development of the Optic Technology, he purchased certain inventory and supplies totalling approximately $70,000. Mr. Fiskum believes these items could be used in the manufacture of products for Jasper. The Company and Mr. Fiskum have an understanding whereby if such inventory and supplies are needed by the Company, the Company will purchase such items from Mr. Fiskum at a fair price, as determined in good faith by the parties.

Other than as listed above, the Company has not entered into any other material transactions with any of its officers, directors or affiliates. If any future transactions between the Company and its officers, directors or affiliates are entered into in the future, they will provide terms at least as favorable as could be obtained from unaffiliated third parties.

PRINCIPAL SHAREHOLDERS

The following table sets forth the information as of September 30, 1996, regarding beneficial ownership of the Company's common stock as adjusted to reflect the sale of the Shares, for (i) all directors and each executive officers named in the Summary Compensation table set forth in "Management," (ii) all directors and executive officers as a group and (iii) each person known by the Company to be the beneficial owner of 5% or more of the outstanding shares of common stock of the Company.

                                          SHARES BENEFICIALLY       SHARES BENEFICIALLY
                                                 OWNED                     OWNED
                                           PRIOR TO OFFERING          AFTER OFFERING
                                          --------------------      --------------------
                                          NUMBER       PERCENT
NAME AND ADDRESS OF BENEFICIAL OWNER      BEFORE       BEFORE       NUMBER       PERCENT
- ------------------------------------      ------       -------      ------       -------
Barry M. Wendt(1)
 7201 York Avenue South
 Apartment 211
 Edina, MN 55435 .....................     618,750      24.66        618,750      17.14
Richard T. Fiskum
 28690 -- 660th Avenue
 Litchfield, MN 55355 ................     618,750      24.66        618,750      17.14
Gary E. Wendt(2)
 1950 Sixth Lane
 Elk River, MN 55330 .................     202,500       8.07        202,500       5.61
Benedict A. Wittig
 10264 Scarborough Circle
 Bloomington, MN 55432 ...............     618,750      24.66        618,750      17.14
All officers and Directors
 as a group (4 persons) ..............   2,058,750      82.05      2,058,750      57.03


(1) Barry M. Wendt also maintains a residence at 9708 Park Brook Avenue, Las Vegas, Nevada 89134.

(2) Gary E. Wendt also maintains a residence at 3738 St. Phillip Court, North Las Vegas, Nevada 89031.

SHARES ELIGIBLE FOR FUTURE SALE

Upon completion of this offering, the Company will have outstanding 3,608,750 shares of common stock (or 3,718,750 shares of common stock if the Underwriter's over-allotment option is exercised in full). Of these shares, the 1,210,000 Shares being sold in this offering (if the over-allotment option is exercised in full) will be freely tradable without restriction under the Securities Act of 1933, as amended (the "Securities Act"). In addition, subsequent to the date hereof, the Company may file a Registration Statement on Form S-8 (the "S-8 Registration Statement") to register the 375,000 shares underlying the Company's 1996 Stock Option Plan. Shares issued upon exercise of options and awards pursuant to the 1996 Stock Option Plan may be freely tradeable once the S-8 Registration Statement becomes effective. Sales of substantial amounts of common stock in the public market could adversely affect the then prevailing market price. See "Description of Securities."

Of the 2,508,750 shares of common stock currently outstanding, none have been registered under the Securities Act, and all are "restricted securities" under Rule 144 of the Securities Act (the "Restricted Shares") and may not be sold in the absence of a registration under the Securities Act unless an exemption from registration is available, including an exemption contained in Rule 144. The 1,440,000 of the shares held by certain founders have been held for more than two years and may be transferred upon the expiration of the lock-up period described below, subject to Rule 144 and any state law imposed escrow requirements. The shares held by Mr. Fiskum must be held for a minimum of two years before they can be sold pursuant to Rule 144, and will not become eligible for resale thereunder until the middle of 1997 and later.

The Company has obtained lock-up agreements from Messrs. Barry M. Wendt, Richard Fiskum, Gary T. Wendt and Benedict A. Wittig. In the lock-up agreement each shareholder agrees not to sell, offer to sell, contract to sell, or otherwise transfer or dispose of any shares of common stock they own after consummation of this offering for a period of one year after the date of this Prospectus without the written consent of the Underwriter. See "Underwriting."

In general, under Rule 144 as currently in effect, a holder of Restricted Shares who has beneficially owned such shares for at least two years (including the holding period of any prior owner other than an affiliate of the Company) is entitled to sell within any three-month period a number of shares that does not exceed the greater of (i) 1% of the then outstanding shares of common stock
(approximately 36,088 shares immediately after this offering) not including: (a)
375,000 shares reserved for issuance under the Company's 1996 Stock Option Plan;
(b) up to 44,496 shares issuable upon exercise of the Underwriter's Warrant; (c) 110,000 shares issuable pursuant to the Underwriter's over-allotment option; (d) 50,000 shares of Common Stock which may be issued upon exercise of warrants issued to the investors in connection with bridge financing arrangements at an exercise price of $2.00 per share; and (e) 41,639 shares of Common Stock which may be issued upon exercise of warrants issued to the Underwriter in connection with a private placement and bridge financing arrangements at an adjusted exercise price of $6.00 per share; or (ii) the average weekly trading volume of the common stock in the public market during the four calendar weeks preceding the date on which notice of the sale is filed with the Securities and Exchange Commission. The 50,000 shares of Common Stock referenced in above item (d) will be eligible for sale under Rule 144 two years after exercise of the warrants. The 41,639 shares of Common Stock referenced in above item (e) will be eligible for sale under Rule 144 the earlier of: (i) two years after the exercise of the warrants or (ii) two years after issuance of such warrant, if a cashless exercise is effected by the Underwriter pursuant to the terms of such warrant. Sales under Rule 144 are also subject to certain manner of sale provisions, notice requirements and the availability of current public information about the Company. A person who is not an affiliate of the Company at any time during the 90 days preceding a sale and who beneficially owns shares that were not acquired from the Company or an affiliate of the Company within the past three years is entitled to sell such shares under Rule 144(k) without regard to volume limitations, manner of sale provisions, notice requirements or the availability of current public information concerning the Company. Under Rule 701, shares privately issued under certain compensatory stock-based plans, may be resold under Rule 144 by nonaffiliates subject only to the manner of sale requirements, and by affiliates without regard to the two-year holding period requirement, commencing 90 days after the date of this Prospectus.

DESCRIPTION OF SECURITIES

COMMON STOCK

The Company is authorized to issue up to 20,000,000 shares of capital stock, $0.01 par value, of which 2,508,750 shares are outstanding and beneficially owned by 66 holders of record as of the date of this Prospectus. The Company may, but to this day has not, established multiple classes and series of stock.

Holders of common stock are entitled to receive such dividends as are declared by the Company's Board, out of funds legally available for the payment of dividends. The Company expects to retain any earnings to finance the development of its business. Accordingly, the Company does not anticipate payment of any dividends on the common stock, for the foreseeable future. In the event of any liquidation, dissolution or winding-up of the Company, the holders of common stock will be entitled to receive a pro rata share of the net assets of the Company remaining after payment, or provision for payment, of the debts and other liabilities of the Company; provided, no assurance can be given that there will be any net assets of the Company remaining for such a pro rata distribution to the holders of the common stock after the payment or provision for payment, of the debts and other liabilities of the Company.

Holders of common stock are entitled to one vote per share in all matters to be voted upon by shareholders. There is no cumulative voting for the election of Directors, which means that the holders of shares entitled to exercise more than 50% of the voting rights in an election of Directors, are able to elect all of the Directors standing for election. Holders of common stock have no preemptive rights to subscribe for or to purchase any additional shares of common stock, or other obligations convertible into shares of common stock, which may hereafter be issued by the Company.

All of the outstanding shares of common stock, and the Shares to be sold pursuant to this offering, are validly issued and will be fully paid and non-assessable. Holders of common stock of the Company are not liable for further calls or assessments.

UNDESIGNATED SHARES

The Board has the authority, in most instances, without further shareholder action, to issue, from time to time, all or any part of the 16,391,250 authorized but unissued shares of voting common stock. The Board can issue voting common stock in one or more classes or series, and the Board has authority to determine the designation and number of shares, in each class or series, and to fix the dividend, redemption, liquidation, retirement, conversion and voting rights, if any, of each class or series, and any other rights and preferences thereof.

There are presently no undesignated shares subject to designation as preferred stock by the Board. In order to create additional, undesignated shares, the Company's shareholders would be required to approve an amendment to the Articles of Incorporation authorizing such action. Any undesignated shares created in such manner will be subject to designation as preferred stock by the Board. The Board will have the authority, in most instances without further shareholder action, to issue from time to time all, or any part of, the undesignated shares. Undesignated shares will be issuable in one or more classes or series and the Board will be authorized to determine the designation and number of shares in each class or series and to fix the dividend, redemption, liquidation, refinement, conversions and voting rights, if any, of each class or series and any other right and preferences thereof. In the event the Company's shareholders vote to amend the Articles of Incorporation to provide for undesignated shares, any undesignated shares which may subsequently be issued may have disproportionately high voting rights or class voting rights, may be convertible into shares of Common Stock, and may rank prior to the shares of Common Stock as to payment of dividends and to the distribution of assets upon liquidation or dissolution. The further consent of the holders of Common Stock (beyond amending the Articles of Incorporation) would not be required for any such issuance of the undesignated shares.

The existence of any such undesignated shares may have the effect of discouraging an attempt, through acquisition of a substantial number of Common Stock, to acquire control of the Company with a view to effecting a merger, sale or exchange of assets or similar transaction. The Board, without further shareholder approval, could issue shares of preferred stock with voting and conversion rights which could adversely affect the voting power of the Common Stock.

STOCK OPTIONS AND WARRANTS

The Company has reserved 375,000 shares of its common stock for issuance pursuant to its 1996 Stock Option Plan and has granted options for the purchase of 173,000 shares under the Plan. None of these 173,000 options granted are exercisable within 60 days from the date of this Prospectus. See "Management--1996 Stock Option Plan."

The Company issued to the investors, in connection with the May 17, 1996 Bridge Loan, warrants to purchase 50,000 shares of common stock, at $2.00 per share.

The Company issued to the Underwriter, in connection with the July, 1996 private placement and May 17, 1996 Bridge Loan, warrants to purchase 41,639 shares of common stock, at an adjusted exercise price of $6.00 per share.

The Company has agreed to sell to the Underwriter in connection with this offering a warrant to purchase up to 44,496 shares of common stock, exercisable for a period of four years commencing one year from the date of this Prospectus, at an exercise price of, $7.20 per share. See "Underwriting."

MINNESOTA ANTI-TAKEOVER LAW

The Company is governed by the provisions of Sections 302A.671 and 302A.673 of the Minnesota Business Corporation Act. In general, Section 302A.671 provides that the shares of a corporation acquired in a "control share acquisition" have no voting rights unless the control share acquisition is approved in a prescribed manner. A "control share acquisition" is an acquisition, directly or indirectly, of beneficial ownership of shares that would, when added to all other shares beneficially owned by the acquiring person, cause the acquiring person to have voting power in the election of directors to exceed any one of the following thresholds of ownership: 20%, 33-1/3% or 50%. In general, Section 302A.673 prohibits a publicly-held Minnesota corporation from engaging in a "business combination" with an "interested shareholder" for a period of four years after the date of transaction in which the person became an interested shareholder, unless the business combination is approved in a prescribed manner. "Business combination" includes mergers, asset sales and other transactions resulting in a financial benefit to the interested shareholder. An "interested shareholder" is a person who is the beneficial owner, directly or indirectly, of 10% or more of the corporation's voting stock or who is an affiliate or associate of the corporation and at any time within four years prior to the date in question was the beneficial owner, directly or indirectly, of 10% or more of the corporation's voting stock.

INDEMNIFICATION

The Company's Bylaws and the provisions of the Minnesota Business Corporation Act, which govern the actions of the Company, provide that present and former directors and officers of the Company shall be indemnified against certain liabilities and expenses which any of them may incur as a result of being, or having been, an officer of the Company. Indemnification is contingent upon certain conditions being met, including, that the person: has not been previously indemnified by another party for the same matter; has acted in good faith; has received no improper personal benefit; and, in the case of a criminal proceeding, has no reason to believe that the conduct complained of was unlawful and reasonably believed that the conduct complained of was in the best interests of the Company, or in certain circumstances, reasonably believed that, the conduct complained of was not opposed to the best interests of the Company.

In addition, the Company's Articles of Incorporation provide that a director of the Company shall not be liable for monetary damages for a breach of such director's fiduciary duty, except for a breach of the duty of loyalty, acts not in good faith or in knowing violation of law, violations of state securities laws, or for actions from which the director derived an improper personal benefit. The Company has not obtained directors and officers liability insurance.

Insofar as the indemnification of liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Company pursuant to the provisions of its Articles of Incorporation, Bylaws and the provision of the Minnesota Business Corporation Act, or otherwise, the Company has been advised that, in the opinion of the Securities and Exchange Commission, such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.

TRANSFER AGENT AND REGISTRAR

The Company's transfer agent is Firstar Trust Company.

UNDERWRITING

Subject to the terms and conditions set forth in an underwriting agreement (the "Underwriting Agreement"), the Company has agreed to sell to the Underwriter, and the Underwriter has agreed to purchase from the Company the 1,100,000 Shares offered hereby. The Underwriter has been in business as a broker-dealer only since May of 1994 and to date, has completed only one prior public offering.

The Underwriting Agreement provides that the obligations of the Underwriter are subject to certain conditions precedent. The nature of the Underwriter's obligation is that it is committed to purchase all Shares offered hereby if any of the Shares are purchased.

The Company has been advised by the Underwriter that the Underwriter proposes to offer the Shares directly to the public at the Price to Public set forth on the cover page of this Prospectus and to certain securities dealers who are members of the National Association of Securities Dealers, at such price less usual and customary commissions. The Underwriter shall purchase the Shares from the Company at the Price to Public set forth on the cover page of this Prospectus less an underwriting discount of $0.51 per Share. The Company has agreed to pay the Underwriter a nonaccountable expense allowance of 2% of the aggregate public offering price of the Shares sold to the public. The Underwriter may reallow all or a portion of the underwriting discount and expense allowance to selected dealers with regard to Shares sold by them in this offering. After the initial public offering of the Shares, the offering price of the Shares and other selling terms may be changed by the Underwriter.

The Company has granted to the Underwriter an option, exercisable for a period of thirty days after the closing of the sale of the Shares offered hereunder. the date of this Prospectus, and subject to the terms and conditions set forth in the Underwriting Agreement, to purchase up to 110,000 additional shares of common stock at the Price to Public, less the underwriting discount of $0.51 per Share. The Underwriter may exercise such option only to cover over-allotments made in connection with the sale of the Shares offered hereby.

The Company has agreed to issue to the Underwriter, for nominal consideration, a warrant (the "Warrant") to purchase up to 44,496 shares of the Company's common stock. The Warrant is not exercisable during the first year after the date of this Prospectus and thereafter is exercisable at a price per share equal to $7.20 for a period of four years. The Warrant contains customary antidilution provisions and obligates the Company to register the shares underlying the Warrant under the Securities Act once at the election of the holders and at any other time the Company has a registration statement pending under the Securities Act. The Underwriter's Warrant also includes "cashless" exercise provisions entitling the holder to convert the Warrant into shares of common stock. For a period of one year from the date of this Prospectus, the Warrant will be restricted from sale, transfer, assignment or hypothecation, except to persons that are officers or partners of the Underwriter.

The Underwriter owns warrants to purchase 41,639 shares of the Company's common stock at an adjusted exercise price of $6.00 per share, which were issued as part of the Underwriter's compensation for a private offering of common stock which concluded in July, 1996. A person associated with the Underwriter owns 5,000 shares of the Company's common stock which was acquired in the Company's private offering in July, 1996. A person associated with another broker-dealer owns 12,615 shares of the Company's common stock and a warrant to purchase 6,250 shares of such common stock both of which were acquired in a private offering of the Company's convertible notes and warrants in May, 1996.

The Underwriter has informed the Company that the Underwriter does not intend to confirm sales of the Shares to any accounts over which it exercises discretionary authority.

The Company has agreed to indemnify the Underwriter against certain liabilities, including liabilities under the Securities Act.

The Underwriter has required that Messrs. Barry M. Wendt, Richard T. Fiskum, Gary E. Wendt and Benedict A. Wittig agree not to offer, sell or contract to sell or otherwise dispose of, directly or indirectly, any of the shares of common stock or any other security convertible into or exchangeable for shares of common stock which they legally or beneficially own after consummation of this offering (without the prior written consent of the Underwriter) for a period of one year after the date of this Prospectus.

Prior to this offering, there has been no public market for the Shares. Consequently, the Price to Public was determined through negotiation between the Company and the Underwriter and bears no relation to the Company's current earnings, book value, net worth or financial statement criteria of value. There can be no assurance that the price at which the Shares will sell in the public market after this offering will not be lower than the initial Price to Public. The Price to Public of the Shares offered hereby were determined by negotiations between the Company and the Underwriter, and is based upon such factors as the amount required by the Company for working capital, to discharge indebtedness, to acquire capital equipment to begin manufacturing, to begin marketing its products, and to engage in further research and development, and upon a comparison with then-current market prices of publicly-traded common stock of other companies in the finger-print identification industry.

LEGAL MATTERS

The validity of the shares of common stock offered hereby will be passed upon for the Company by Doherty, Rumble & Butler Professional Association, Minneapolis, Minnesota. Certain legal matters in connection with this offering will be passed upon for the Underwriter by Merritt, Furber & Timmer, Minneapolis, Minnesota.

EXPERTS

The financial statements of the Company as of December 31, 1994 and 1995, appearing in this Prospectus and Registration Statement have been audited by Divine, Scherzer & Brody Ltd., independent certified public accountants, as set forth in their report (which includes an explanatory paragraph with respect to the Company's ability to continue as a going concern) appearing elsewhere herein and in the Registration Statement, and are included in reliance upon such report and the authority of such firm as experts in accounting and auditing.

ADDITIONAL INFORMATION

The Company has filed with the WASHINGTON, D.C. Office of the Securities and Exchange Commission (the "Commission") a Registration Statement on Form SB-2 under the Act with respect to the Common Stock offered hereby. This Prospectus does not contain all of the information set forth in the Registration Statement and the exhibits thereto. For further information with respect to the Company and the Common Stock, reference is made to such Registration Statement and exhibits. Statements made in this Prospectus as to the contents of any contract, agreement or other documents referred to are not necessarily complete. With respect to each such contract, agreement or other document filed as an exhibit to the Registration Statement, reference is made to the exhibit for a more complete description of the matter involved. The Registration Statement and exhibits may be inspected without charge and copied at the public reference facilities maintained by the Commission at 450 Fifth Street, N.W., Washington, D.C. 20549. Copies of such material may be obtained at prescribed rates from the Commission's Public Reference Section at the same address. In addition, the Commission maintains a Web site that contains reports, proxy and information statements, and other information regarding issuers which, like the Company, file electronically with the Commission. The address of such site is http://www.sec.gov.

The Company currently is not a reporting company. After completion of this offering, the Company intends to make available to its shareholders annual reports containing financial statements audited by its independent accountants and quarterly reports for the first three quarters of each fiscal year containing unaudited financial information.

INDEX TO FINANCIAL STATEMENTS

Report of Independent Certified Public Accountants ......  F-2

Balance Sheets ..........................................  F-3

Statements of Operations ................................  F-4

Statement of Stockholders' Equity (Deficit) .............  F-5

Statements of Cash Flows ................................  F-6

Notes to Financial Statements ...........................  F-7

REPORT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS

Board of Directors and Stockholders
SAC Technologies, Inc.

We have audited the accompanying balance sheets of SAC Technologies, Inc. (a Minnesota corporation in the development stage) as of December 31, 1994 and 1995 and the related statements of operations, stockholders' equity (deficit) and cash flows for each of the two years in the period ended December 31, 1995, and the period January 7, 1993 (date of inception) through December 31, 1995. These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audits.

We conducted our audits in accordance with generally accepted auditing standards. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe our audits provide a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of SAC Technologies, Inc. as of December 31, 1994 and 1995, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 1995, and the period January 7, 1993 (date of inception) through December 31, 1995, in conformity with generally accepted accounting principles.

The accompanying financial statements have been prepared in conformity with generally accepted accounting principles, which contemplate continuation of the Company as a going concern. However, as discussed in Note B to the financial statements, the Company is in the development stage and has not generated significant revenues since inception, and the Company has a deficit accumulated during the development stage and a deficit in working capital as of December 31, 1995 that raise substantial doubt about its ability to continue as a going concern. Management's plans in regard to these matters are also discussed in Note B. The financial statements do not include any adjustments that might result from this uncertainty.

DIVINE, SCHERZER & BRODY, LTD.

St. Paul, Minnesota
October 18, 1996 (except for notes E and L, as to which the date is December 18, 1996, and note G, as to which the date is January 9, 1997)

SAC TECHNOLOGIES, INC.
(A CORPORATION IN THE DEVELOPMENT STAGE)

BALANCE SHEETS (NOTE B)
ASSETS (NOTE E)

                                                                   DECEMBER 31,          SEPTEMBER 30,
                                                               1994            1995          1996
                                                             ---------      ---------    ------------
                                                                                         (UNAUDITED)
CURRENT ASSETS
  Cash and cash equivalents (note A3) ..................     $   1,049      $   5,221      $ 173,300
                                                             ---------      ---------      ---------
  Inventories (note A4) ................................         5,549          5,613         81,544
  Prepaid expenses .....................................          --            4,657         24,184
                                                             ---------      ---------      ---------
    Total current assets ...............................         6,598         15,491        279,028

EQUIPMENT AND FURNITURE AND FIXTURES -
 AT COST, less accumulated depreciation (notes A5 and C)          --            6,415         22,924

OTHER ASSETS (notes A5, A6 and D) ......................          --            2,233         23,625
                                                             ---------      ---------      ---------
                                                             $   6,598      $  24,139      $ 325,577
                                                             =========      =========      =========

  LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

CURRENT LIABILITIES
  Notes payable (note E) ...............................     $    --        $ 142,000      $ 117,000
  Accounts payable (note I) ............................        10,723          6,304         63,292
  Accrued liabilities ..................................         1,503          1,023          8,367
                                                             ---------      ---------      ---------
    Total current liabilities ..........................        12,226        149,327        188,659

COMMITMENTS AND CONTINGENCIES
 (notes F, I and L) ....................................          --             --             --

STOCKHOLDERS' EQUITY (DEFICIT) (notes E and G)
  Common stock -- authorized,
   20,000,000 shares of $.01 par value
    Class A -- issued and outstanding,
     1,125,000, 1,029,375 and 0 shares .................        11,250         10,294           --
    Class B -- issued and outstanding,
     1,125,000, 1,029,375 and 0 shares .................        11,250         10,294           --
    Common stock -- issued and outstanding,
     0, 0 and 2,508,750 shares .........................          --             --           25,088
  Additional contributed capital .......................        13,753           --          775,005
  Deficit accumulated during the development stage .....       (41,881)      (145,776)      (663,175)
                                                             ---------      ---------      ---------
                                                                (5,628)      (125,188)       136,918
                                                             ---------      ---------      ---------
                                                             $   6,598      $  24,139      $ 325,577
                                                             =========      =========      =========

The accompanying notes are an integral part of these statements.

SAC TECHNOLOGIES, INC.
(A CORPORATION IN THE DEVELOPMENT STAGE)

STATEMENTS OF OPERATIONS (NOTE B)

                                                                     JANUARY 7,                                    JANUARY 7,
                                                                     1993 (DATE                                    1993 (DATE
                                                                    OF INCEPTION)          NINE MONTHS            OF INCEPTION)
                                        YEARS ENDED DECEMBER 31,      THROUGH           ENDED SEPTEMBER 30,         THROUGH
                                       --------------------------   DECEMBER 31,    --------------------------    SEPTEMBER 30,
                                          1994          1995            1995            1995           1996           1996
                                       -----------    -----------   ------------    -----------    -----------    -------------
                                                                                    (UNAUDITED)    (UNAUDITED)     (UNAUDITED)
Revenues (notes A2 and I)
  Reimbursed research and
   development .....................   $    76,000    $   145,320    $   238,306    $    69,623    $      --      $   238,306
  Other services ...................        31,000         83,751        114,751         83,751           --          114,751
                                       -----------    -----------    -----------    -----------    -----------    -----------
                                           107,000        229,070        353,057        153,374           --          353,057
Costs and other expenses (note I)
  Cost of other services ...........        33,154         28,799         61,953         28,799           --           61,953
  Selling, general and
   administrative ..................        12,932         35,849         73,806         18,787        164,437        238,243
  Research and development (note A7)        72,199        250,808        345,565        228,583        326,051        671,616
                                       -----------    -----------    -----------    -----------    -----------    -----------
                                           118,285        315,456        481,324        276,169        490,488        971,812
                                       -----------    -----------    -----------    -----------    -----------    -----------

    Operating loss .................       (11,285)       (86,386)      (128,267)      (122,795)      (490,488)      (618,755)
Other income (expense)
  Interest income ..................          --             --             --             --            3,680          3,680
  Interest expense .................          --             --             --             --          (30,591)       (30,591)
                                       -----------    -----------    -----------    -----------    -----------    -----------
                                              --             --             --             --          (26,911)       (26,911)
                                       -----------    -----------    -----------    -----------    -----------    -----------
    NET LOSS .......................   $   (11,285)   $   (86,386)   $  (128,267)   $  (122,795)   $  (517,399)   $  (645,666)
                                       ===========    ===========    ===========    ===========    ===========    ===========
Loss per common share (note A8) ....   $      --      $      (.03)   $      (.05)   $      (.05)   $      (.20)   $      (.24)
                                       ===========    ===========    ===========    ===========    ===========    ===========
Weighted average number of shares
 outstanding (note A8) .............     2,717,067      2,712,351      2,715,486      2,717,067      2,574,728      2,687,190
                                       ===========    ===========    ===========    ===========    ===========    ===========

The accompanying notes are an integral part of these statements.

SAC TECHNOLOGIES, INC.
(A CORPORATION IN THE DEVELOPMENT STAGE)

STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT) (NOTES B, E AND G)

                                                          COMMON STOCK             COMMON STOCK
                                                             CLASS A                  CLASS B               COMMON STOCK
                                                       -------------------      -------------------       ---------------
                                                       SHARES      AMOUNT       SHARES       AMOUNT       SHARES     AMOUNT
                                                       ------      ------       ------       ------       ------     ------
Sales of common stock January 7, 1993 ............     787,500   $    7,875      787,500   $    7,875         --    $     --
Sale of common stock January 7, 1993
 at $.04 per share ...............................     337,500        3,375      337,500        3,375         --          --
Contribution of services .........................        --           --           --           --           --          --
Net loss for the period from January 7, 1993
 (date of inception) through December 31, 1993 ...        --           --           --           --           --          --
Net loss for the year ended December 31, 1994 ....        --           --           --           --           --          --
                                                     ---------   ----------    ---------   ----------    ---------  ---------
    Balance as of December 31, 1994 ..............   1,125,000       11,250    1,125,000       11,250         --          --

Redemption of director and officers common
 stock August 4, 1995 at $0 per share ............     (67,500)        (675)     (67,500)        (675)        --          --
Sale of common stock August 4, 1995
 at $.48 per share ...............................     236,250        2,363      236,250        2,363         --          --
Redemption of common stock August 4, 1995
 at $.47 per share ...............................    (168,750)      (1,688)    (168,750)      (1,688)        --          --
Sale of common stock December 22, 1995
 at $.34 per share ...............................      73,125          732       73,125          732         --          --
Redemption of common stock December 22, 1995
 at $.44 per share ...............................    (168,750)      (1,688)    (168,750)      (1,688)        --          --
Net loss for the year ended December 31, 1995 ....        --           --           --           --           --          --
                                                     ---------   ----------    ---------   ----------    ---------  ---------
    Balance as of December 31, 1995 ..............   1,029,375       10,294    1,029,375       10,294         --          --

Conversion of Class A and B common stock into
 common stock (unaudited) ........................  (1,029,375)     (10,294)  (1,029,375)     (10,294)   2,058,750      20,588
Issuance of detachable warrants on May 17, 1996,
 in connection with bridge financing arrangements,
 valued at $25,000, to purchase an aggregate of
 50,000 shares of common stock at $2.00 per share
 (unaudited) .....................................        --           --           --           --           --          --
Sales of common stock during June and July, 1996
 at $2.00 per share, less offering costs of
 $124,663 (unaudited) ............................        --           --           --           --        349,080       3,491
Conversion of bridge notes plus accrued
 interest of $1,841 to common stock on June 28,
 1996 at $2.00 per share (unaudited) .............        --           --           --           --        100,920       1,009
Net loss for the nine months ended September
 30, 1996 (unaudited) ............................        --           --           --           --           --          --
                                                     ---------   ----------    ---------   ----------    ---------  ---------
    Balance as of September 30, 1996 (unaudited) .        --     $     --           --     $     --      2,508,750  $   25,088
                                                     =========   ==========    =========   ==========    =========  ==========

[WIDE TABLE CONTINUED FROM ABOVE]

                                                                    DEFICIT
                                                                   ACCUMULATED
                                                      ADDITIONAL   DURING THE
                                                     CONTRIBUTED   DEVELOPMENT
                                                       CAPITAL        STAGE       TOTAL
                                                     -----------   -----------    -----


Sales of common stock January 7, 1993 ............   $  (15,747)  $     --     $        3
Sale of common stock January 7, 1993
 at $.04 per share ...............................       18,250         --         25,000
Contribution of services .........................       11,250         --         11,250
Net loss for the period from January 7, 1993
 (date of inception) through December 31, 1993 ...         --        (30,596)     (30,596)
Net loss for the year ended December 31, 1994 ....         --        (11,285)     (11,285)
                                                     ----------   ----------   ----------
    Balance as of December 31, 1994 ..............       13,753      (41,881)      (5,628)

Redemption of director and officers common
 stock August 4, 1995 at $0 per share ............        1,350         --           --
Sale of common stock August 4, 1995
 at $.48 per share ...............................      220,274         --        225,000
Redemption of common stock August 4, 1995
 at $.47 per share ...............................     (154,798)        --       (158,174)
Sale of common stock December 22, 1995
 at $.34 per share ...............................       48,536         --         50,000
Redemption of common stock December 22, 1995
 at $.44 per share ...............................     (129,115)     (17,509)    (150,000)
Net loss for the year ended December 31, 1995 ....         --        (86,386)     (86,386)
                                                     ----------   ----------   ----------
    Balance as of December 31, 1995 ..............         --       (145,776)    (125,188)

Conversion of Class A and B common stock into
 common stock (unaudited) ........................         --           --           --
Issuance of detachable warrants on May 17, 1996,
 in connection with bridge financing arrangements,
 valued at $25,000, to purchase an aggregate of
 50,000 shares of common stock at $2.00 per share
 (unaudited) .....................................       25,000         --         25,000
Sales of common stock during June and July, 1996
 at $2.00 per share, less offering costs of
 $124,663 (unaudited) ............................      570,006         --        573,497
Conversion of bridge notes plus accrued
 interest of $1,841 to common stock on June 28,
 1996 at $2.00 per share (unaudited) .............      179,999         --        181,008
Net loss for the nine months ended September
 30, 1996 (unaudited) ............................         --       (517,399)    (517,399)
                                                     ----------   ----------   ----------
    Balance as of September 30, 1996 (unaudited) .   $  775,005   $ (663,175)  $  136,918
                                                     ==========   ==========   ==========

The accompanying notes are an integral part of this statement.

SAC TECHNOLOGIES, INC.
(A CORPORATION IN THE DEVELOPMENT STAGE)

STATEMENTS OF CASH FLOWS (NOTES A3, B AND J)

                                                                            JANUARY 7,                                  JANUARY 7,
                                                                            1993 (DATE                                  1993 (DATE
                                                                           OF INCEPTION)                               OF INCEPTION)
                                              YEARS ENDED DECEMBER 31,       THROUGH            NINE MONTHS               THROUGH
                                             --------------------------    DECEMBER 31,      ENDED SEPTEMBER 30,       SEPTEMBER 30,
                                                 1994          1995           1995           1995          1996            1996
                                             -----------   ------------   -------------  -------------  -----------   ------------
                                                                                           (UNAUDITED)  (UNAUDITED)    (UNAUDITED)
Increase (Decrease) in Cash and
 Cash Equivalents
  Cash flows from operating activities
    Net loss ............................   $   (11,285)   $   (86,386)   $  (128,267)   $  (122,795)   $  (517,399)   $  (645,666)
    Adjustments to reconcile net loss to
     net cash used in operating
     activities:
      Depreciation (note A5) ............          --              509            509            200          2,584          3,093
      Amortization (note A5) ............          --             --             --             --             --             --
      Revenues realized due to offset of
      billings against a stock repurchase          --         (170,174)      (170,174)       (88,174)          --         (170,174)
      Research and development ..........          --          117,000        117,000        117,000           --          117,000
      Contribution of services ..........          --             --           11,250           --             --           11,250
      Change in assets and liabilities:
       Inventories ......................        (3,705)           (64)        (5,613)            31        (75,931)       (81,544)
       Prepaid expenses .................          --           (4,657)        (4,657)       (10,435)       (19,527)       (24,184)
       Accounts payable .................        10,028         (4,419)         6,304        (10,723)        56,988         63,292
       Accrued liabilities ..............         1,479           (480)         1,023           (503)         7,344          8,367
                                            -----------    -----------    -----------    -----------    -----------    -----------
                                                  7,802        (62,285)       (44,358)         7,396        (28,542)       (79,900)
                                            -----------    -----------    -----------    -----------    -----------    -----------
         Net cash used in
          operating activities ..........        (3,483)      (148,671)      (172,625)      (115,399)      (545,941)      (718,566)

Cash flows from investing activities
  Capital expenditures ..................          --           (6,924)        (6,924)        (6,200)       (19,093)       (26,017)
  Security deposits .....................          --           (2,233)        (2,233)        (2,233)        (2,650)        (4,883)
  Patents and trademarks ................          --             --             --             --           (4,514)        (4,514)
                                            -----------    -----------    -----------    -----------    -----------    -----------
         Net cash used for
          investing activities ..........          --           (9,157)        (9,157)        (8,433)       (26,257)       (35,414)

Cash flows from financing activities
  Net borrowings (repayments) under
   short-term borrowing agreements ......          --           25,000         25,000           --          (25,000)          --
  Deferred offering costs ...............          --             --             --             --          (14,228)       (14,228)
  Sales of common stock .................          --          275,000        300,003        225,000        754,505      1,054,508
  Issuance of warrants ..................          --             --             --             --           25,000         25,000
  Redemption of common stock ............          --         (138,000)      (138,000)       (70,000)          --         (138,000)
                                            -----------    -----------    -----------    -----------    -----------    -----------
         Net cash provided by
          financing activities ..........          --          162,000        187,003        155,000        740,277        927,280
                                            -----------    -----------    -----------    -----------    -----------    -----------
         Net increase (decrease) in cash         (3,483)         4,172          5,221         31,168        168,079        173,300

Cash and cash equivalents at beginning of
 period .................................         4,532          1,049           --            1,049          5,221           --
                                            -----------    -----------    -----------    -----------    -----------    -----------
Cash and cash equivalents at end of
 period .................................   $     1,049    $     5,221    $     5,221    $    32,217    $   173,300    $   173,300
                                            ===========    ===========    ===========    ===========    ===========    ===========

The accompanying notes are an integral part of these statements.

SAC TECHNOLOGIES, INC.
(A CORPORATION IN THE DEVELOPMENT STAGE)

NOTES TO FINANCIAL STATEMENTS

Years ended December 31, 1994 and 1995 (audited) and nine months ended September 30, 1995 and 1996 (unaudited)

NOTE A -- NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NATURE OF BUSINESS

SAC Technologies, Inc. (formerly B.B.G. Engineering, Inc.) was incorporated in Minnesota in January 1993 to develop real time, stand-alone systems capable of identifying individuals through automated fingerprint analysis for use in controlling access to resources, information and facilities. The Company is a development stage enterprise that conducts its operations from Minnesota and Las Vegas. From inception through most of 1996 the Company's development efforts, which by agreement (see note I) were to be funded by Jasper Consulting, Inc. ("Jasper"), were principally focused on the development of its fingerprint identification and analysis products. In the second half of 1996, the Company shifted its principal focus from development to marketing and sales of its products. Jasper was a stockholder of the Company from inception through December 1995.

The Company's more significant current product offerings incorporate the Company's "Optic Technology" and "Biometric Solution" with "FIDS Technology." The "FIDS Technology" was developed by the Company for Jasper (see note I). The Company has licensed the "FIDS Technology" from Jasper. The Company has a world-wide license agreement with Jasper for use of the FIDS technology in all markets except for financial services, law enforcement, national identification systems, and personal identification systems for government and medical applications, which market rights belong to Jasper. In addition, Jasper has a worldwide license agreement with the Company for use of the "Optics Technology" and "Biometric Solution" technology within Jasper's above described markets.

The Company also has completed development of a Set Top Box, which provides for basic personal computer functions and Internet access via a wireless keyboard and a conventional television set. However, the Company does not believe that the promotion and marketing of the Set Top Box is within its focus and, accordingly, conveyed the technology in exchange for a 50% ownership interest in the initial equity of Inter-Con/PC, Inc. ("Inter-Con"), a development stage company during October 1996. See note L for additional information.

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

A summary of the significant accounting policies consistently applied in the preparation of the accompanying financial statements follows:

1. UNAUDITED INTERIM INFORMATION

In the opinion of management, the unaudited September 30, 1995 and 1996 interim financial statements reflect all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation. The results of operations for these periods are not necessarily indicative of future results.

2. REVENUE RECOGNITION

Revenue is recognized from product sales and services when a product is shipped or the services are provided, the sales price is fixed, and when collection is considered probable. Where collectibility is considered doubtful, revenue is recognized on the basis of cash received (see note I).

3. CASH AND CASH EQUIVALENTS

The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents.

4. INVENTORIES

Inventories are stated at the lower of cost or market. Cost is determined using the first-in, first-out (FIFO) method.

5. DEPRECIATION AND AMORTIZATION

Depreciation is provided for in amounts sufficient to relate the cost of depreciable assets to operations over their estimated services lives of five to seven years using the straight-line method for financial reporting purposes and accelerated methods for tax reporting purposes. Deferred income taxes are provided for these differences.

Amortization of the discount on debt issuance is provided for on the interest method over the term of the debt. Amortization of finance costs is provided over the respective term of the debt agreement.

Costs associated with patents and trademarks are capitalized and amortized over sixty months or the remaining life of the patent or trademark, whichever is shorter.

6. OTHER ASSETS

Deferred offering costs consist of legal fees and related expenses in connection with a proposed initial public offering of the Company's common stock (note G). Should the offering prove unsuccessful, the deferred costs, as well as any additional expenses to be incurred, will be charged to operations.

7. RESEARCH AND DEVELOPMENT EXPENDITURES

All costs related to development of new products are charged to expense as incurred. Such costs are required to be expensed until technological feasibility and proven marketability of the product are established. There have been no costs capitalized post technological feasibility.

8. LOSS PER SHARE

Loss per common share is determined by dividing the net loss by the weighted average number of shares of common stock and common stock equivalents outstanding.

Under Securities and Exchange Commission rules for initial public offerings, common stock equivalents for all periods presented include shares sold or options or warrants granted within twelve months prior to the date of the Company's initial public offering at per share prices less than that of the initial public offering (assumed to be $6.00 per share) even if the impact is antidilutive.

9. INCOME TAXES

The Company provides for income taxes based on income reported for financial reporting purposes. Certain charges to earnings differ as to timing from those deducted for tax purposes; these relate primarily to revenue recognition and net operating loss carry forwards. The tax effect of these differences are recorded as deferred income taxes.

10. ACCOUNTING FOR STOCK BASED COMPENSATION

No accounting recognition is given to employee stock options issued at fair market value or greater until they are exercised, at which time the proceeds are credited to the capital accounts. With respect to non-statutory compensatory options, the Company may recognize a tax benefit upon exercise of these options in an amount equal to the excess of the fair market value of the common stock over the option price on the day of the exercise. With respect to incentive stock options, tax benefits arising from disqualifying dispositions are recognized at the time of disposition. Tax benefits related to stock options are credited to additional contributed capital.

Financial Accounting Standards Board Statement No. 123, "Accounting for Stock-Based Compensation," issued in October 1995 and effective for fiscal years beginning after December 15, 1995, encourages, but does not require, a fair value based method of accounting for employee stock options or similar equity instruments. As permitted under the new standard, the Company will continue to account for employee stock options under Accounting Principles Board Opinion No. 25, "Accounting for Stock Issued to Employees." See note G for further information.

11. USE OF ESTIMATES

In preparing financial statements in conformity with generally accepted accounting principles, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

NOTE B -- DEVELOPMENT STAGE ENTERPRISE AND GOING CONCERN

The accompanying financial statements have been prepared in conformity with generally accepted accounting principles, which contemplate continuation of the Company as a going concern. However, the Company is a development stage enterprise with no significant sales of its products. There can be no assurance that the Company will be able to generate significant sales of its products. Additionally, the Company has a deficit accumulated during the development stage of $663,175 (unaudited) as of September 30, 1996. Management anticipates net losses will continue for the foreseeable future. Management believes existing cash and availability under it's line of credit agreement with a bank will not be adequate to last beyond early 1997. Additional financing, which may not be available, will be necessary during the period required to complete development and enhancement of the Company's products and to develop markets for the Company's products.

The matters described in the preceding paragraph raise substantial doubt about the Company's ability to continue as a going concern. Recoverability of a major portion of the recorded asset amounts shown in the accompanying balance sheet is dependent upon the Company advancing beyond the development stage and continuing its operations, which in turn is dependent upon the Company's ability to obtain additional financing, meet its financing requirements on a continuing basis, and succeed in its future operations. The accompanying financial statements do not include any adjustments that might be necessary should the Company be unable to continue in existence.

During May through July 1996, the Company raised $900,000 of gross proceeds through bridge financing arrangements and through a private offering of its common stock. Additionally, the Company plans to raise additional funds to support operations through a $6,600,000 (before deduction of offering costs) "firm commitment" initial public offering of its common stock (see note G). Management believes that if the gross proceeds are raised (of which there can be no assurance), the proceeds will be adequate to fund operations through approximately mid-1998.

NOTE C -- EQUIPMENT AND FURNITURE AND FIXTURES

                                                                 DECEMBER 31,    SEPTEMBER 30,
                                                                     1995            1996
                                                                 ------------    -------------
                                                                                 (UNAUDITED)
Equipment ....................................................     $   6,924      $  25,017
Furniture and Fixtures .......................................          --            1,000
                                                                   ---------      ---------
                                                                       6,924         26,017
Accumulated depreciation .....................................          (509)        (3,093)
                                                                   ---------      ---------
                                                                   $   6,415      $  22,924
                                                                   =========      =========
NOTE D -- OTHER ASSETS

                                                                  DECEMBER 31,   SEPTEMBER 30,
                                                                      1995          1996
                                                                 ------------    -------------
                                                                                 (UNAUDITED)

Deferred offering costs ......................................     $    --        $  14,228
Patents ......................................................          --            4,514
Security deposits ............................................         2,233          4,883
                                                                   ---------      ---------
                                                                   $   2,233      $  23,625
                                                                   =========      =========

NOTE E -- NOTES PAYABLE

                                                                 DECEMBER 31,   SEPTEMBER 30,
                                                                      1995          1996
                                                                 ------------   -------------
                                                                                 (UNAUDITED)

Non-interest bearing demand note payable to stockholder with
 interest imputed at 8%; collateralized by a $117,000
 receivable
 from Jasper (note I) ........................................     $ 117,000      $ 117,000
Unsecured note payable to stockholder bearing interest at 9%;
 interest and principle due 60 days after closing on financing
 equal to or greater than $200,000 ...........................        25,000           --
                                                                   ---------      ---------
                                                                   $ 142,000      $ 117,000
                                                                   =========      =========

During January 1996, the Company entered into a revolving line of credit agreement with a bank for borrowings of up to $150,000 at 1% above the prime rate of interest. During December 1996, the agreement was amended to provide for borrowings of up to $250,000 at the same rate of interest and to extend the maturity date of the agreement to January 1998. The agreement requires paydown of outstanding balances to $100 for thirty days, is collateralized by substantially all assets and is guaranteed by three stockholders. The agreement contains covenants limiting additional indebtedness, change in ownership, and mergers and sale of company assets, among other matters.

In connection with issuance of $200,000 of 8% convertible bridge notes in May 1996, the Company issued warrants to purchase 50,000 shares of common stock (see note G). A total of $25,000 was assigned as the value of the warrants and a corresponding $25,000 discount on debt issuance was recorded.

During June 1996, the convertible bridge note holders converted the bridge notes and $1,841 of related accrued interest at $2.00 per share into 100,920 shares of common stock. In connection with this conversion, the unamortized discount on convertible bridge notes of $20,833 was also transferred to stockholders' equity.

NOTE F -- COMMITMENTS AND CONTINGENCIES

LEASE AGREEMENTS

The Company operates from leased facilities under noncancelable operating leases that expire during August 1998 for its Minnesota location and May 1997 for its Nevada location. The Company pays for property taxes, maintenance, insurance, and other occupancy expense applicable to the leased premises.

Minimum rental commitments of non-cancelable operating leases are approximately as follows:

Year ending December 31,
   1996 .................................................  $30,000
   1997 .................................................   29,000
   1998 .................................................   15,000
                                                           -------
                                                           $74,000
                                                           =======

Rental expense was as follows:

Year ended December 31,
   1994 .................................................  $ 6,000
   1995 .................................................   11,094

January 7, 1993 (date of inception) through
  December 31, 1995 .....................................   17,094

Nine months ended September 30, (unaudited)
   1995 .................................................    5,190
   1996 .................................................   27,220

January 7, 1993 (date of inception) through
  September 30, 1996 (unaudited) ........................   44,314

EMPLOYMENT AGREEMENTS

The Company has employment agreements with four individuals. The employment agreements contain non-compete clauses that prohibit the employees from being employed by a competitor of the Company. The non-compete clause is in effect for two years for voluntary terminations and three years for terminations with cause. In the event of "constructive termination," as defined, the agreements provide each employee with up to five years and three months salary (as of September 30, 1996) reduced by one month each month thereafter until December 31, 2001, at which time the amount of severance is two years. As of September 30, 1996, the aggregate commitment approximates $1,638,000 (unaudited).

NOTE G -- STOCKHOLDERS' EQUITY

AUTHORIZED CAPITAL AND STOCK SPLIT

Originally, the Company authorized 1,000,000 shares of capital stock. The Company's Class A and Class B common stock are identical in all terms except the Class A stock has voting privileges. In April 1996, the articles of incorporation were amended and restated to authorize 20,000,000 shares of $.01 par value common stock. The existing shares of Class A and Class B common stock were converted into the new $.01 par value common stock. Concurrently, the Company declared a nine for two stock split in the form of a stock dividend. The financial statements and accompanying notes for the periods presented have been restated for the changes in the authorized capital stock and the stock split.

During August 1995, the Company redeemed 67,500 shares each of Class A and Class B common stock at no cost from its then existing stockholders.

1996 STOCK OPTION PLAN

During May 1996, the Board of Directors and stockholders of the Company adopted the 1996 Stock Option Plan (the Plan). Under the Plan, 375,000 shares of common stock are reserved for issuance to employees, officers, directors, and consultants of the Company at exercise prices which may not be below 100% of fair market value for incentive stock options and 50% for all others. Pursuant to the Plan, the term of incentive stock options and nonstatutory stock options granted may not exceed ten years. Options issued under the Plan vest pursuant to the terms of stock option agreements with the recipients. The Plan terminates in May 2006.

The Plan contains a director option formula option arrangement. Pursuant to the formula arrangement, each non-employee director, upon election to the board of directors, will be granted options to purchase shares of common stock equal to 25,000 multiplied by a percentage, the numerator is the total months remaining between grant date and May 2001 and the denominator is 60 months. The formula arrangement is reset every five years (again in May 2001) whereby the numerator becomes the number of months remaining between grant date and May 2006. The options vest annually during May at 5,000 shares per year except the first partial year vested amount represents that portion applicable to one twelfth of the total number of months from grant date to the following May.

In the event of a change in control, as defined, all options outstanding vest immediately and are exercisable for their remaining terms. During July 1996, the Company issued stock options to employees, consultants and directors as follows:

                                           TOTAL OPTIONS       PRICE
                                            OUTSTANDING      PER SHARE
                                            -----------      ---------

Balance December 31, 1995 ..............           --          $  --
  Nonstatutory stock options
   (unaudited) .........................       15,000           2.00
  Nonstatutory stock options
   (unaudited) .........................      114,500           2.25
  Incentive stock options (unaudited) ..       43,500           2.25
                                              -------
Balance September 30, 1996 (unaudited)..      173,000
                                              =======

No stock options are exercisable at September 30, 1996, nor have any options been exercised.

COMMON STOCK WARRANTS

The Company issued warrants to purchase shares of common stock to convertible bridge noteholders in May 1996 and to the underwriter of a private stock offering that was completed in July 1996. No warrants have been exercised through September 30, 1996 (unaudited). Warrant activity is summarized as follows:

                                                                         PRICE
                                                        OUTSTANDING    PER SHARE    EXPIRATION DATE
                                                        -----------    ---------    ---------------
Balance December 31, 1995 ............................         --        $  --             --
  Granted to bridge noteholders (unaudited) ..........     50,000         2.00           1999
  Granted to underwriter (unaudited) .................     41,639         2.40(1)        2001
                                                           ------
Balance September 30, 1996 (unaudited) ...............     91,639
                                                           ======
Total exercisable at $2.00 per share at September
 30, 1996 (unaudited) ................................     50,000
                                                           ======

(1) See "Initial Public Offering" below for discussion of an adjustment to the exercise price of the warrants from $2.40 to $6.00 in the event of a successful completion of the Company's planned initial public offering.

INITIAL PUBLIC OFFERING

The Company has entered into a non-binding letter of intent with Tuschner & Company (the "Agent") whereby the Agent intends, on a "firm commitment" basis, to sell 1,100,000 shares of the Company's common stock (subject to an increase to 1,210,000 shares for a 110,000 share over-allotment) at $6.00 per share. The original terms of the letter of intent provided for payment of a ten percent (10%) commission and a three percent (3%) non-accountable expense allowance from the gross proceeds, and also provided for a five-year warrant to purchase 110,000 shares of common stock at an exercise price of 120% of the offering price per share.

During January 1997, the Agent consented to modify the terms of the letter of intent as follows:

* The commission was reduced to eight and one-half percent (8.5%) of the gross proceeds.

* The non-accountable expense allowance was reduced to two percent (2%) of the gross proceeds.

* The five year warrant to purchase 110,000 shares of common stock at an exercise price of 120% of the offering price per share was reduced to a warrant to purchase 44,496 shares of common stock under similar terms.

Additionally, in connection with the above, the Agent consented to adjust the exercise price of their warrant to purchase 41,639 shares of common stock from $2.40 per share to $6.00 per share upon successful completion of the Company's planned initial public offering.

NOTE H -- INCOME TAXES

Deferred taxes consist of the following:

                                           DECEMBER 31,       SEPTEMBER 30,
                                       1994         1995           1996
                                       ----         ----      -------------
                                                               (UNAUDITED)
Revenue recognition ...............  $  4,000     $ 30,000      $ 153,000
Net operating loss carryforwards ..     6,000        3,000         89,000
                                     --------     --------      ---------
                                       10,000       33,000        242,000
Less valuation allowance ..........   (10,000)     (33,000)      (242,000)
                                     --------     --------      ---------
                                     $     --     $     --      $      --
                                     ========     ========      =========

Valuation allowances have been recorded due to uncertainty of realization of deferred tax assets principally due to the development stage nature and operating loss history of the Company. However, the valuation allowances could be reduced or eliminated based on future earnings and future estimates of taxable income.

As of December 31, 1995, the Company had federal and Minnesota net operating loss carryforwards of approximately $10,000. Net operating loss carryforwards available to offset future taxable income may be subject to the limitations under Section 382 of the Internal Revenue Code due to changes in the equity ownership of the Company.

NOTE I -- RELATED PARTY TRANSACTIONS

RESEARCH AND DEVELOPMENT ARRANGEMENT WITH JASPER

Jasper agreed to fund research and development for the Company's products from inception through April 1996 principally in consideration of an assignment of the patent rights to the FIDS Technology. Research and development funding after this date was the responsibility of the Company.

The Company has billed various amounts for reimbursement under the development arrangement with Jasper. Jasper has not paid the majority of these billings. The Company believes Jasper does not have the financial wherewithal to pay for such amounts. The Company has an agreement with Jasper, whereby the Company may offset future product royalties (see below) due to Jasper, if any, against outstanding billings. The Company may also charge an additional $800 for each product manufactured by the Company for Jasper.

The Company has sold no products which would require payment of royalties to Jasper. The Company has no orders to manufacture products on behalf of Jasper. No assurance can be given that future sales subject to payment of royalty to Jasper or orders to manufacture products on behalf of Jasper will occur in amounts sufficient to offset the uncollected billings, if at all. Therefore, realizability of outstanding billings to Jasper are not assured and have not been recognized. Should outstanding billings to Jasper be collected in the future, they will be reflected in income upon receipt.

The following summarizes outstanding billings to Jasper:

                                    DECEMBER 31,        SEPTEMBER 30,
                                 1994         1995           1996
                                 ----         ----      -------------
                                                          (UNAUDITED)
Research and development:
 Optics technology (note E)...  $    --     $117,000       $117,000
 Other .......................   15,421           --        290,000
                                -------     --------       --------
                                $15,421     $117,000       $407,000
                                =======     ========       ========

Total costs incurred pursuant to the development arrangement with Jasper were as follows:

Year ended December 31,
    1994 .......................................  $ 72,199
    1995 .......................................   236,891

Nine months ended September 30,
    1995 .......................................   228,583
    1996 .......................................    72,471

January 7, 1993 (date of inception) through
    December 31, 1995 ..........................   331,647
    September 30, 1996 (unaudited) .............   404,118

FIDS LICENSE AGREEMENT WITH JASPER

The Company's underlying technology consists of "Optic Technology," "Biometric Solution" technology, "FIDS Technology," and "SAC_App." To the extent patentable, Jasper has patent rights to the "FIDS Technology" and the Company maintains the patent rights to the other technologies.

The following are the more significant terms and conditions of the FIDS license arrangement with Jasper:

* The Company and Jasper have exclusive world wide license rights to each other's technologies as defined (see note A).

* The Company is to pay a $30.50 per unit royalty to Jasper for all sales made by the Company of products utilizing the "FIDS Technology."

* The Company is to receive a $30.00 per unit royalty from Jasper for sales made by Jasper of products utilizing the "FIDS Technology."

* Jasper receives all rights to future modifications or improvements made by the Company to the "FIDS Technology."

* The Company may not sell, assign, or transfer its "FIDS Technology" or grant sublicenses without consent of Jasper. In the event of sale, assignment, transfer, or sublicense of "FIDS Technology" by the Company, 42% of any sales proceeds are required to be remitted to Jasper and 10% to be retained to fund ongoing development. Additionally, in the event of sale, assignment, transfer, or sublicense of "FIDS Technology" by Jasper, 42% of any sales proceeds are required to be remitted to the Company, with 10% of such amount to be utilized to fund ongoing development.

* The term of the agreement expires the later of April 2016 or the date of the last patent to expire (as of September 30, 1996 no patents were issued, and none can be assured of being issued).

There was no royalty income or expense during the periods presented.

OTHER TRANSACTIONS OR AGREEMENTS WITH JASPER

The Company has the exclusive right to manufacture certain products sold by Jasper during the term of the license agreement discussed above. Repayment of amounts due are subject to 45 day payment terms.

Total accounts payable to Jasper were $6,304 as of December 31, 1995.

OTHER TRANSACTIONS

                                                                    JANUARY 7,                                    JANUARY 7,
                                                                    1993 (DATE                                    1993 (DATE
                                                                   OF INCEPTION)         NINE MONTHS             OF INCEPTION)
                                         YEARS ENDED DECEMBER 31,     THROUGH         ENDED SEPTEMBER 30,           THROUGH
                                         ------------------------  DECEMBER 31,    -------------------------      SEPTEMBER 30,
                                           1994         1995           1995            1995           1996            1996
                                           ----         ----       ------------    ----------     ----------      -------------
                                                                                   (UNAUDITED)    (UNAUDITED)      (UNAUDITED)
Revenues from Jasper ...............     $107,000     $229,070       $353,057        $153,374        $    -         $353,057
Purchase of optics technology
 (see below) .......................         --        117,000        117,000         117,000             -          117,000
Payments for rent, assembly, and
 computer aided design services
 from an affiliate .................       48,893       22,156         77,049          22,156             -           77,049
Equipment purchased from stockholder         --          5,000          5,000           5,000             -            5,000

During August 1995, the Company purchased certain elements of its "Optic Technology" from an individual who also purchased common stock of the Company. The total purchase price of $117,000 was agreed to be reimbursed by Jasper. See note F for information on related party notes payable.

NOTE J -- SUPPLEMENTARY DISCLOSURES OF CASH FLOW INFORMATION

                                                               JANUARY 7,                                      JANUARY 7,
                                                              1993 (DATE                                     1993 (DATE
                                           YEARS ENDED       OF INCEPTION)          NINE MONTHS             OF INCEPTION)
                                           DECEMBER 31,         THROUGH          ENDED SEPTEMBER 30,            THROUGH
                                         --------------       DECEMBER 31,    ---------------------------    SEPTEMBER 30,
                                         1994      1995           1995            1995           1996            1996
                                         ----      ----       ------------    -----------     -----------   --------------
                                                              (UNAUDITED)     (UNAUDITED)     (UNAUDITED)
1. Cash Paid for Interest Expense and
   Income Taxes
    Interest ..........................  $ --    $     --       $     --        $    --         $19,415         $ 19,415
    Income taxes ......................    --          --             --             --              --               --
2. Noncash Financing Activities
    Common stock repurchases ..........    --     170,174        170,174         88,174              --          170,174

NOTE K -- FAIR VALUES OF FINANCIAL INSTRUMENTS

The financial statements include various estimated fair value information as of December 31, 1994 and 1995, and September 30, 1996 (unaudited) as required by FASB Statement 107. Such information, which pertains to the Company's financial instruments, is based on the requirements set forth in that Statement and does not purport to represent the aggregate net fair value of the Company. All material financial instruments as of December 31, 1994 and 1995 and September 30, 1996 (unaudited), for which it is practicable to estimate the value, approximated fair value because of the short maturity of those instruments.

NOTE L -- SUBSEQUENT EVENT

During October 1996, the Company contributed its "Set Top Box" technology to Inter-Con for a 50% ownership interest in the initial equity of Inter-Con. Inter-Con is a development stage enterprise founded in June 1996 to market and distribute the "Set Top Box" and related products.

The Company will receive a 2% royalty on sales of Inter-Con through November 2002 or until Inter-Con becomes a public company, as defined. The Company has also entered into a technical support agreement with Inter-Con for technical support to Inter-Con for a fee of up to $20,000 per month. The technical support agreement expires October 31, 1999, however, it is subject to three successive one year periods at Inter-Con's option.

The Company is obligated to complete development of certain products for Inter-Con. The Company believes the total costs associated with such commitment to be approximately $30,000.

NO DEALER, SALESPERSON, OR OTHER PERSON HAS BEEN AUTHORIZED TO GIVE ANY INFORMATION OR TO MAKE ANY REPRESENTATION NOT CONTAINED IN THIS PROSPECTUS IN CONNECTION WITH THE OFFERING MADE HEREBY. IF GIVEN OR MADE, SUCH INFORMATION OR REPRESENTATION MUST NOT BE RELIED UPON AS HAVING BEEN AUTHORIZED BY THE COMPANY OR THE UNDERWRITER. THIS PROSPECTUS DOES NOT CONSTITUTE AN OFFER TO SELL OR SOLICITATION OF AN OFFER TO PURCHASE BY ANY PERSON IN ANY JURISDICTION IN WHICH SUCH OFFER WOULD BE UNLAWFUL. NEITHER THE DELIVERY OF THIS PROSPECTUS NOR ANY SALE MADE HEREUNDER SHALL UNDER ANY CIRCUMSTANCES CREATE ANY IMPLICATION THAT THE INFORMATION CONTAINED HEREIN IS CORRECT AS OF ANY TIME SUBSEQUENT TO THE DATE HEREOF.

TABLE OF CONTENTS

                                           Page
Prospectus Summary                            3
Risk Factors                                  5
Use of Proceeds                              10
Dilution                                     11
Dividend Policy                              12
Capitalization                               12
Selected Financial Data                      13
Management's Discussion and Analysis of
 Financial Condition and
 Results of Operations                       14
Business                                     17
Management                                   23
Certain Transactions                         26
Principal Shareholders                       28
Shares Eligible for Future Sale              29
Description of Securities                    30
Underwriting                                 32
Legal Matters                                33
Experts                                      33
Additional Information                       33
Index to Financial Statements               F-1

Until , 1997 (25 days after the date of this Prospectus), all dealers effecting transactions in the registered securities, whether or not participating in this distribution, may be required to deliver a Prospectus. This is in addition to the obligation of dealers to deliver a Prospectus when acting as underwriters and with respect to their unsold allotments or subscriptions.

1,100,000 SHARES

[LOGO] SAC TECHNOLOGIES, INC.

SAC TECHNOLOGIES, INC.

COMMON STOCK

PROSPECTUS

Tuschner & Company, Inc.

, 1997

PART II
INFORMATION NOT REQUIRED IN PROSPECTUS:

ITEM 24. INDEMNIFICATION OF DIRECTORS AND OFFICERS.

The small business issuer's Bylaws provide for the indemnification of certain corporate agents, including the small business issuer's directors, officers and employees. The indemnification provided to the Company's directors, officers and employees includes coverage for amounts actually and reasonably incurred by such individuals in connection with proceedings arising by reason of each such individual's status as an officer, director or employee. The amount for which the director, employee or officer is to be indemnified includes expenses, including attorney's fees, judgments, fines and amounts paid in settlement of claims.

The Company is governed by the provisions of Sections 302A.671 and 302A.673 of the Minnesota Business Corporation Act. In general, Section 302A.671 provides that the shares of a corporation acquired in a "control share acquisition" have no voting rights unless the control share acquisition is approved in a prescribed manner. A "control share acquisition" is an acquisition, directly or indirectly, of beneficial ownership of shares that would, when added to all other shares beneficially owned by the acquiring person, cause the acquiring person to have voting power in the election of directors to exceed any one of the following thresholds of ownership: 20%, 33-1/3% or 50%. In general, Section 302A.673 prohibits a publicly-held Minnesota corporation from engaging in a "business combination" with an "interested shareholder" for a period of four years after the date of transaction in which the person became an interested shareholder, unless the business combination is approved in a prescribed manner. "Business combination" includes mergers, asset sales and other transactions resulting in a financial benefit to the interested shareholder. An "interested shareholder" is a person who is the beneficial owner, directly or indirectly, of 10% or more of the corporation's voting stock or who is an affiliate or associate of the corporation and at any time within four years prior to the date in question was the beneficial owner, directly or indirectly, of 10% or more of the corporation's voting stock.

The small business issuer does not carry any directors' and officers' liability insurance.

ITEM 25. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION.

SEC registration fee ................ $  2,200
NASD filing fee .....................    1,226
Nasdaq SmallCap Market listing fee ..    5,000
Accounting fees and expenses ........   60,000
Legal fees and expenses .............  125,000
Printing expenses ...................   15,000
Blue Sky fees and expenses ..........   10,000
Transfer agent fees and expenses ....    5,000
Miscellaneous .......................   11,574
                                      --------
  Total                               $235,000
                                      ========

Except for the SEC registration fees and the Nasdaq fees, all of the foregoing expenses have been estimated. The Selling Shareholders will not bear any of the expenses of this offering.

ITEM 26. RECENT SALES OF UNREGISTERED SECURITIES.

During the past three years, the small business issuer has sold the following securities pursuant to exemptions from registration under the Securities Act. All such sales were made in reliance upon the exemptions from registration provided under Section 4(2) or Regulation D of the Securities Act of 1933, as amended (the "Securities Act") and related state securities laws. Unless otherwise stated, all shares were issued directly by the Company, no underwriters were involved, and no discount, commission or other transaction related remuneration was paid.

On August 4, 1995, the Company issued 618,750 shares in the aggregate of the Company's Class A and Class B common stock (137,500 shares prior to the stock split) each to Barry M. Wendt and Benedict A. Wittig, officers and directors of the Company, in a recapitalization of their previous equity interests in the Company. Concurrently, the Company issued 202,500 shares of the Company's Class A and Class B common stock (45,000 shares prior to the stock split) to Gary E. Wendt, a third officer and director, in a recapitalization of his previous interests in the Company. Each of these individuals had previously paid $1.00 for their interests in the Company. On April 24, 1996, all of these shares were converted into shares of common stock of one class.

On August 4, 1995, the Company issued and sold 472,500 shares of the Company's Class A and Class B common stock (105,000 shares prior to the split) to Richard T. Fiskum, an officer and director of the Company. In addition, on December 22, 1995, the Company issued and sold an additional 146,250 shares of the Company's Class A and Class B common stock (132,500 shares prior to the split) to Mr. Fiskum for a total consideration of $50,000. On April 24, 1996, all of these shares were converted into shares of common stock of one class.

During August and December, 1995 the Company repurchased all of the shares of common stock held by Jasper Consulting, Inc. for a total price of $308,174, of which $138,000 was paid in cash. See "Business--Technology Rights."

On May 17, 1996, the Company issued and sold, in connection with a bridge loan, an aggregate of $200,000 of eight percent promissory notes which may, at the option of the holder, be converted into shares of the Company's Common Stock at a price of $2.00 (the "Convertible Note"). Each Convertible Note converted into shares of the Company's Common Stock at a price of $2.00 per share upon completion of the private placement described below. The lenders in the Bridge Loan also received warrants to purchase (at a price of $2.00 per share) a number of shares of the Company's Common Stock equal to one-half the principle amount of each Convertible Note by $2.00. The Underwriter acted as the selling agent for the Bridge Loan and received a commission and expense allowance in the amount of $8,660.

On July 17, 1996, the Company completed the issuance and sale, in connection with a private placement of its Common Stock, an aggregate amount of $900,000 of its Common Stock at a per share price of $2.00. Of this $900,000, approximately $200,000 was represented by the conversion of the Bridge Loans described immediately above. The Underwriter acted as the selling agent for the private placement and received a commission and expense allowance in an approximate amount of $110,279 and a warrant to purchase 41,639 shares of common stock at an adjusted exercise price of $6.00 per share.

ITEM 27. EXHIBITS.

EXHIBIT
NO. EXHIBITS

1.1 Form of Underwriting Agreement (with form of Underwriter's Warrant and Lockup Agreement attached)

1.2 Form of Selected Dealer Agreement

*3.1 Amended and Restated Articles of Incorporation of small business issuer

*3.2 Amended and Restated Bylaws of small business issuer

4.1 Specimen of Common Stock Certificate

5.1 Opinion of Doherty, Rumble & Butler Professional Association

*10.1 SAC Technologies, Inc. 1996 Stock Option Plan

*10.2 License and Marketing Agreement by and among Harinder S. Takhar, Barry M. Wendt, Benedict A. Wittig and Richard T. Fiskum, Jasper Consulting, Inc. and the Company dated April 26, 1996 (with OEM Agreement by and between Jasper Consulting, Inc. and the Company dated April 26, 1996 attached as Exhibit A)

*10.3 Employment Agreement by and between Barry M. Wendt and the Company dated as of May 10, 1996 (with Non-Competition Letter effective May 10, 1996 attached as Exhibit A)

*10.4 Employment Agreement by and between Richard T. Fiskum and the Company dated as of May 10, 1996 (with Non-Competition Letter effective May 10, 1996 attached as Exhibit A)

*10.5 Employment Agreement by and between Gary E. Wendt and the Company dated as of May 10, 1996 (with Non-Competition Letter effective May 10, 1996 attached as Exhibit A)

*10.6 Employment Agreement by and between Benedict A. Wittig and the Company dated as of May 10, 1996 (with Non-Competition Letter effective May 10, 1996 attached as Exhibit A)

*10.7 Technical Support and Cooperative Development Agreement by and between the Company and Inter-Con/PC, Inc. effective November 1, 1996 (with Exhibits A-C)

*11.1 Computation of Loss per share

23.1 Consent of Divine, Scherzer & Brody, Ltd.

23.2 Consent of Doherty, Rumble & Butler Professional Association (to be included in Exhibit 5.1.)

23.3 Consent of Merritt, Furber & Timmer

*24.1 Power of Attorney (included in the signature page to the Registration Statement)


* PREVIOUSLY FILED

ITEM 28. UNDERTAKINGS.

The undersigned small business issuer hereby undertakes:

(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

(i) To include any prospectus required by section 10(a)(3) of the Securities Act of 1933;

(ii) To reflect in the prospectus any facts or events which, individually or together, represent a fundamental change in the information in the registration statement; and

(iii) To include any additional or changed material information on the plan of distribution;

(2) To, for determining liability under the Securities Act of 1933, treat each post-effective amendment as a new registration statement of the securities offered, and the offering of the securities at that time to be the initial bona fide offering.

(3) To file a post-effective amendment to remove from registration any of the securities that remain unsold at the end of the offering.

(4) To provide to the Underwriter at the closing specified in the Underwriting Agreement certificates in such denominations and registered in such names as required by the Underwriter to permit prompt delivery to each purchaser.

(5) Insofar as indemnification for liabilities arising under the Securities Act of 1933 (the "Act") may be permitted to directors, officers and controlling persons of the small business issuer pursuant to the foregoing provisions, or otherwise, the small business issuer has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the small business issuer of expenses incurred or paid by a director, officer or controlling person of the small business issuer in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the small business issuer will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.

SIGNATURES

In accordance with the requirements of the Securities Act of 1933, the small business issuer certifies that it has reasonable grounds to believe that it meets all of the requirements of filing on Form SB-2 and authorized this Amendment to Registration Statement to be signed on its behalf by the undersigned, in the City of Minneapolis, State of Minnesota on January 9, 1997.

SAC TECHNOLOGIES, INC.

By        /S/ BARRY M. WENDT
   ----------------------------------
            Barry M. Wendt,
        CHIEF EXECUTIVE OFFICER

In accordance with the requirements of the Securities Act of 1933, this Amendment No. 1 to Registration Statement was signed by the following persons in the capacities stated below on January 9, 1997.

         SIGNATURE                          TITLE
         ---------                          -----

     /S/ BARRY M. WENDT            Chief Executive Officer, Director
- -------------------------------    (Principal Executive Officer)
      Barry M. Wendt


  /S/ RICHARD T. FISKUM*           President, Director
- -------------------------------
      Richard T. Fiskum


     /S/ GARY E. WENDT*            Chief Financial Officer, Director
- -------------------------------    (Principal Accounting Officer)
         Gary E. Wendt


  /S/ BENEDICT A. WITTIG*          Secretary, Director
- -------------------------------
      Benedict A. Wittig

*Barry M. Wendt, by signing his name hereto, does hereby sign this document on behalf of each of the above-named directors and officers of the small business issuer pursuant to a power of attorney duly executed by such person.

By
Barry M. Wendt, Attorney-in-fact

EXHIBIT INDEX

EXHIBIT
NO. DESCRIPTION PAGE

1.1 Form of Underwriting Agreement (with form of Underwriter's Warrant and Lockup Agreement attached)

1.2 Form of Selected Dealer Agreement

*3.1 Amended and Restated Articles of Incorporation of small business issuer

*3.2 Amended and Restated Bylaws of small business issuer

4.1 Specimen of Common Stock Certificate

5.1 Opinion of Doherty, Rumble & Butler Professional Association

*10.1 SAC Technologies, Inc. 1996 Stock Option Plan

*10.2 License and Marketing Agreement by and among Harinder S. Takhar, Barry M. Wendt, Benedict A. Wittig and Richard T. Fiskum, Jasper Consulting, Inc. and the Company dated April 26, 1996 (with OEM Agreement by and between Jasper Consulting, Inc. and the Company dated April 26, 1996 attached as Exhibit A)

*10.3 Employment Agreement by and between Barry M. Wendt and the Company dated as of May 10, 1996 (with Non-Competition Letter effective May 10, 1996 attached as Exhibit A)

*10.4 Employment Agreement by and between Richard T. Fiskum and the Company dated as of May 10, 1996 (with Non-Competition Letter effective May 10, 1996 attached as Exhibit A)

*10.5 Employment Agreement by and between Gary E. Wendt and the Company dated as of May 10, 1996 (with Non-Competition Letter effective May 10, 1996 attached as Exhibit A)

*10.6 Employment Agreement by and between Benedict A. Wittig and the Company dated as of May 10, 1996 (with Non-Competition Letter effective May 10, 1996 attached as Exhibit A)

*10.7 Technical Support and Cooperative Development Agreement by and between the Company and Inter-Con/PC, Inc. effective November 1, 1996 (with Exhibits A-C)

*11.1 Computation of Loss per share

23.1 Consent of Divine, Scherzer & Brody, Ltd.

23.2 Consent of Doherty, Rumble & Butler Professional Association (to be included in Exhibit 5.1.)

23.3 Consent of Merritt, Furber & Timmer

*24.1 Power of Attorney (included in the signature page to the Registration Statement)


* previously filed

Underwriting Agreement

_____________, 1997

Tuschner & Company, Inc.
120 South Sixth Street
Suite 800, One Financial Plaza
Minneapolis, MN 55402

Gentlemen,

SAC Technologies, Inc., a Minnesota corporation (the "Company"), hereby confirms its agreement with you (the "Underwriter") as follows:

SECTION I

DESCRIPTION OF SECURITIES

The Company's authorized and outstanding capitalization when the offering of the securities contemplated hereby is permitted to commence and at the Closing Date (hereinafter defined), will be as set forth in the Registration Statement and Prospectus included therein (hereinafter defined). The Company proposes to issue and sell to the Underwriter in a public offering under the Securities Act of 1933 an aggregate of 1,100,000 shares of its authorized $0.01 par value common Shares (the "Shares"), on the terms as hereinafter set forth. The Underwriter shall also have an over-allotment option to purchase up to an additional 110,000 shares as provided in Section 3.01 hereof.

The Company proposes to issue and sell to the Underwriter, on the Closing Date, for $0.01 each, warrants (the "Warrants") to purchase shares of the Company's common Shares (the "Warrant Shares") as provided in Section 3.03 hereof.

SECTION 2

REPRESENTATIONS, AND WARRANTIES OF THE COMPANY

In order to induce the Underwriter to enter into this Agreement, the Company hereby covenants, represents, and warrants to and agrees with the Underwriter, as of the date hereof and as of each Closing Date, as if the Closing Date were substituted for the date hereof, as follows:

2.01. REGISTRATION STATEMENT AND PROSPECTUS. A registration statement on Form SB-2 File No. 333-16451, (the "Registration Statement") with respect to the Shares, the related Prospectus, Copies of which have heretofore been delivered by the Company to the Underwriter, has been prepared by the Company in conformity with the requirements of the Securities Act of 1933, as amended (the "Act"), and the rules and regulations (the "Regulations") of the Securities and Exchange Commission (the "Commission") thereunder, and said Registration Statement has been filed with the Commission under the Act; one or more amendments to said Registration Statement, copies of which have heretofore been delivered to the Underwriter, has or have heretofore been filed; and the Company may file on or prior to the effective date additional amendments to said Registration Statement, including the final Prospectus. Included in such Registration Statement are an additional 110,000 shares of the Company's Common Shares, which shares are reserved against exercise of the Underwriter's Warrants to be granted by the Company, as more particularly described hereinafter.

As used in this Agreement, the term "Registration Statement" refers to and means said Registration Statement on Form SB-2 and all amendments thereto, including the Prospectus; any preliminary and any amended or supplementary Prospectus; and all exhibits and financial statements. The term "Prospectus" refers to and means the Prospectus included in the Registration Statement when it becomes effective; and any "Preliminary Prospectus" which term refers to and means any prospectus included in said Registration Statement before it becomes effective. The terms "effective date" and "effective" refer to the date the Commission declares the Registration Statement effective pursuant to Section 8 of the Act.

2.02. ACCURACY OF REGISTRATION STATEMENT AND PROSPECTUS. The Commission has not issued any order preventing or suspending the use of any Preliminary Prospectus with respect to the Shares, and the Registration Statement and each Preliminary Prospectus and Prospectus has conformed in all material respects with the requirements of the Act and the applicable Regulations thereunder and has not included at the time of filing any untrue statement of a material fact or omitted to state a material fact necessary to make the statements therein not misleading. When the Registration Statement becomes effective and on the Closing Date (as hereinafter defined), the Registration Statement and Prospectus and any further amendments or supplements thereto will contain all statements which are required to be stated therein in accordance with the Act and the Regulations for the purposes of the proposed public offering of the Shares, and all statements of material fact contained in the Registration Statement and Prospectus are and will be true and correct, and neither the Registration Statement nor the Prospectus does or will include any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading; provided, however, the Company does not make any representations or warranties as to information contained in or omitted from the Registration Statement or the Prospectus or Preliminary Prospectus in reliance upon written information furnished on behalf of the Underwriter specifically for use therein.

2.03. FINANCIAL STATEMENTS. The financial statements of the Company together with related schedules and notes as set forth in the Registration Statement and Prospectus present fairly the financial position of the Company and the results of its operations and the changes in its financial position at the respective dates and for the respective periods for which they apply; such financial statements have been prepared in accordance with the Regulations and generally accepted accounting principles consistently applied throughout the periods concerned except as otherwise stated therein.

2.04. INDEPENDENT PUBLIC ACCOUNTANT. Divine, Scherger & Brody, Ltd., which has certified or shall certify certain of the financial statements filed or to be filed with the Commission as part of the Registration Statement and Prospectus, are independent certified public accountants within the meaning of the Act and the Regulations.

2.05. NO MATERIAL ADVERSE CHANGE. Except as may be reflected in or contemplated by the Registration Statement or the Prospectus, subsequent to the dates as of which information is given in the Registration Statement and Prospectus, (i) the Company has no contingent liabilities or claims and has received no threats of such claims or liabilities; (ii) there has not been any material adverse change in the condition, financial or otherwise, of the Company or in its business taken as a whole; (iii) there has not been any material transaction entered into by the Company other than transactions in the ordinary course of business which do not, in the aggregate, have a material adverse effect in the condition, financial or otherwise, or business of the Company;
(iv) the Company has not incurred any material obligations, contingent or otherwise; (vi) there shall not have been nor will there be any change in the capital stock or long-term debt (except current payments) of the Company; and
(v) the Company has not and will not have paid or declared any dividends or other distributions on its common shares; and (vi) the Company has not and will not have committed to any of the foregoing.

2.06. NO DEFAULTS. The Company is not in material default in the performance of any obligation, agreement, or condition contained in any debenture, note, or other evidence of indebtedness, or any indenture or loan agreement of the Company, or any other agreement or commitment to which the Company is a party or by which it or its properties are bound. The execution and delivery of this Agreement and the consummation of the transactions herein contemplated, and compliance with the terms of this Agreement will not conflict with or result in a breach of, or give any party the right to accumulate or terminate under, any of the terms, conditions, or provisions of or constitute a breach, violation, or default under: the articles of incorporation, as amended, or bylaws of the Company; any note, indenture, mortgage, deed of trust, or other agreement or instrument to which the Company is a party or by which it or any of its property is bound; or any existing law, order, rule, regulation, writ, injunction, or decree of any government, governmental instrumentality, agency or body, arbitration tribunal or court, domestic or foreign, having jurisdiction over the Company or its property. The consent, approval, authorization, or order of any court or governmental instrumentality, agency or body is not required for the consummation of the transactions herein contemplated except such as may be required under the Act or under the blue sky or securities laws of any state or jurisdiction.

2.07. INCORPORATION AND STANDING. The Company is duly incorporated and validly existing in good standing as a corporation under the laws of Minnesota with authorized and outstanding capital stock as set forth in the Registration Statement and the Prospectus, and with full power and authority (corporate and other) to own its property and conduct its business, present and proposed, as described in the Registration Statement and Prospectus; the Company has full power and authority to enter into this Agreement and has taken all necessary corporate action to authorize the execution of this Agreement and the Underwriter's Warrant and the issuance of the Shares and the Warrant Shares. The Company is duly qualified and in good standing as a foreign corporation in each jurisdiction in which it owns or leases real property or transacts business requiring such qualification except where failure to qualify as such would not have a material adverse effect on the Company's business or financial or other condition. The Company has no subsidiaries other than as shown in the Registration Statement.

2.08. LEGALITY OF OUTSTANDING SHARES. The outstanding capital stock of the Company has been duly and validly authorized and issued and is fully paid and nonassessable, and conforms to all statements with regard thereto contained in the Registration Statement and Prospectus. No sales of securities have been made by the Company in violation of the registration and prospectus delivery provisions of the Act.

2.09. LEGALITY OF SHARES, WARRANT SHARES AND WARRANTS. The Shares and Warrant Shares have been duly and validly authorized and, when issued and delivered against payment therefor as provided in this Agreement, will be validly issued, fully paid, and nonassessable. The Shares and Warrant Shares, upon issuance, will not be subject to the preemptive rights of any shareholders of the Company; the Underwriter's Warrants, when sold and delivered, will constitute valid and binding obligations of the Company enforceable in accordance with the terms thereof, except as enforcement may be limited by bankruptcy or similar laws of general application affecting creditors' rights, and except as the availability of equitable remedies requires the exercise of judicial discretion, and except as enforcement of the indemnification provisions therein may be limited by Federal and state securities laws. A sufficient number of shares of Common Stock have been reserved for issuance upon exercise of the Warrants. The Shares and Warrants will conform to all statements with regard thereto in the Registration Statement and Prospectus.

2.10. PRIOR SALES. No securities of the Company, of an affiliate or of a predecessor of the Company have been sold within one year prior to the date hereof, except as set forth in Part II of the Registration Statement.

2.11. LITIGATION. Except as set forth in the Registration Statement and Prospectus, there is no action, suit or proceeding before any court or governmental agency, authority or body pending or to the knowledge of the Company threatened which might result in judgments against the Company not adequately covered by insurance or which collectively might result in any material adverse change in the condition (financial or otherwise), the business, or the prospects of the Company, or would materially affect the properties or assets of the Company.

2.12. WARRANTS. Upon delivery of and payment for the Warrants to be sold by the Company as set forth in Section 3.03 of this Agreement, the Underwriter and the Underwriter's designees will receive good and marketable title thereto, free and clear of all liens, encumbrances, charges and claims whatsoever; and the Company will have on the effective date of the Registration Statement and at the time of delivery of such Warrants full legal right and power and all authorization and approval required by law to sell, and deliver such Warrants in the manner provided hereunder.

2.13. NO FINDERS. There is no outstanding claim (and no basis for any claim) for services in the nature of a finder's fee or origination fee with respect to the sale of the Shares hereunder.

2.14. EXHIBITS. There are no contracts or other documents which are required to be filed as exhibits to the Registration Statement by the Act or by the Regulations which have not been so filed and each contract to which the Company is a party and to which reference is made in the Prospectus has been duly and validly executed, is in full force and effect in all material respects in accordance with their respective terms, none of such contracts have been assigned by the Company; and the Company knows of no present situation or condition or fact which would prevent compliance with the terms of such contracts, as amended to date. Except for amendments or modifications of such contracts in the ordinary course of business, the Company has no intention of exercising any right which it may have to cancel any of its obligations under any of such contracts, and has no knowledge that any other party to any of such contracts has any intention not to render full performance under such contracts.

2.15. TAX RETURNS. The Company has filed all federal and state tax returns which are required to be filed by it and has paid all taxes shown on such returns and on all assessments received by it to the extent such taxes have become due. All taxes with respect to which the Company is obligated have been paid or adequate accruals have been set up to cover any such unpaid taxes.

2.16. PROPERTY. Except as otherwise set forth in or contemplated by the Registration Statement and Prospectus, the Company has good title or a valid leasehold interest, free and clear of all liens, encumbrances, and defects, except liens for current taxes not due and payable, to all property and assets which are described in the Registration Statement and the Prospectus as being owned or leased by the Company, subject only to such exceptions which are not material and which do not adversely affect the financial or other condition, business, or prospects of the Company.

2.17. AUTHORITY. The execution and delivery by the Company of this Agreement has been duly authorized by all necessary corporate action and this Agreement is the valid, binding, and legally enforceable obligation of the Company, except as enforcement may be limited by bankruptcy or similar laws of general application affecting creditors' rights, except as the availability of equitable remedies requires the exercise of judicial discretion, and except as enforcement of the indemnification provisions herein may be limited by Federal or state securities laws.

SECTION 3

PURCHASE AND SALE OF THE SHARES

3.01. PURCHASE OF SHARES AND OVER-ALLOTMENT OPTION. The Company hereby agrees to sell to the Underwriter and the Underwriter agrees to purchase from the Company upon the basis of the representations and warranties herein contained, but subject to the conditions hereinafter stated, the Shares hereto at a purchase price of $5.49 per share.

The Company hereby grants to the Underwriter an option (the "Over-Allotment Option") for a period of 30 days after Closing to purchase at a purchase price of $5.49 per share up to 110,000 additional shares of Shares (the "Option Shares") in order to cover over- allotments.

3.02. PUBLIC OFFERING PRICE. After the Commission notifies the Company that the Registration Statement has become effective, the Underwriters propose to offer the Shares and the Option Shares if the Over-Allotment Option is exercised to the public at a public offering price of $6.00 per share, as set forth in the Registration Statement. The Underwriters may allow such concessions and discounts upon sales to selected dealers as may be determined from time to time by the Underwriter.

3.03. PAYMENT FOR SHARES. Payment for the Shares (including Option Shares) which the Underwriter agrees to purchase shall be made to the Company or its order by certified or official bank check or checks, or by wire transfer in the amount of the purchase price by or on behalf of the Underwriter at the offices of the Underwriter set forth above in Minneapolis, Minnesota upon delivery to the Underwriter of certificates for shares and Warrants in definitive form or otherwise providing evidence of the sale of the Shares and Warrants in such numbers and registered in such names as the Underwriter requests in writing at least one full business days prior to such delivery.

3.04. CLOSING. The time and date of delivery and payment hereunder is herein called the "Closing Date" and shall take place at the office of the Underwriter at the address set forth above at 2:00 P.M., or such other time and place as the parties mutually agree, on the third business day following the effective date. Should the Underwriter elect to exercise any part of the over-allotment option pursuant to Section 3.01 herein-above, the time and date of delivery and payment for said over- allotment shares shall be as mutually agreed, but not later than the 30th calendar day after the "Closing Date." Said date is hereinafter referred to as the "Over-Allotment Closing Date," and shall be a Closing Date for the purposes of Section 8 herein.

3.05. INSPECTION OF CERTIFICATES. For the purpose of expediting the checking and packaging of the certificates for Shares and Warrants, the Company agrees to make the certificates and Warrants available for inspection by the Underwriter at the office of the Underwriter set forth above in Minneapolis, Minnesota at least one full business day prior to the proposed delivery date.

3.06. SALE OF WARRANTS. The Company will sell and deliver to the Underwriter at a purchase price of $0.01 per Warrant, Warrants, dated the date of Closing, substantially in the form of Exhibit A, attached hereto and by this reference incorporated herein, evidencing the right of the Underwriter to purchase such number of Warrant Shares equal to ten percent (10%) of the number of Shares purchased by the Underwriter (exclusive of the Option Shares and reduced by 41,639 Shares subject to that certain warrant issued by the Company to the Underwriter heretofore, and by an additional 23,8650 shares) at the price per share and upon the terms and conditions provided in the Warrants. The Company shall not be obligated to sell and deliver the Warrants, and the Underwriter will not be obligated to purchase and pay for the Warrants, except upon payment for the shares pursuant to Subsection 3.03 hereof.

3.07. UNDERWRITER'S EXPENSE ALLOWANCE. It is understood that the Company shall reimburse the Underwriter for its expenses on a nonaccountable basis in the amount of 2% of the gross proceeds of the offering, including proceeds from the sale of the Over-Allotment Shares. At the Closing and, if applicable, on the Over-Allotment Closing Date, the Company shall pay to the Underwriter the unpaid balance of such allowance to defray the expenses incurred by the Underwriter in connection with the offering. The Underwriter shall be solely responsible for all expenses incurred by it in connection with the offering including, but not limited to, the expenses of its own counsel except as set forth in subsection 5.07 hereof.

3.08. REPRESENTATIONS AS OF THE CLOSING DATE. The Company warrants, covenants, and represents that as of the Closing Date the representations herein contained and the statements contained in all the certificates theretofore or simultaneously delivered by any party to another, pursuant to this Agreement, shall in all material respects be true and correct.

3.09. POST-CLOSING INFORMATION. The Underwriter covenants that reasonably promptly after the Closing Date, it will supply the Company with all information required from the Underwriters for the completion of Form SR and such additional information as the Company may reasonably request to be supplied to the securities commissions of such states in which the Shares has been qualified for sale.

3.10. RE-OFFERS BY SELECTED DEALERS. On each sale by the Underwriters of any of the Shares to selected dealers, the Underwriter shall require the selected dealer purchasing any such Shares to agree to re-offer the same on the terms and conditions of the offering set forth in the Registration Statement and Prospectus.

SECTION 4

REGISTRATION STATEMENT AND PROSPECTUS

4.01. DELIVERY OF REGISTRATION STATEMENTS. The Company shall deliver to the Underwriter without charge four signed copies of the Registration Statement, including all financial statements and exhibits filed therewith and any amendments or supplements thereto, and shall deliver without charge to the Underwriter ten conformed copies of the Registration Statement and any amendment or supplement thereto, including such financial statements and exhibits. The signed copies of the Registration Statement so furnished to the Underwriter will include signed copies of any and all consents and certificates of the independent public accountant certifying to the financial statements included in the Registration Statement and Prospectus and signed copies of any and all consents and certificates of any other persons whose profession gives authority to statements made by them and who are named in the Registration Statement or Prospectus as having prepared, certified, or reviewed any part thereof.

4.02. DELIVERY OF PRELIMINARY PROSPECTUS. The Company will deliver to the Underwriter, without charge, as many copies of each Preliminary Prospectus filed with the Commission conforming to Item 501(a)(8) of Regulation S-B as may be required by the Underwriters. The Company consents to the use of such documents by the Underwriters and by dealers prior to the effective date of the Registration Statement. The Company will deliver at its expense such copies of the Preliminary Prospectus as the Underwriter may deem necessary in order to recirculate the Preliminary Prospectus and/or to permit compliance with the provisions of Rule 15c-2(8)(b) of the Commission. For purposes of the paragraph, the term "Preliminary Prospectus" shall be deemed to include after the effective date of the Registration Statement a Rule 430A subject to completion prospectus, and the Company will deliver to the Underwriter, after the effective date at its expense, such copies of the Rule 430A subject to completion prospectus the underwriter deems necessary in connection with the offering.

4.03. DELIVERY OF PROSPECTUS. The Company will deliver at its expense as many printed copies of the Prospectus as the Underwriter may require for the purposes contemplated by this Agreement and shall deliver said printed copies of the Prospectus to the Underwriter as soon as practicable on effectiveness of this Agreement, but in no event more than one business day after the effective date of this Agreement. The Company will deliver such additional copies at its expense as may be necessary to permit dealers to comply with the requirements of Rule 174. If the Underwriter determines to use a Term Sheet together with a prospectus subject to completion in accordance with Rule 434 to satisfy the prospectus delivery requirement, the Company shall furnish the Underwriter with such number of copies of the Term Sheet meeting the requirements of Rule 434 and will file such number of copies of the Commission as required by Rule 424(b) to permit the Underwriter to deliver the final prospectus to purchasers in the offering in this manner.

4.04. FURTHER AMENDMENTS AND SUPPLEMENTS. If during such period of time as in the opinion of the Underwriter or its counsel, a Prospectus relating to this offering is required to be delivered under the Act, any event occurs or any event known to the Company relating to or affecting the Company shall occur as a result of which the Registration Statement would include an untrue statement of a material fact, or omit to state any material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, or if it is necessary at any time after the effective date of the Registration Statement to amend or supplement the Registration Statement or the Prospectus to comply with the Act, the Company will forthwith notify the Underwriter thereof and prepare and file with the Commission such further amendment to the Registration Statement or Prospectus as may be required, and will furnish and deliver to the Underwriter and to others whose names and addresses are designated by the Underwriter, all at the cost of the Company, a reasonable number of copies of the amended Registration Statement or amended or supplemented Prospectus which, as so amended or supplemented, will not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the Statements therein not misleading in the light of the circumstances under which they were made when it is delivered to a purchaser or prospective purchaser, and which will comply in all respects with the Act.

4.05. USE OF PROSPECTUS. The Company authorizes the Underwriters, in connection with the distribution of the Shares, and all dealers to whom any of the Shares may be sold by the Underwriters, to use the Prospectus as from time to time amended or supplemented, in connection with the offering and sale of the Shares and in accordance with the applicable provisions of the Act and the applicable Regulations and applicable state blue sky or state securities laws.

SECTION 5

COVENANTS OF THE COMPANY

The Company covenants and agrees with the Underwriters that:

5.01. OBJECTION OF UNDERWRITER TO AMENDMENTS OR SUPPLEMENTS. After the date hereof, the Company will not at any time, whether before or after the effective date of the Registration Statement, file any Registration Statement or amendment or supplement to the Registration Statement or Prospectus unless and until a copy of such Registration Statement or amendment or supplement has been previously furnished to the Underwriter within a reasonable time period prior to the proposed filing thereof, or of which the Underwriter or counsel for the Underwriter has reasonably objected to, in writing, on the ground that such Registration Statement or amendment or supplement is not in compliance with the Act or the Regulations.

5.02. COMPANY'S BEST-EFFORTS TO CAUSE REGISTRATION STATEMENT TO BECOME EFFECTIVE. The Company will use its best efforts to cause the Registration Statement and any post effective amendment subsequently filed to become effective as promptly as reasonably practicable and will promptly advise the Underwriter, and will confirm such advice in writing: (i) when the Registration Statement shall have become effective and when any amendment thereto shall have become effective and when any amendment of or supplement to the Prospectus shall be filed with the Commission; (ii) when the Commission shall make a request or suggestion for any amendment to the Registration Statement or the Prospectus or for additional information and the nature and substance thereof; (iii) of the issuance by the Commission of an order suspending the effectiveness of the Registration Statement pursuant to Section 8 of the Act or of the initiation of any proceedings for that purpose; (iv) of the happening of any event which in the judgment of the Company makes any material statement in the Registration Statement or Prospectus untrue or of the omission of any material fact which makes the statements made therein misleading, or which requires the making of any changes in the Registration Statement or Prospectus in order to make the statements therein not misleading, and (v) of the refusal to qualify or the suspension of the qualification of the Shares for offering or sale in any jurisdiction, or of the institution of any proceedings for any of such purposes. The Company will use every reasonable effort to prevent the issuance of any such order or of any order preventing or suspending such use, to prevent any such refusal to qualify or any such suspension, and to obtain as soon as possible a lifting of any such order, the reversal of any such refusal and the termination of any such suspension.

5.03. PREPARATION AND FILING OF AMENDMENTS AND SUPPLEMENTS. The Company will prepare and file promptly with the Commission, upon request of the Underwriter, such amendments or supplements to the Registration Statement or Prospectus, in form satisfactory to counsel to the Company, as in the opinion of counsel to the Underwriter and of counsel to the Company may be necessary in connection with the offering or distribution of the Shares and will use its best efforts to cause the same to become effective as promptly as possible.

5.04. PUBLICITY. The Company will issue no press releases or other form of publicity, prior to the effective date, without the prior consent of the Underwriter.

5.05. BLUE-SKY QUALIFICATION. The Company will, when and as requested by the Underwriter, use reasonable efforts to qualify the Shares or such part thereof as the Underwriter may determine for sale under the so-called blue sky laws of the State of Minnesota, and of so many other states as the Underwriter may reasonably request, and to continue such qualification in effect so long as required for the purposes of the distribution of the Shares; provided, however, the Company shall not be required to make a blue sky filing in any state which would require that shares representing so-called "cheap stock" be escrowed for more than two years.

5.06. FINANCIAL STATEMENTS. The Company will, at its own expense, prepare and give, and will continue to give, such financial statements and other information to and as may be required by the Commission or by the proper public bodies of the states in which the Shares may be qualified.

5.07. ACCELERATION. The Company will not request acceleration of the effectiveness of the Registration Statement without the Underwriter's prior consent.

5.08. REPORTS AND FINANCIAL STATEMENTS TO THE UNDERWRITER. During the period of five years from the Closing Date, the Company will deliver to the Underwriter, copies of each annual report of the Company, and will deliver to the Underwriter: (i) within 90 days after the close of each fiscal year of the Company, a financial report of the Company and its subsidiaries, if any, on a consolidated basis, and a similar financial report of all unconsolidated subsidiaries, if any, all such reports to include a balance sheet as of the end of the preceding fiscal year, an income statement, a statement of changes in financial condition and an analysis of shareholders' equity covering such fiscal year, and all to be in reasonable detail and certified by independent public accountants for the Company; (ii) within 45 days after the end of each quarterly fiscal period of the Company other than the last quarterly fiscal period in any fiscal year, copies of the consolidated income statement and statement of changes in financial condition for that period, and the balance sheet as of the end of that period of the Company and its subsidiaries, if any, and the income statement, statement of changes in financial condition, and the balance sheet of each unconsolidated subsidiary, if any, of the Company for that period, all subject to year-end adjustment, certified by the principal financial or accounting officer of the Company; (iii) copies of all other statements, documents, or other information which the Company shall mail or otherwise make available to any class of its security holders, or shall file with Commission; and (iv) upon request in writing from the Underwriter, furnish to the Underwriter such other information as may reasonably be requested and which may be properly disclosed to the Underwriter with reference to the property, business, and affairs of the Company and its subsidiaries, if any.

5.09. EXPENSES PAID BY THE COMPANY. The Company will pay, whether or not the transactions contemplated hereunder are consummated or this Agreement is prevented from becoming effective or is terminated, all costs and expenses incident to the performance of its obligations under this Agreement, including all expenses incident to the authorization of the Shares and their issue and delivery to the Underwriter; any original issue taxes in connection therewith; all transfer taxes, if any, incident to the initial sale of the Shares to the public; the fees and expenses of the Company's counsel and accountants; the costs and expenses incident to the preparation, printing and filing under the Act and with the National Association of Securities Dealers, Inc. of the Registration Statement, any Preliminary Prospectus, and the Prospectus and any amendments or supplements thereto, the cost of printing, reproducing, and filing all exhibits to the Registration Statement, the underwriting documents, and the Selected Dealers Agreement; the cost of printing and furnishing to the Underwriter copies of the Registration Statement and copies of the Prospectus as herein provided; the cost of "tombstone" or other similar advertising permitted under the Act; and the cost of qualifying the Shares under the state securities or Blue Sky laws as provided in Section 5.04 herein, including expenses and disbursements of the Underwriter incurred in connection with such qualification.

5.10. REPORTS TO SHAREHOLDERS. During the period of five years from the Closing Date, the Company will, as promptly as possible, not to exceed 120 days, after each annual fiscal period, render and distribute reports to its shareholders which will include audited statements of its operations and changes of financial position during such period and its balance sheet as of the end of such period, as to which statements the Company's independent certified public accountants shall have rendered an opinion.

5.11. SECTION 11(A) FINANCIALS. The Company will make generally available to its security holders and will deliver to the Underwriter, as soon as practicable, but in no event later than the first day of the sixteenth full calendar month following the effective date of the Registration Statement, an earnings statement (as to which no opinion need be rendered but which will satisfy the provisions of Section 11(a) of the Act) covering a period of at least 12 months beginning after the effective date of the Registration Statement.

5.12. POST-EFFECTIVE AVAILABILITY OF PROSPECTUS. Within the time during which the Prospectus is required to be delivered under the Act, the Company will comply, at its own expense, with all requirements imposed upon it by the Act, as now or hereafter amended, by the Rules and Regulations, as from time to time may be in force, and by any order of the Commission, so far as necessary to permit the continuance of sales or dealings in the Shares.

5.13. APPLICATION OF PROCEEDS. The Company will apply the net proceeds from the sale of the Shares substantially in the manner set forth in the Registration Statement and Prospectus.

5.14. UNDERTAKINGS OF CERTAIN SHAREHOLDERS. The Company will deliver to the Underwriter, prior to or simultaneously with the execution of this Agreement, the undertaking of each officer, director, and each employee of the Company who owns five percent (5%) or more of shares of the Company (based on the number of shares to be outstanding prior to the completion of the offering) that such person shall not directly or indirectly offer or sell to the public any portion of the shares owned prior to the effective date of this Agreement or hereafter acquired by exercise of an option for a period of twelve months from the effective date of the Registration Statement without the Underwriter's prior written consent.

5.15. DELIVERY OF DOCUMENTS. At the Closing, the Company will deliver to the Underwriter true and correct copies of the articles of incorporation and certificate of incorporation of the Company and all amendments thereto, all such copies to be certified by the Secretary of State of the State of Minnesota; true and correct copies of the bylaws of the Company and of the minutes of all meetings of the directors and shareholders of the Company held prior to the Closing Date which in any way relate to the subject matter of this Agreement, certified by the Company's Secretary.

5.16. COOPERATION WITH UNDERWRITER'S DUE DILIGENCE. At all times prior to any Closing Date, the Company will cooperate with the Underwriter and its counsel in such investigation as the Underwriter may make or cause to be made of all the properties, business, and operations of the Company in connection with the purchase and public offering of the Shares, and the Company will make available to the Underwriter in connection therewith such documents and information in its possession as the Underwriter or its counsel may reasonably request.

5.17. NO SALE PERIOD. No offering, sale, or other disposition of any common Shares, equity, or long-term debt will be made within one year after the effective date of the Prospectus, directly or indirectly, by the Company, otherwise than hereunder or with the Underwriter's consent (not to be unreasonably withheld).

5.18. APPOINTMENT OF TRANSFER AGENT. The Company has appointed Firstar Trust Company as Transfer Agent for the Shares subject to the Closing. The Company will not change or terminate such appointment for a period of three years from the effective date without first obtaining the written consent of the Underwriter, which consent shall not be unreasonably withheld.

5.19. COMPLIANCE WITH CONDITIONS PRECEDENT. The Company will use all reasonable efforts to comply or cause to be complied with the conditions precedent to the several obligations of the Underwriters in Section 8 hereof.

5.20. FILINGS OF FORM SR. The Company agrees to file with the Commission all required reports on Form SR in accordance with the provisions of Rule 463 promulgated under the Act and to provide a copy of such reports to the Underwriter and its counsel.

5.21. REGISTRATION UNDER THE EXCHANGE ACT. The Company shall, as soon as practicable, but not later than 90 days after the effective date, register the class of equity securities which constitutes the Shares by filing with the Securities and Exchange Commission a registration statement (and such copies thereof as the Commission may require) with respect to such security, containing such information and documents as the Commission may specify comparable to that which is required in an application to register a security pursuant to subsection (g) of Section 12 of the Securities Exchange Act of 1934, as amended.

5.22. APPLICATION TO MOODY'S. The Company shall, within 60 days after the effective date, apply for listing in Standard and Poor's or Moody's Over-the-Counter Manual and shall use its best efforts to have the Company listed in such manuals.

5.23. PUBLIC RELATIONS. After the effective date, the Company will engage a firm reasonably acceptable to the Underwriter for assistance in conducting the Company's investor relations.

5.24. APPLICATION TO NASDAQ. The Company shall apply for entry of the Company's common stock on the NASD automated quotation system ("small-cap" listing) and shall in such event use its best efforts to have its common stock continue to be quoted on that system.

5.25 ENGAGEMENT OF COMPTROLLER. Within ninety (90) days after the Closing, engage a comptroller or similar employee, reasonably satisfactory to the Underwriter, who is qualified and experienced in the financial reporting and disclosure obligations of publicly-held companies.

SECTION 6

INDEMNIFICATION

6.01. INDEMNIFICATION BY COMPANY. The Company agrees to indemnify and hold harmless the Underwriter, and each person who controls the Underwriter within the meaning of Section 15 of the Act against any and all losses, claims, damages or liabilities, joint or several, to which it may become subject under the Act or any other statute or at common law and to reimburse persons indemnified as above for any legal or other expenses (including the cost of any investigation and preparation) incurred by it in connection with any litigation, whether or not resulting in any liability, but only insofar as such losses, claims, damages, liabilities and litigation arise out of or are based upon any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement or any amendment thereto or any application or other document filed in order to qualify the Shares under the Blue Sky or securities laws of the states where filings were made, or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, all as of the date when the Registration Statement or such amendment, as the case may be, becomes effective, or any untrue statement or alleged untrue statement of a material fact contained in the Prospectus (as amended or supplemented if the Company shall have filed with the Commission any amendments thereof or supplements thereto), or the omission or alleged omission to state therein a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided, however, that the indemnity agreement contained in this subsection 6.01 shall not apply to amounts paid in settlement of any such litigation if such settlements are effected without the consent of the Company, nor shall it apply to the Underwriter or any person controlling the Underwriter in respect of any such losses, claims, damages, liabilities, or actions arising out of or based upon any such untrue statements or alleged untrue statement, or any such omission or alleged omission, if such statement or omission was made in reliance upon information furnished in writing to the Company by the Underwriter specifically for use in connection with the preparation of the Registration Statement and Prospectus or any such amendment or supplement thereto. This indemnity agreement is in addition to any other liability which the Company may otherwise have to the Underwriter. The Underwriter agrees within ten days after the receipt by it of written notice of the commencement of any action against them or against any person controlling them as aforesaid, in respect of which indemnity may be sought from the Company on account of the indemnity agreement contained in this subsection 6.01 to notify the Company in writing of the commencement thereof. The failure of the Underwriter so to notify the Company of any such action shall relieve the Company from any liability which it may have to the Underwriter or any person controlling it as aforesaid on account of the indemnity agreement contained in this subsection 6.01, but shall not relieve the Company from any other liability which it may have to the Underwriter or such controlling person. In case any such action shall be brought against the Underwriters or any such controlling person and the Underwriter shall notify the Company of the commencement thereof, the Company shall be entitled to participate in (and, to the extent that it shall wish, to direct) the defense thereof at its own expense, but such defense shall be conducted by counsel of recognized standing and reasonably satisfactory to the Underwriter or such controlling person or persons, defendant or defendants in such litigation. The Company agrees to notify the Underwriter promptly of commencement of any litigation or proceedings against it or any of its officers or directors, of which it may be advised, in connection with the issue and sale of any of its securities and to furnish to the Underwriter, at its request, copies of all pleadings therein and permit the Underwriter to be an observer therein and apprise the Underwriter of all developments therein, all at the Company's expense. Provided, however, that in no event shall the indemnification agreement contained in this Section 6.01 inure to the benefit of any Underwriter (or any person controlling such Underwriter) on account of any losses, claims, damages, liabilities or actions arising from the sale of the Shares upon the public offering to any person by such Underwriter if such losses, claims, damages, liabilities or actions arise out of, or are based upon, an untrue statement or omission or alleged untrue statement or omission in a Preliminary Prospectus and if the Prospectus shall correct the untrue statement or omission, or the alleged untrue statement or omission, which is the basis of the loss, claim, damage, liability or action for which indemnification is sought, and a copy of the Prospectus had not been sent or given to such person at or prior to the confirmation of such sale to him in any case where such delivery is required by the Securities Act, unless such failure to deliver the Prospectus was a result of non-compliance by the Company with Section 4.03 hereof.

6.02. INDEMNIFICATION BY UNDERWRITER. The Underwriter agrees, to the extent of and in the same manner as set forth in subsection 6.01 above, to indemnify and hold harmless the Company, the directors of the Company and each person, if any, who controls the Company within the meaning of Section 15 of the Act with respect to any statement in or omission from the Registration Statement or any amendment thereto, or the Prospectus (as amended or as supplemented, if amended or supplemented as aforesaid) or any application or other document filed in any state or jurisdiction in order to qualify the Shares under the blue sky or securities laws thereof, or any information furnished pursuant to Section 3.09 hereof, if such statement or omission was made in reliance upon information and furnished in writing to the Company by the Underwriter on its behalf specifically for use in connection with the preparation thereof or supplement thereto. The Underwriter shall not be liable for amounts paid in settlement of any such litigation if such settlement was effected without the consent of the Underwriter. In case of commencement of any action in respect of which indemnity may be sought from the Underwriter on account of the indemnity agreement contained in this subsection 6.02, each person agreed to be indemnified by the Underwriter shall have the same obligation to notify the Underwriter as the Underwriter have toward the Company in subsection 6.01 above, subject to the same loss of indemnity in the event such notice is not given, and the Underwriter shall have the same right to participate in (and, to the extent that it shall wish, to direct) the defense of such action at its own expense, but such defense shall be conducted by counsel of recognized standing and satisfactory to the Company. The Underwriter agrees to notify the Company promptly of the commencement of any litigation or proceeding against the Underwriter,, or against any such controlling person, of which it may be advised, in connection with the issue and sale of any of the securities of the Company, and to furnish to the Company at its request copies of all pleadings therein and apprise it of all the developments therein, all at the Underwriter's expense, and permit the Company to be an observer therein.

6.03 CONTRIBUTION. If the indemnification provided for in this Section 6 is unavailable to or insufficient to hold harmless an indemnified party in respect of any losses, claims, damages, expenses or liabilities (or actions in respect thereof) referred to therein, then each indemnifying party shall in lieu of indemnifying such indemnified party contribute to the amount paid or payable by such indemnified party as a result of such losses, claims, damages, expenses or liabilities (or actions in respect thereof) in such proportion as is appropriate to reflect not only (i) the relative benefits received by the Company on the one hand and the Underwriter on the other from the offering of the Shares, but also (ii) the relative fault of the Company and the Underwriter in connection with the statements or omissions which resulted in such losses, claims, damages, expenses or liabilities (or action in respect thereof), as well as any other relevant equitable considerations. The relative benefits received by the Company on the one hand and the Underwriter on the other shall be deemed to be in the same proportion as the total net proceeds from the offering of the Shares (before deducting expenses other than the nonaccountable expense allowance payable by the Company to the Underwriter) received by the Company bear to the total underwriting commissions and expense allowance received by the Underwriter in each case as set forth in the table on the cover page of the Prospectus. The relative fault shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company or the Underwriter, and the parties' relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. The Company and the Underwriter agree that it would not be just and equitable if contribution pursuant to this Section 6.03 were determined by pro rata allocation or by any other method of allocation which does not take account of the equitable considerations referred to above in this
Section 6.03. The amount paid or payable by an indemnified party as a result of the losses, claims, damages, expenses or liabilities (or actions in respect thereof) referred to above in this Section 6.03 shall he deemed to include any legal or other expenses to which such indemnified party would be entitled if
Section 6.01 and 6.02 were applied. Notwithstanding the provisions of this
Section 6.03, the Underwriter shall not be required to contribute any amount in excess of the amount by which the total price which the Shares underwritten by it and distributed to the public exceeds the amount of any damages which the Underwriter has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission plus the Underwriter's proportionate share of such legal or other expenses; and any punitive or exemplary damages if the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by or statements made by the Underwriter. No person guilty of fraudulent misrepresentation (within the meaning of Section 11 of the Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.

SECTION 7

EFFECTIVENESS OF AGREEMENT

This Agreement shall become effective upon release by the Underwriter of the Shares for offering after the effective date. The time of the release by the Underwriter of the Shares for offering, for the purposes of this Section 7, shall mean the time of the release by the Underwriter of the Shares for public sale pursuant to the Registration Statement. The Underwriter agrees to notify the Company immediately after the Underwriter shall have released the Shares that this Agreement has become effective. This Agreement shall, nevertheless, become effective at such time earlier than the time specified above, after the effective date, as the Underwriter may determine by notice to the Company.

SECTION 8

CONDITIONS OF THE UNDERWRITER'S OBLIGATIONS

The Underwriters' obligations hereunder to purchase the Shares and to make payment to the Company hereunder on the Closing Date shall be subject to the accuracy, as of the Closing Date, of the representations and warranties on the part of the Company herein contained, to the performance by the Company of all its agreements herein contained, to the fulfillment of or compliance by the Company with all covenants and conditions hereof, and to the following additional conditions:

8.01. EFFECTIVENESS OF REGISTRATION STATEMENT. The Registration Statement shall have become effective on or prior to 12:00 Noon Minneapolis time, on February 14, 1997, or such later date as the Underwriter may agree to. On or prior to the Closing Date, no order suspending the effectiveness of the Registration Statement shall have been issued and no proceeding for that purpose shall have been initiated or threatened by the Commission or be pending; any request for additional information on the part of the Commission (to be included in the Registration Statement or Prospectus or otherwise) shall have been complied with to the satisfaction of the Commission; and neither the Registration Statement or the Prospectus nor any amendment thereto shall have been filed to which counsel to the Underwriter shall have reasonably objected in writing or have not given their consent.

8.02. ACCURACY OF REGISTRATION STATEMENT. The Underwriter shall not have disclosed in writing to the Company that the Registration Statement or the Prospectus or any amendment thereof or supplement thereto contains an untrue statement of a fact which, in the opinion of counsel to the Underwriter, is material, or omits to state a fact which, in the opinion of such counsel, is material and is required to be stated therein, or is necessary to make the statements therein not misleading.

8.03. CASUALTY AND OTHER CALAMITY. Between the date hereof and the Closing Date, the Company shall not have sustained any loss on account of fire, explosion, flood, accident, calamity or any other cause, of such character as materially adversely affects its business or property considered as an entire entity, whether or not such loss is covered by insurance and neither the President nor any other officer of the Company shall have suffered any injury or disability of a nature which would materially adversely affect his ability to properly function as an officer and director of the Company.

8.04. LITIGATION AND OTHER PROCEEDINGS. Between the date hereof and the Closing Date, there shall be no litigation instituted or threatened against the Company and there shall be no proceeding instituted or threatened against the Company before or by any federal or state commission, regulatory body or administrative agency or other governmental body, domestic or foreign, wherein an unfavorable ruling, decision or finding would materially adversely affect the business, franchises, licenses, patents, operations or financial condition or income of the Company considered as an entity.

8.05. LACK OF MATERIAL CHANGE. Except as contemplated herein or as set forth in the Registration Statement and Prospectus, during the period subsequent to the date of the last audited balance sheet included in the Registration Statement and prior to the Closing Date, the Company: (a) shall have conducted its business in the ordinary course as the same was being conducted on the date of the last audited balance sheet included in the Registration Statement, (b) except in the ordinary course of its business, the Company shall not have incurred any liabilities or obligations (direct or contingent) or disposed of any of its assets, or entered into any material transaction or suffered or experienced any materially adverse change in its condition, financial or otherwise, and (c) there shall have been no material adverse change in the condition (financial or otherwise), business, or prospects of the Company. At the Closing Date, the capital stock, and stockholder's equity of the Company shall be substantially the same as at the date of the last audited balance sheet included in the Registration Statement, without considering the proceeds from the sale of the Shares, other than as may be set forth in the Prospectus, and except as the stockholder's equity reflects the result of continued losses from operations.

8.06. REVIEW BY AND OPINION OF UNDERWRITER'S COUNSEL. The authorization of the Shares, the Warrants, the Warrant Shares, the Registration Statement, and the Prospectus and all corporate proceedings and other legal matters incident thereto and to this Agreement shall be reasonably satisfactory in all respects to counsel to the Underwriter. The Underwriter shall have received an opinion dated as of the Closing Date from its counsel, substantially in the form of the opinion called for by Section 8.07(viii), and an opinion as to the due authorization, execution, and delivery of this Agreement, qualified in such manner as the Underwriter may deem acceptable.

8.07. OPINION OF COUNSEL. The Company (which term shall include any subsidiaries of the Company) shall have furnished to the Underwriter the opinion, dated the Closing Date, addressed to the Underwriter, from Doherty, Rumble & Butler, counsel to the Company, to the effect that based upon a review by them of the Registration Statement, the Prospectus, the Company's Articles of incorporation, bylaws, and relevant corporate proceedings, an examination of such statutes they deem necessary, and such other investigation by such counsel as they deem necessary to express such opinion:

(i) The Company has been duly incorporated and is a validly existing corporation in good standing under the laws of Minnesota, with full corporate power and authority to own and operate its properties and to carry on its business as set forth in the Registration Statement and Prospectus.

(ii) The Company is not required to qualify or register as a foreign corporation in any state, and there are no jurisdictions in which the Company's ownership of property or its conduct of business requires such qualification or registration and where the failure to so qualify would have a material adverse effect on its operations.

(iii) The Company has authorized and outstanding capital stock as set forth in the Registration Statement and Prospectus; the outstanding capital stock of the Company, the Shares, and the Underwriter's Warrants conform to the statements concerning them in the Registration Statement and Prospectus; the outstanding capital stock of the Company has been duly and validly issued and is fully-paid and nonassessable and contain no preemptive rights; the Shares have been, and the Warrant Shares issuable upon due exercise of the Warrants will be, when delivered against payment, duly and validly authorized and, upon issuance thereof and payment therefor in accordance with this Agreement and the Warrants, will be duly and validly issued, fully paid, and nonassessable, and will not be subject to the preemptive rights of any shareholder of the Company.

(iv) The Underwriter's Warrants have been duly and validly authorized and issued and are valid and binding instruments enforceable against the Company in accordance with their terms, except as enforcement may be limited by bankruptcy or similar laws affecting creditors' rights general application affecting creditors' rights, except as the availability of equitable remedies requires the exercise of judicial discretion, and except as enforcement of the indemnification provisions therein may be limited by federal or state securities laws.

(v) A sufficient number of shares of the Company's common stock have been duly reserved for issuance upon exercise of the Underwriter's Warrants.

(vi) No consents, approvals, authorizations, or orders of agencies, officers, or other regulatory authorities are known to such counsel which are necessary for the valid authorization, issue, or sale of the Shares and Warrant Shares hereunder, except as required under the Act or blue sky or state securities laws.

(vii) The issuance and sale of the Shares, the Warrants, the Warrant Shares, and the consummation of the transactions herein contemplated and compliance with the terms of this Agreement will not conflict with or result in a breach of any of the terms, conditions, or provisions of or constitute a default under the articles of incorporation or bylaws of the Company, or under any note, indenture, mortgage, deed of trust, or other agreement or instrument known to such counsel after reasonable investigation to which the Company is a party or by which the Company or any of its property is bound, or under any existing law (provided this paragraph shall not relate to federal or state securities laws), order, rule, regulation, writ, injunction, or decree known to such counsel of any government, governmental instrumentality, agency, body, arbitration tribunal, or court, domestic or foreign, having jurisdiction over the Company or its property.

(viii) The Registration Statement has become effective under the Act and, to the best knowledge of such counsel after reasonable investigation, no order suspending the effectiveness of the Registration Statement has been issued and no proceedings for that purpose have been instituted or are pending or contemplated by the Commission under the Act or by any authority acting under any state securities or blue-sky law; and the Registration Statement and Prospectus, and each amendment and supplement thereto, comply as to form in all material respects with the requirements of the Act and the Regulations thereunder, and such counsel is familiar with all contracts referred to in the Registration Statement or Prospectus and such contracts are sufficiently summarized or disclosed therein or filed as exhibits thereto as required, and such counsel, after a reasonable investigation, does not know of any contracts required to be summarized or disclosed or filed, and such counsel, after a reasonable investigation, does not know of any legal or governmental proceedings pending or threatened to which the Company is the subject of such a character required to be disclosed in the Registration Statement or the Prospectus which are not disclosed and properly described therein.

(ix) This Agreement has been duly authorized and executed by the Company and is a valid and binding agreement of the Company and is enforceable against the Company in accordance with its terms, except as enforcement may be limited by bankruptcy or similar laws affecting creditors' rights general application affecting creditors' rights and except as the availability of equitable remedies requires the exercise of judicial discretion, and except as enforcement of the indemnification provisions therein may be limited by federal or state securities laws.

(x) After a reasonable investigation such counsel has no reason to believe that either the Registration Statement nor the Prospectus or any such amendment or supplement contains any untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances under which made [except that no opinion need be expressed as to financial statements contained in the Registration Statement or Prospectus].

As to routine factual matters such as the issuance of stock certificates and receipt of payment therefor, the states in which the Company transacts business, the adoption of resolutions reflected by the Company's minute book and the like, such counsel may rely on the certificate of an appropriate officer of the Company. Such opinion shall also cover such other matters incident to the transactions contemplated by this Agreement as the Underwriter shall reasonably request.

8.08.01. ACCOUNTANT'S COMFORT LETTER. The Underwriter shall have received a letter addressed to it and dated the date of this Agreement and the Closing Date, respectively, from Divine, Scherzer & Brody, Ltd., independent public accountants for the Company, stating that (i) with respect to the Company they are independent public accountants within the meaning of the Act and the applicable Regulations thereunder and the response to Item 509 of Regulation S-B as reflected by the Registration Statement is correct insofar as it relates to them; (ii) in their opinion, the financial statements of the Company examined by them at all dates and for all periods referred to in their opinion and included in the Registration Statement and Prospectus, comply in all material respects with the applicable accounting requirements of the Act and the Regulations thereunder with respect to registration statements on Form S-B2; (iii) on the basis of certain indicated procedures (but not an examination in accordance with generally accepted accounting principles), including examinations of the instruments of the Company set forth under "Capitalization" in the Prospectus, a reading of the latest available interim unaudited financial statements of the Company, whether or not appearing in the Prospectus, inquiries of the officers of the Company or other persons responsible for its financial and accounting matters regarding the specific items for which representations are requested below, and a reading of the minute books of the Company, nothing has come to their attention which would cause them to believe that during the period from the last audited balance sheet included in the Registration Statement to a specified date not more than five days prior to the date of such letter (a) there has been any change in the capital stock or other securities of the Company or any payment or declaration of any dividend or other distribution in respect thereof or exchange therefor from that shown on its audited balance sheets or in the debt of the Company from that shown or contemplated under "Capitalization" in the Registration Statement or Prospectus other than as set forth in or contemplated by the Registration Statement or Prospectus; (b) there have been any material decreases in net current assets, or net assets as compared with amounts shown in the last audited balance sheet included in the Prospectus so as to make said financial statements misleading; and (c) on the basis of the indicated procedures and discussions referred to in clause (iii) above, nothing has come to their attention which, in their judgment, would cause them to believe or indicate that (1) the unaudited financial statements and schedules set forth in the Registration Statement and Prospectus do not present fairly the financial position and results of the Company for the periods indicated, in conformity with the generally accepted accounting principles applied on a consistent basis with the audited financial statements, and (2) the dollar amounts, percentages and other financial information set forth in the Registration Statement and Prospectus under the captions "Prospectus Summary," "Risk Factors," "Dilution," "Capitalization," "Executive Compensation," "1996 Stock Option Plan," "Principal Shareholders," and "Certain Transactions," are not in agreement with the Company's general ledger, financial records, or computations made by the Company therefrom.

8.08.02. CONFORMED COPIES OF ACCOUNTANT'S LETTER. The Underwriter shall be furnished without charge, in addition to the original signed copies, such number of signed or photostatic or conformed copies of such letters as the Underwriter shall reasonably request.

8.09. OFFICERS' CERTIFICATE. The Company shall have furnished to the Underwriter a certificate by the chief executive officer and chief financial officer, dated as of the Closing Date, to the effect that:

(i) The representations and warranties of the Company in this Agreement are true and correct at and as of the Closing Date, and the Company has complied with all the agreements and has satisfied all the conditions on its part to be performed or satisfied at or prior to the Closing Date.

(ii) The Registration Statement has become effective and no order suspending the effectiveness of the Registration Statement has been issued and to the best of the knowledge of the respective signers, no proceeding for that purpose has been initiated or is threatened by the Commission.

(iii) The respective signers have each carefully examined the Registration Statement and Prospectus and any amendments and supplements thereto, and the Registration Statement and the Prospectus and any amendments and supplements thereto contain all statements required to be stated therein, and all statements contained therein are true and correct, and neither the Registration Statement nor Prospectus nor any amendment or supplement thereto includes any untrue statement of a material fact or omits to state any material fact required to be stated therein or necessary to make the statements therein not misleading and, since the effective date of the Registration Statement, there has occurred no event required to be set forth in an amended or a supplemented Prospectus which has not been so set forth.

(iv) Except as set forth in the Registration Statement and Prospectus since the respective dates as of which the periods for which information is given in the Registration Statement and Prospectus and prior to the date of such certificate, (a) there has not been any material adverse change, financial or otherwise, in the financial or other condition, business, or prospects of the Company, and (b) the Company has not incurred any liabilities, direct or contingent, or entered into any transactions, otherwise than in the ordinary course of business.

(v) Subsequent to the respective dates as of which information is given in the Registration Statement and Prospectus, no dividends or distribution whatever have been declared and/or paid on or with respect to the common Shares of the Company.

8.10. TENDER OF DELIVERY OF SHARES. All of the Shares being offered by the Company and the Warrants being purchased from the Company by the Underwriter shall be tendered for delivery in accordance with the terms and provisions of this Agreement.

8.11. BLUE-SKY QUALIFICATION. The Shares shall be qualified in such states as the Underwriter may reasonably request pursuant to Section 5.04, and each such qualification shall be in effect and not subject to any stop order or other proceeding on the Closing Date.

8.12. APPROVAL OF UNDERWRITER'S COUNSEL. All opinions, letters, certificates and evidence mentioned above or elsewhere in this Agreement shall be deemed to be in compliance with the provisions hereof only if they are in form and substance satisfactory to counsel to the Underwriter, whose approval shall not be unreasonably withheld. The suggested form of such documents shall be provided to the counsel for the Underwriter at least one business day before the Closing Date. The Underwriter's counsel will provide a written memorandum stating such closing documents which he deems necessary for their review. Such memorandum shall be delivered five business days before the Closing Date to counsel for the Company.

8.13. OFFICERS' CERTIFICATE AS A COMPANY REPRESENTATIVE. Any certificate signed by an officer of the Company and delivered to the Underwriter or to counsel for the Underwriter will be deemed a representation and warranty by the Company to the Underwriter as to the statements made therein.

SECTION 9

TERMINATION

9.01. TERMINATION BECAUSE OF NON-COMPLIANCE. This Agreement may be terminated by the Underwriter by notice to the Company in the event that the Company shall have failed or been unable to comply with any of the terms, conditions or provisions of this Agreement on the part of the Company to be performed, complied with or fulfilled (including but not limited to those specified in Sections 2, 3, 4, 5, and 8 hereof) within the respective times herein provided for, unless compliance therewith or performance or satisfaction thereof shall have been expressly waived by the Underwriter in writing.

9.02. MARKET OUT TERMINATION. This Agreement may be terminated by the Underwriter by notice to the Company at any time if, in the judgment of the Underwriter, payment for and delivery of the Shares is rendered impracticable or inadvisable because (i) trading in securities generally on the New York Shares Exchange, American Shares Exchange, or NASDAQ shall have been suspended or materially limited, (ii) a general moratorium on commercial banking activities in New York or Colorado shall have been declared by either federal or state authorities, or (iii) there shall have occurred a war or other national calamity, or a crisis or change in political, financial, or economic conditions, the effect of which on the financial markets of the United States is such as it would be undesirable, impracticable or inadvisable in the judgment of the Underwriter to proceed or continue with this Agreement or with the public offering. Notice of such termination may be given to the Company by telegram, telecopy or telephone and shall subsequently be confirmed by letter.

9.03. EFFECT OF TERMINATION HEREUNDER. Any termination of this Agreement pursuant to this Section 9 shall be without liability of any character (including, but not limited to, loss of anticipated profits or consequential damages) on the part of any party thereto, except that the Company shall remain obligated to pay the costs and expenses provided to be paid by it specified in
Section 5.07; and the Company and the Underwriter shall be obligated to pay, respectively, all losses, claims, damages or liabilities, joint or several, under Section 6.01 in the case of the Company and Section 6.02 in the case of the Underwriter.

SECTION 10

UNDERWRITER'S REPRESENTATIONS, WARRANTIES, AND COVENANTS

The Underwriter represents and warrants to and agrees with the Company that:

10.01. REGISTRATION AS BROKER-DEALER AND MEMBER OF NASD. The underwriter is and each selected dealer will be (a) registered as a broker-dealer with the Securities and Exchange Commission, (b) registered as a broker-dealer in all states in which it conducts business, and (c) is a member in good standing of the National Association of Securities Dealers, Inc.

10.02. NO PENDING PROCEEDINGS. There is not now pending or threatened against the Underwriter any action or proceeding of which it has been advised, either in any court of competent jurisdiction, before the Securities and Exchange Commission or any state securities commission concerning its activities as a broker or dealer, nor has the Underwriter been named as a "cause" in any such action or proceeding.

10.03. COMPANY'S RIGHT TO TERMINATE. In the event any action or proceeding of the type referred to in subparagraph 10.02 above shall be instituted or threatened against the Underwriter at any time prior to the effective date hereunder, or in the event there shall be filed by or against it in any court pursuant to any federal, state, local or municipal statute, a petition in bankruptcy or insolvency or for reorganization or for the appointment of a receiver or trustee of its assets or if it makes an assignment for the benefit of creditors, the Company shall have the right on three days' written notice to the Underwriter to terminate this Agreement without any liability to the Underwriter of any kind except for the payment of all expenses as provided herein.

10.04. EXERCISE PRICE OF WARRANT. The Underwriter will exercise the Warrant for 41,639 Shares referred to in section 3.06 herein at a price of $6.00 per share, subject to adjustment as provided in such Warrant for such events as splits, reverse splits, recapitalizations, as described therein.

SECTION 11

NOTICE

11.01. NOTICE TO THE COMPANY. Whenever notice is required by the provisions of this Underwriting Agreement to be given to the Company, such notice shall be in writing addressed to the Company as follows:

Barry Wendt
Secure Access Control Technologies, Inc. 4444 West 76th Street
Suite 600
Edina, MN 55435

with a copy to:

Stephen E. Smith, Esq. or Daniel R. Tenenbaum, Esq. Doherty, Rumble, & Butler
3500 Fifth Street Towers
150 South Fifth Street
Minneapolis, MN 55402.

11.02. NOTICE TO THE UNDERWRITER. Whenever notice is required by the provisions of this Agreement to be given to the Underwriters, such notice shall be given in writing addressed to the Underwriter at the address set out at the beginning of this Agreement, with a copy to:

Tuschner & Company, Inc.
Attention: John Tuschner
Suite 800, One Financial Plaza
120 South Sixth Street
Minneapolis, MN 55402

Michael L. Berde, Esq. or Kevin S. Spreng, Esq. Merritt, Furber & Timmer
2100 Metropolitan Centre
333 South Seventh Street
Minneapolis, MN 55402.

SECTION 12

MISCELLANEOUS

12.01. BENEFIT. This Agreement is made solely for the benefit of the Underwriter, the Company, their respective officers and directors and any controlling person referred to in Section 15 of the Act, and their respective successors and assigns, and no other person shall acquire or have any right under or by virtue of this Agreement. The term "successor" or the term "successors and assigns" as used in this Agreement shall not include any purchasers, as such, of any of the Shares.

12.02. SURVIVAL. The respective indemnities, agreements, representations, warranties, covenants and other statements of the Company or its officers as set forth in or made pursuant to this Agreement and the indemnity agreements of the Company and the Underwriter contained in Section 6 hereof shall survive and remain in full force and effect, regardless of (i) any investigation made by or on behalf of the Company or the Underwriters or any such officer or director thereof or any controlling person of the Company or of the Underwriter, (ii) delivery of or payment for the Shares, (iii) the Closing Date, and (iv) any successor of the Company and the Underwriter or any controlling person, officer or director thereof, as the case may be, shall be entitled to the benefits hereof.

12.03. GOVERNING LAW. The validity, interpretation and construction of this Agreement and of each part hereof will be governed by the laws of the State of Minnesota.

12.04. UNDERWRITER'S INFORMATION. The statements with respect to the public offering of the Shares on the cover page of the Prospectus and under the caption "Underwriting" in the Prospectus constitute the written information furnished by or on behalf of the Underwriters referred to in subsection 2.02 hereof, in subsection 6.01 hereof and subsection 6.02 hereof.

12.05. COUNTERPARTS. This Agreement may be executed in any number of counterparts, each of which may be deemed an original and all of which together will constitute one and the same instrument.

Please confirm that the foregoing correctly sets forth the Agreement between you and the Company.

Very truly yours,

SAC TECHNOLOGIES, INC.

ATTEST:

By_________________________________
______________________, President

WE HEREBY CONFIRM AS OF THE DATE HEREOF THAT THE ABOVE LETTER SETS FORTH THE AGREEMENT BETWEEN THE COMPANY AND US.


TUSCHNER & COMPANY, INC.

By____________________________________
Its____________________________________

Exhibit A

RESTRICTION ON TRANSFER

THE SECURITIES REPRESENTED BY THIS INSTRUMENT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR APPLICABLE STATE LAW AND MAY NOT BE TRANSFERRED IN THE ABSENCE OF (1) A LAWFUL EXEMPTION FROM SUCH REGISTRATION OR (2) SUCH REGISTRATION.

WARRANT TO PURCHASE SHARES OF COMMON STOCK
OF SAC TECHNOLOGIES, INC.

This Certifies that, for value received, Tuschner & Company, Inc., or its permitted assigns (the "Holder"), is entitled, upon the terms and subject to the conditions hereafter set forth, to subscribe for and purchase from SAC Technologies, Inc., a Minnesota corporation (the "Company"), __________________ (______) fully paid and nonassessable shares of the Company's Common Stock, $0.01 par value (the "Common Stock"). The number and exercise price of the securities that may be purchased upon the exercise of this Stock Purchase Warrant (the "Warrant") are subject to adjustment as provided herein.

Section 1 Exercise Period

The purchase rights represented by this Warrant are exercisable by the Holder, in whole or in part, at any time or from time to time on or after the first anniversary hereof and on or before the fifth anniversary hereof (the "Exercise Period").

Section 2 Exercise Price

The price per share for purchase of the Common Stock upon exercise of the Warrant shall initially be $7.20 one hundred twenty percent (120%) per share of the "Price to Public" of the shares sold pursuant to the Company's Registration Statement No. _______ (the "Exercise Price"). Such initial Exercise Price shall be subject to adjustment as provided in Section 8 hereof.

Section 3 Exercise of Warrant

During the Exercise Period, the Warrant shall be exercised, in whole or in part and from time to time, by the surrender of this Warrant and the Notice of Exercise annexed hereto duly executed at the office of the Company, in Edina, Minnesota (or such other office or agency of the Company as it may designate) and upon payment of the Exercise Price of the shares thereby purchased (payment to be by check or bank draft payable to the order of the Company). Upon exercise, the Holder shall be entitled to receive, within a reasonable time, one or more certificates, issued in the Holder's name or in such name or names as the Holder may direct, for the number of shares of Common Stock so purchased. The shares so purchased shall be deemed to be issued as of the close of business on the date on which this Warrant shall have been exercised.

The Company covenants that all shares of Common Stock that are issued upon the exercise of rights represented by this Warrant will be fully paid, nonassessable, and free from all taxes, liens, and changes in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).

Section 4 No Fractional Shares or Scrip

No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. In lieu thereof, a cash payment shall be made equal to such fraction multiplied by the Exercise Price per share as then in effect.

Section 5 Charges, Taxes, and Expenses

Issuance of certificates for shares of Common Stock upon the exercise of this Warrant shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such certificate, all of which taxes and expenses shall be paid by the Company.

Section 6 No Rights as Shareholders

This Warrant does not entitle the Holder to any voting rights or other rights as a shareholder of the Company prior to exercise and payment of the Exercise Price in accordance with Section 3 hereof.

Section 7 Registration Rights

7.1 Certain Definitions. As used in this Section 7, the following terms shall have the following respective meanings:

1. "Commission" means the Securities and Exchange Commission, or any other federal agency at the time administering the 1933 Act.

2. "1933 Act" means the Securities Act of 1933, as amended, or any similar federal statute, and the rules and regulations of the Commission issued under such Act, as they each may, from time to time, be in effect.

3. "Registration Statement" means a registration statement filed by the Company with the Commission for a public offering and sale of securities of the Company.

4. "Registrable Shares" means the shares of Common Stock issued or issuable upon exercise of the Warrant.

5. "Registration Expenses" means all expenses incurred by the Company in compliance with Subsections 7.2 and 7.3 hereof, including, without limitation, all registration and filing fees, printing expenses, fees and disbursements of counsel for the Company, blue sky fees and expenses, exchange listing fees, the expense of any special audits incident to or required by any such registration, fees of the custodian for the selling Stockholders, transfer agent fees, all travel, lodging, and reasonable living expenses incurred by the Company in marketing the shares registered in such registration, and the expenses associated with the Company's obligations under Subsection 7.5 hereof.

6. "Selling Expenses" means all underwriting discounts and selling commissions applicable to the sale of Registrable Shares and all fees and disbursements of counsel, accountants, and experts for any selling Stockholder.

7. "Stockholder" means the holder of (1) the Warrant or (2) Common Stock obtained upon exercise of the Warrant.

7.2 Demand Registration.

(a) At any time during the Exercise Period (following the Company's initial public offering of its securities under the 1933 Act or Regulation A thereunder), a Stockholder or Stockholders holding more than 50 percent of the Registrable Shares then outstanding may request the Company, in writing, to effect the registration, under the 1933 Act, of Registrable Shares owned by such Stockholder or Stockholders, pursuant to a public offering to be filed on a Form S-3 Registration Statement (or, if such Registration Statement is not available, such other form of Registration Statement as may be selected by the Company in its sole discretion), and to be managed by an investment banking firm to be selected by the Company pursuant to Subsection 7.8 hereof. Such request shall indicate the number of Registrable Shares proposed to be sold by the requesting Stockholder or Stockholders and indicate that the requesting Stockholder or Stockholders propose to enter into a "firm commitment" underwriting agreement with such investment banking firm contemplating immediate resale to the public of such Registrable Shares. Upon receipt of any such request, the Company shall promptly give written notice of such proposed registration to all Stockholders. Such Stockholders shall have the right, by giving written notice to the Company within twenty days after the Company provided its notice, to elect to have included in such registration such of their Registrable Shares as such Stockholders may request in such notice of election, subject to the limitations set forth in Subsection 7.2(f) hereof. Thereupon, the Company shall, as expeditiously as possible, use its best efforts to effect the registration of all Registrable Shares that the Company has been requested to register.

(b) The Company shall be required to effect only one registration pursuant to Subsection 7.2(a) hereof. In no event shall the Company be required to effect such registration within three months after the effective date of any other Registration Statement of the Company (except a Registration Statement on Form S-8 or Form S-4 or any successor forms thereto).

7.3. Incidental Registration.

(a) Whenever the Company proposes to file a Registration Statement at any time and from time to time during the Exercise Period (following the Company's initial public offering of its securities under the 1933 Act or Regulation A thereunder), except on Forms S-4 or S-8, it will, prior to such filing, on three occasions give written notice to all Stockholders of its intention to do so and, upon the written request of a Stockholder or Stockholders given within twenty days after the Company provides such notice, the Company shall, subject to Subsection 7.3(b) hereof, use its best efforts to cause all Registrable Shares that the Company has been requested by such Stockholder or Stockholders to register to be registered under the 1933 Act; provided that the Company shall have the right to postpone or withdraw any registration effected pursuant to this Subsection 7.3 without obligation to any Stockholder, except, in the case of a registration that is withdrawn, to pay counsel fees and expenses incurred by the Stockholders in connection with such withdrawn registration.

(b) If the offering to which the proposed registration under this Subsection 7.3 relates is to be distributed by or through an underwriter or underwriters, and if in the opinion of the managing underwriter the registration of all, or part, of the Registrable Shares that the Stockholders have requested to be included would materially and adversely affect such public offering, then the Company shall be required to include in the underwriting only that number of Registrable Shares, if any, that the managing underwriter believes may be sold without causing such adverse effect. If the number of Registrable Shares to be included in the underwriting in accordance with the foregoing is less than the number of shares that the Stockholders have requested to be included, then the Stockholders who have requested registration shall participate in the underwriting pro rata based on their total ownership of Registrable Shares and if any Stockholder would thus be entitled to include more shares than such Stockholder requested to be registered, the excess shall be allocated among other requesting Stockholders pro rata based on their total ownership of Registrable Shares. By accepting this Warrant, the Holder agrees that if requested by such underwriter, the Holder and/or its assigns will sell any Registrable Shares that are subject to the Registration Statement to or through such underwriters at the same price to be paid to the Company or other selling stockholders if the Company or other selling stockholders are offering Common Stock.

(c) In the event that the Company proceeds to register Registrable Shares pursuant to a request made under this Subsection 7.3, the Holder, if a Stockholder who sells Registrable Shares in such registered offering, agrees to sign such supplemental agreements as the Company and/or the managing underwriter shall request, restricting such Stockholder from selling or offering for sale any Registrable Shares
(other than those being sold pursuant to the Registration Statement) for a period of up to ninety days after the effective date of such Registration Statement, provided that all officers, directors, and 5-percent-or-greater shareholders also sign such agreements. The Company may impose stop-transfer instructions with respect to the Registrable Shares subject to the foregoing restriction until the end of the required period.

7.4 Exemption From Registration.

Notwithstanding any provision in Subsections 7.2 and 7.3 of this Warrant, the Company shall not be required to cause a Registration Statement to be filed with respect to any Registrable Shares, if at the time of the Company's receipt of a request to register Registrable Shares, the entire number of Registrable Shares proposed to be sold by the requesting Stockholders may be sold by them, in the manner proposed by them, pursuant to Rule 144 promulgated under the 1933 Act (or any successor rule) (Rule 144) within not more than ninety days from the date of such receipt (based on the number of shares of Common Stock outstanding on the date of such opinion and the average weekly trading volume for such Common Stock for the four weeks preceding the date of such receipt, if applicable).

7.5 Registration Procedures.

If and whenever the Company is required by Subsection 7.2 or 7.3 of this Warrant to use its best-efforts to effect the registration of any of the Registrable Shares under the 1933 Act, the Company shall:

(a) File with the Commission a Registration Statement with respect to such Registrable Shares and use its best efforts to cause that Registration Statement to become and remain effective;

(b) As expeditiously as possible prepare and file with the Commission any amendments and supplements to the Registration Statement and the prospectus included in the Registration Statement as may be necessary to keep the Registration Statement effective for a period sufficient to effect the sale of the Registrable Securities, but in any event not more than ninety days from the effective date;

(c) As expeditiously as possible furnish to each selling Stockholder such reasonable numbers of copies of the prospectus, including a preliminary prospectus, in conformity with the requirements of the 1933 Act, and such other documents as the selling Stockholder may reasonably request in order to facilitate the public sale or other disposition of the Registrable Shares owned by the selling Stockholder;

(d) As expeditiously as possible use its best efforts to register or qualify the Registrable Shares covered by the Registration Statement under the securities or Blue Sky laws of such states or jurisdictions as the managing underwriter deems appropriate, and do any and all other acts and things that may be necessary or desirable to enable the selling Stockholder to consummate the public sale or other disposition in such jurisdictions of the Registrable Shares owned by the selling Stockholder; provided, however, that the Company shall not be required in connection with this Subsection 7.5 to qualify as a foreign corporation or execute a general consent to service of process in any jurisdiction; and

(e) Enter into an underwriting agreement with the underwriters designated pursuant to Subsection 7.8 hereof containing customary terms including representations, covenants, indemnification, and contribution provisions.

If the Company has delivered preliminary or final prospectuses to a selling Stockholder and, after having done so, the prospectus must be amended to comply with the requirements of the 1933 Act, the Company shall promptly notify the selling Stockholder and, by accepting this Warrant, the Holder agrees to cease making offers of Registrable Shares immediately upon such request and to return all prospectuses to the Company. The Company shall promptly provide the selling Stockholder with revised prospectuses and, following receipt of the revised prospectuses the selling Stockholder shall be free to resume making offers of the Registrable Shares.

By accepting this Warrant, the Holder and/or its assigns agree not to participate in a registration unless such Stockholder (a) completes and executes all questionnaires, indemnities, underwriting agreements, and other documents required under the terms of any underwriting arrangement relating to such registration or under any applicable rules and regulations of the Commission and
(b) provides to the Company in writing such information as the Company may reasonably require from such Stockholder (i) for inclusion in the Registration Statement relating to such registration, (ii) describing the manner and circumstances of the proposed sale or transfer of Registrable Shares by such Holder, and (iii) to enable the Company to determine if an exemption provided for in this Warrant from the Company's obligation to file a Registration Statement may be applicable.

7.6 Allocation of Expenses.

All Registration Expenses incurred in connection with any registration pursuant to this Section 7 shall be borne by the Company, and all Selling Expenses shall be borne individually and pro rata by the selling Stockholder(s) on the basis of the number of their shares so registered; provided, however, that the Company shall not be required to pay the Registration Expenses of a selling Stockholder if, as a result of the withdrawal of a request for registration by such selling Stockholder, the registration statement does not become effective, in which case such selling Stockholder shall bear his own Registration Expenses pro rata on the basis of the number of shares so included in the registration request (except for the fees of any counsel for the selling Stockholders, which shall be borne only by the persons whom such counsel represented, pro rata on the basis of the number of their shares so included in the registration request).

7.7 Indemnification.

(a) In the event of any registration of any of the Registrable Shares under the 1933 Act pursuant to this Warrant, the Company will indemnify and hold harmless the seller of such Registrable Shares, each underwriter of such Registrable Shares, and each other person, if any, who controls such seller or underwriter within the meaning of the 1933 Act against any losses, claims, damages, or liabilities, joint or several, to which such seller, underwriter, or controlling person may become subject under the 1933 Act, or otherwise, insofar as such losses, claims, damages, or liabilities, or actions in respect thereof, arise out of or are based on any untrue statement or alleged untrue statement of any material fact contained in any Registration Statement under which such Registrable Shares were registered under the 1933 Act, any preliminary prospectus or final prospectus contained in the Registration Statement, or any amendment or supplement to such Registration Statement, or arise out of or are based on the omission or alleged omission of a material fact or facts required to be stated therein or necessary to make the statements therein not misleading; and the Company will reimburse such seller, underwriter, and each such controlling person for any legal or any other expenses reasonably incurred by such seller, underwriter, or controlling person in connection with investigating or defending any such loss, claim, damage, liability, or action; provided, however, that the Company will not be liable in any such case to the extent that any such loss, claim, damage, liability, or action arises out of or is based on any untrue statement or omission or alleged untrue statement or omission made in such Registration Statement, preliminary prospectus, or prospectus, or any such amendment or supplement, in reliance upon and in conformity with written information furnished to the Company through an instrument duly executed by or on behalf of such seller, underwriter, or controlling person specifically for use in the preparation thereof.

(b) By accepting this Warrant, the Holder agrees that in the event of any registration of any of the Holder's and/or its assigns' Registrable Shares under the 1933 Act, such Stockholder will indemnify and hold harmless the Company, each of its directors and officers, each legal counsel and independent accountant of the Company, each underwriter (if any) of the Company's Registrable Shares covered by any Registration Statement, and each person, if any, who controls the Company or any such underwriter within the meaning of the 1933 Act, against any losses, claims, damages, or liabilities, joint or several, to which the Company or any such director and officer, underwriter, or controlling person may become subject under the 1933 Act, insofar as such losses, claims, damages, liabilities, or actions in respect thereof arise out of or are based on any untrue statement or alleged untrue statement of a material fact contained in any Registration Statement under which such Registrable Shares were registered under the 1933 Act, any preliminary prospectus or final prospectus contained in the Registration Statement, or any amendment or supplement to the Registration Statement, or arise out of or are based on any omission or alleged omission of a material fact or facts required to be stated therein or necessary to make the statements therein not misleading, and will reimburse the Company, and each such director and officer, underwriter, and controlling person for any legal or any other expenses reasonably incurred in connection with investigating or defending any such loss, claim, damage, liability, or action, in each case to the extent, but only to the extent, that the statement or omission was made in reliance upon and in conformity with information furnished in writing to the Company by or on behalf of such Holder, specifically for use in connection with the preparation of such Registration Statement, prospectus, amendment, or supplement.

(c) Each party entitled to indemnification under this Subsection 7.7 (Indemnified Party) shall give notice to the party required to provide indemnification (Indemnifying Party) promptly after such Indemnified Party has actual knowledge of any claim as to which indemnity may be sought, and shall permit the Indemnifying Party to assume the defense of any such claim or any litigation resulting therefrom, provided that counsel for the Indemnifying Party, who shall conduct the defense of such claim or any litigation resulting therefrom, shall be approved by the Indemnified Party (whose approval shall not unreasonably be withheld), and the Indemnified Party may participate in such defense at such Indemnified Party's expense. The failure of any Indemnified Party to give notice as provided herein shall relieve the Indemnifying Party of its obligations under this Subsection 7.7 only if such failure is prejudicial to the ability of the Indemnifying Party to defend such action, and such failure shall in no event relieve the Indemnifying Party of any liability that it may have to any Indemnified Party otherwise than under this Subsection 7.7. No Indemnifying Party, in the defense of any such claim or litigation, shall, except with the consent of each Indemnified Party, consent to entry of any judgment or enter into any settlement that does not include as an unconditional term thereof the giving by the claimant or plaintiff to such Indemnified Party of a release from all liability in respect to such claim or litigation.

(d)(1) In order to provide for just and equitable contribution in circumstances in which the indemnification provided for in this Section 7.7 is for any reason held, by a court of competent jurisdiction, to be unenforceable as to any party entitled to indemnity, the Company shall contribute to the aggregate losses, claims, damages and liabilities (including any investigation, legal and other expenses incurred in connection with, and any amount paid in settlement of, any action, suit or proceeding or any claims asserted) to which the holder hereof, or of the common stock purchased upon exercise hereof, or any controlling person of the foregoing may be subject in such proportion as is appropriate to reflect the relative fault of the Company, on the one hand, and of such holders or controlling persons on the other, in connection with the statements or omissions which resulted in such loss, claim, damage, liability or expense, as well as any other relevant equitable considerations. The relative fault of the Company, on the one hand, and of the holder hereof or such holder's controlling person on the other shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company, on the one hand, or by the holder or controlling person on the other, and the parties' relative intent, knowledge, access to information, and opportunity to correct or prevent such statement or omission.

(d)(2) The Company and the holder hereof agree that it would not be just and equitable if contribution pursuant to this subsection (d) were determined by pro rata allocation or by any other method of allocation which does not take account of the equitable considerations referred to above. The amount paid or payable by an indemnified party as a result of the losses, claims, damages, liabilities and expenses referred above shall be deemed to include, subject to the limitations set forth above, any legal or other expenses actually and reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the 1933 Act), or guilty of misstating or misrepresenting a material fact or failing to state a material fact shall be entitled to contribution, as to any liability arising from such fraudulent misrepresentation or omission from any person who was not guilty of such fraudulent misrepresentation or omission.

7.8 Designation of Underwriter.

The Company shall have the right to designate the managing underwriter, which underwriter shall be an investment banking firm having an established reputation.

7.9 Amendments.

The provisions of this Section 7 may be modified or amended at any time and from time to time by an agreement or consent in writing executed by the Company and the holders of at least a majority of the Registrable Shares, excluding any Registrable Shares than have been publicly sold prior thereto.

7.10 Rule 144 Requirements.

The Company shall undertake to make publicly available, pursuant to Rule 144 of the Commission under the 1933 Act, such information as is necessary to enable the Stockholders to make sales of Registrable Shares pursuant to that Rule.

Section 8 Adjustments

8.1 Adjustment of the Exercise Price for Stock Splits, Reverse Stock Splits, and Stock Dividends. In the event that the outstanding shares of Common Stock shall be subdivided (split), combined (reverse split), by reclassification or otherwise, or in the event of any dividend payable on the Common Stock in shares of Common Stock, the applicable Exercise Price and the number of shares of Common Stock available for purchase in effect immediately prior to such subdivision, combination, or dividend shall be proportionately adjusted.

8.2 Adjustment for Capital Reorganizations, Dividends. If at any time there shall be a capital reorganization of the Company's Common Stock or a merger, exchange of shares, or consolidation of the Company with or into another corporation, or the sale of the Company's properties and assets as, or substantially as, an entirety to any other person, or if the Company shall declare a dividend payable in securities or property (other than in cash or Common Stock) then, as part of such reorganization, merger, exchange of shares, consolidation, sale or dividend, lawful and adequate provision shall be made so that the Holder of this Warrant shall thereafter be entitled to receive, on exercise of this Warrant during the period specified in this Warrant and on payment of the Exercise Price then in effect, the number of shares of stock or other securities or property of the Company, or of the successor corporation resulting from such merger, exchange of shares, or consolidation, to which a holder of the Common Stock deliverable on exercise of this Warrant would have been entitled on such capital reorganization, merger, exchange of shares, consolidation, sale, or dividend if this Warrant had been exercised immediately before that capital reorganization, merger, exchange of shares, consolidation, sale, or dividend. In any such case, appropriate adjustment, as determined in good faith by the Board, shall be made in the application of the provisions of this Warrant with respect to the rights and interests of the Holder of this Warrant after the reorganization, merger, exchange of shares, consolidation, sale, or dividend to the end that provisions of this Warrant (including adjustment of the Exercise Price then in effect and the number of shares purchasable on exercise of this Warrant, but without any change in the aggregate Exercise Price) shall be applicable after that event, as near as reasonably may be, in relation to any shares or other securities or property deliverable after that event on exercise of this Warrant.

8.3 Certificate as to Adjustments. Upon the occurrence of each adjustment or readjustment pursuant to this Section 8, the Company at its expense shall promptly compute such adjustment or readjustment in accordance with the terms hereof and furnish to each Holder a certificate setting forth such adjustment or readjustment and showing in detail the facts upon which such adjustment or readjustment is based. The Company shall, upon the written request, at any time, of any Holder, furnish or cause to be furnished to such Holder, a like certificate setting forth: (i) such adjustments and readjustments; (ii) the Exercise Price at the time in effect; and (iii) the number of shares of Common Stock and the amount, if any, of other property that at the time would be received upon the exercise of the Warrant.

8.4 Notices of Record Date. In the event of any taking by the Company of a record of the holders of any class of securities for the purpose of determining the holders thereof who are entitled to receiving any dividend (other than a cash dividend that is the same as cash dividends paid in previous quarters) or other distribution, the Company shall mail to each Holder at least ten days prior to the date specified for the taking of a record, a notice specifying the date on which any such record is to be taken for the purpose of such dividend or distribution.

Section 9 Sale or Transfer of the Warrant; Legend

The Warrant, and any shares of Common Stock of the Company purchased upon exercise of the Warrant, shall not be sold or transferred unless either (i) they first shall have been registered under the 1933 Act, or (ii) the Company first shall have been furnished with an opinion of legal counsel reasonably satisfactory to the Company to the effect that such sale or transfer is exempt from the registration requirements of the 1933 Act. Each certificate representing any Warrant and any such share that has not been registered and that has not been sold pursuant to an exemption that permits removal of the legend shall bear a legend substantially in the form appearing on the first page of this Warrant. For twelve months from date, this warrant is not transferable except to officers of the Holder.

Upon the request of a holder of a certificate representing any Warrant or any such share, the Company shall remove the foregoing legend from the certificate or issue to such holder a new certificate therefor free of any transfer legend, if, with such request, the Company shall have received either
(i) an opinion of counsel reasonably satisfactory to the Company to the effect that such legend may be removed from such certificate or (ii) if the present Paragraph (k) of Rule 144 or a substantially similar successor rule remains in force and effect, representations from the holder that such holder is not then, and has not been during the preceding three months, an affiliate of the Company and that such holder has beneficially owned the security (within the meaning of Rule 144) for three years or more.

Such Warrant and shares may be subject to additional restrictions on transfer imposed under applicable state and federal securities law.

Section 10 Additional Right to Convert Warrant

(a) The holder of this Warrant shall have the right to require the Company to convert this Warrant (the "Conversion Right") at any time it is exercisable, but prior to its expiration, into shares of Common Stock as provided for in this Section 10. Upon exercise of the Conversion Right, the Company shall deliver to the holder (without payment by the holder of any Warrant Exercise Price) that number of shares of Common Stock equal to the quotient obtained by dividing (x) the value of the Warrant at the time the Conversion Right is exercised (determined by subtracting the aggregate Warrant Exercise Price for the Warrant Shares in effect immediately prior to the exercise of the Conversion Right from the aggregate Fair Market Value for the Warrant Shares immediately prior to the exercise of the Conversion Right) by (y) the Fair Market Value of one share of Company Common Stock immediately prior to the exercise of the Conversion Right.

(b) The Conversion Right may be exercised by the holder, at any time or from time to time, prior to its expiration, on any business day by delivering a written notice in the form attached hereto (the "Conversion Notice") to the Company at the offices of the Company exercising the Conversion Right and specifying (i) the total number of shares of Stock the Holder will purchase pursuant to such conversion and (ii) a place and date is not less than one or more than 20 business days from the date of the Conversion Notice for the closing of such purchase.

(c) At any closing under Section 10(b) hereof, (i) the Holder will surrender the warrant and (ii) the Company will deliver to the Holder a certificate or certificates for the number of shares of Company Common stock issuable upon such conversion, together with cash, in lieu of any fraction of a share, and (iii) the Company will deliver to the Holder a new warrant representing the number of shares, if any, with respect to which the warrant shall not have been exercised.

(d) Fair Market Value of a share of Common Stock as of a particular date (the "Determination Date") shall mean:

(i) If the Company's Common Stock is traded on an exchange or is quoted on the National Association of Securities Dealers, Inc. Automated Quotation ("NASDAQ") or the NASDAQ National Market System, then the average closing or last sale prices, respectively reported for the ten (10) business days immediately preceding the Determination Date, and

(ii) If the Company's Common Stock is not traded on an exchange or is quoted on an exchange or on NASDAQ or the NASDAQ National Market System but is traded on the over-the counter market, then the average closing bid and asked prices reported for the ten (10) business days immediately preceding the Determination Date, and

(iii) If the Company's Common Stock is not traded on the over-the-counter market, then the Fair Market Value as determined reasonably and in good faith by the Company's Board of Directors.

Section 11 Loss, Theft, Destruction, or Mutilation of Warrant

Upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction, or mutilation of this Warrant, and in case of loss, theft, or destruction of indemnity or security reasonably satisfactory to it, and upon reimbursement to the Company of all reasonable expenses incidental thereto, and upon surrender and cancellation of this Warrant, if mutilated, the Company will make and deliver a new Warrant of like tenor and dated as of such cancellation in lieu of this Warrant.

Section 12 Saturdays, Sundays, Holidays, Etc.

If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall be a Saturday or a Sunday or shall be a legal holiday, then such action may be taken or such right may be exercised on the next succeeding day that is not a legal holiday.

Section 13 Authorized Shares

The Company covenants that during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of Common Stock upon the exercise of any purchase rights under this Warrant.

Section 14 Issue Date

The provisions of this Warrant shall be construed and shall be given effect in all respects as if it had been issued and delivered by the Company on the date hereof. This Warrant shall be binding upon any successors or assigns of the Company.

Section 15 Governing Law

This Warrant shall constitute a contract under the laws of the state of Minnesota and for all purposes shall be construed in accordance with and governed by the laws of said state.

IN WITNESS WHEREOF, SAC Technologies, Inc. has caused this Warrant to be executed by its duly authorized officer.

Dated as of ___________________, 199__

SAC TECHNOLOGIES, INC.

By: __________________________________
Chief Executive Officer

NOTICE OF EXERCISE

To: SAC Technologies, Inc.

1. Pursuant to the terms of the attached Warrant, the undersigned hereby elects to purchase ______________ shares of Common Stock of SAC Technologies, Inc. (the "Company"), and tenders herewith payment of the purchase price of such shares in full.

2. Please issue a certificate or certificates representing said shares of Common Stock, in the name of the undersigned or in such other name(s) as is/are specified immediately below or, if necessary, on an attachment hereto: [List names and addresses.]

3. In the event of partial exercise, please reissue an appropriate Warrant exercisable into the remaining shares to the undersigned.

4. The undersigned represents that such shares shall not be sold or transferred unless either (a) they first shall have been registered under the Securities Act 1933 and applicable state law or (b) the Company first shall have been furnished with an opinion of legal counsel reasonably satisfactory to the Company to the effect that such sale or transfer is exempt from the foregoing registration requirements. The undersigned consents to a legend imprinted on certificates representing the shares purchased hereby noting the foregoing restrictions.

Date: ___________________


Signature of Warrant Holder


Name of Warrant Holder

NOTICE OF ASSIGNMENT

To: SAC Technologies, Inc.

1. The undersigned hereby assigns the right to purchase the common stock of SAC Technologies, Inc. represented by the attached Warrant:

[ ] in whole, or

[ ] for ________________ shares,

to:


Name


Street Address


City, State, Zip Code


Social Security or Tax ID Number

(attach additional sheets for further assignees)

2. In the event of partial assignment, please reissue an appropriate Warrant exercisable into the remaining shares to the undersigned.

Date: ___________________


Signature of Warrant Holder


Name of Warrant Holder

_________ SHARES

_________________, INC

COMMON STOCK

SELECTED DEALER AGREEMENT

Ladies and Gentlemen:

1. We as the Underwriter named in the Prospectus referred to below (the "Underwriter"), have agreed to purchase, subject to the terms and conditions set forth in the Underwriting Agreement referred to in the Prospectus (the "Underwriting Agreement"), from, a Minnesota corporation (the "Company"), an aggregate of ___________ shares of Common Stock of the Company (the "Firm Shares"). In addition, the Underwriter has been granted an option to purchase from the Company up to an aggregate of an additional _________ shares of Common Stock of the Company (the "Option Shares"), to cover over-allotments in connection with the sale of the Firm Shares. The Firm Shares and the Option Shares are hereinafter collectively called the "Shares." The Shares and the terms upon which they are to be offered for sale by the several Underwriters are more particularity described in the enclosed Prospectus.

2. The Shares are to be offered to the public by the Underwriter at a price of $_.00 per share (hereinafter called the "Public Offering Price") and in accordance with the terms of offering set forth in the Prospectus.

3. The Underwriter is offering, subject to the terms and conditions hereof, a portion of the Shares for sale to (a) certain dealers which are members of the National Association of Securities Dealers, Inc. (the "NASD") and which agree to comply with the provisions of Rules 2420, 2730, 2740, and 2750 of the NASD Conduct Rules (the "NASD Rules") and (b) foreign dealers or institutions ineligible for membership in the NASD which agree (i) not to resell the Shares to purchasers in, or to persons who are nationals or residents of, the United States of America, or when there is a public demand for the Shares, to persons specified as those to whom members of the NASD participating in a distribution may not sell; and (ii) to comply, as though such foreign dealer or institution were a member of the NASD, with the NASD's interpretation with respect to free-riding and withholding and with the foregoing Sections of the NASD Rules, to the extent applicable to foreign nonmember brokers or dealers, (such dealers and institutions agreeing to purchase Shares hereinafter referred to as "Selected Dealers") at the Public Offering Price less a selling concession of $____ per share, payable as hereinafter provided, out of which concession an amount not exceeding $___ per share may be reallowed by Selected Dealers to members of the NASD or to foreign dealers or institutions ineligible for membership therein which agree as aforesaid. This offering is made subject to delivery of the Shares and their acceptance by us, to the approval of all legal matters by counsel and to the terms and conditions herein set forth. Some or all of the Underwriters may be included among the Selected Dealers. The Underwriter has agreed that, during the term of this Agreement, it will be governed by the terms and conditions hereof whether or not such Underwriter is included among the Selected Dealers.

4. We may buy Shares from, or sell Shares to, any Selected Dealer, or any other Underwriter, and any Selected Dealer may buy Shares from, or sell Shares to, any other Selected Dealer or any Underwriter at the Public Offering Price less all or any part of the concession. After the initial public offering we may change the Public Offering Price, the concession and the reallowance.

5. If prior to the termination of this Agreement, we purchase or contract to purchase, in the open market or otherwise, for the account of the Underwriter any Shares purchased by you hereunder, you agree to pay us on demand for our account an amount equal to the concession on such Shares. In addition, we may charge you with any transfer taxes and broker's commission or dealer's mark-up paid in connection with such purchase or contract to purchase.

6. We shall have full authority to take such action as we may deem advisable in respect of all matters pertaining to the public offering of the Shares.

7. If you desire to purchase any of the Shares, your indication of interest should reach us promptly by telephone or facsimile at the offices of Tuschner & Company, Inc., Suite 800, One Financial Plaza, 120 South Sixth Street, Minneapolis, Minnesota 55402. We reserve the right to reject all subscriptions in whole or in part, to make allotments and to close the subscription books at any time without notice. The Shares allotted to you will be confirmed, subject to the terms and conditions of this Agreement.

8. The privilege of purchasing the Shares is extended to you only on behalf of the Underwriter to those Selected Dealers that may lawfully sell the Shares in your state.

9. Any of the Shares purchased by you under the terms of this Agreement may be immediately reoffered to the public in accordance with the terms of the offering thereof set forth herein and in the Prospectus, subject to the securities laws of the various states. Neither you nor any other person is or has been authorized to give any information or to make any representations in connection with the sale of the Shares other than as contained in the Prospectus.

10. This Agreement will terminate when we shall have determined that the public offering of the Shares has been completed and upon telegraphic notice to you of such termination, but, if not previously terminated, this Agreement will terminate at the close of business on the 30th full business day after the date hereof; provided, however, that we shall have the right to extend this Agreement for, an additional period or periods not exceeding 30 full business days in the aggregate upon telegraphic notice to you.

11. For the purpose of stabilizing the market in the Common Stock of the Company, we have been authorized to make purchases and sales thereof, in the open market or otherwise, and, in arranging for sale of the Shares, to over-allot.

12. You agree to advise us from time to time upon request, prior to the termination of this Agreement, of the number of Shares purchased by you hereunder and remaining unsold at the time of such request, and, if in our opinion any such Shares shall be needed to make delivery of Shares sold or over-allotted for the account of the Underwriter, you will, forthwith upon our request, grant to us for our account the right, exercisable promptly after receipt of notice from you that such right has been granted, to purchase, at the Public Offering Price less the selling concession or such part thereof as we shall determine, such number of Shares owned by you as shall have been specified in our request.

13. On becoming a Selected Dealer, and in offering and selling the Shares, you agree (which agreement shall also be for the benefit of the Company) to comply with all applicable requirements of the Securities Act of 1933, as amended (the "Act"), and the Securities Exchange Act of 1934, as amended (the "Exchange Act"). You confirm that you are familiar with Rule 15c2-8 under the Exchange Act relating to the distribution or preliminary and final prospectuses for securities of an issuer and confirm that you have complied and will comply therewith.

14. Upon request, you will be informed as to the jurisdictions in which we have been advised that the Shares have been qualified for sale under the respective securities or Blue Sky laws of such jurisdictions, but we do not assume any obligation or responsibility as to the right of any Selected Dealer to sell the Shares in any jurisdiction or as to any sale therein. You authorize us to file on your benefit a New York Notice, if required.

15. Additional copies of the Prospectus will be supplied to you in reasonable quantities upon request.

16. No Selected Dealer is authorized to act as our agent, or otherwise to act on our behalf in offering or selling the Shares to the public or otherwise.

17. We shall not be under any liability for or in respect of the value, validity or form of the Shares, or delivery of the certificates for the Shares, or the performance by anyone of any agreement on such person's part, or the qualification of the Shares for sale under the laws of any jurisdiction, or for or in respect of any matter connected with this Agreement, except for lack of good faith and for obligations expressly assumed by us in this Agreement. The foregoing provisions shall not be deemed a waiver of any liability imposed under the Act.

18. Payment for the Shares sold to you hereunder is to be made at the Public Offering Price, less selling concession, on or about ________, 199__, or such later date as we may advise, by certified or official bank check, payable to the order of Tuschner and Company, Inc., in current funds, at such place as we shall specify on one day's notice to you against delivery of certificates for the Shares. Notwithstanding the foregoing, if transactions in the Shares can be settled through the facilities of The Depository Trust Company, payment for and delivery of the Shares purchased by you hereunder will be made through the facilities of The Depository Trust Company, if you are a member, unless you have otherwise notified us prior to the date specified in our facsimile or telegram to you, or, if you are not a member, settlement may be made through a correspondent who is a member pursuant to instructions you may send us prior to such specified date.

19. Notice to us should be addressed to us c/o John M. Tuschner, Tuschner and Company, Inc., Suite 800, One Financial Plaza, 120 South Sixth Street, Minneapolis, Minnesota 55402. Notices to you shall be deemed to have been duly given if sent by telefacsimile, telegraphed or mailed to you at the address to which this letter is addressed.

20. This Agreement shall be governed by the internal laws of the State of Minnesota, without giving effect to the principles thereof relating to the conflict of laws.

21. If you desire to purchase any of the Shares, please confirm your subscription by signing and returning to us your confirmation overleaf on the duplicate copy of this letter enclosed herewith even though you have previously advised us thereof by telephone or telefacsimile.

Very truly yours,

TUSCHNER AND COMPANY, INC.

By:________________________

Dated: ________________________

CONFIRMATION

We confirm our agreement to purchase ________ shares of Common Stock of ________ Corporation (the "Shares"), subject to all the terms and conditions set forth in the foregoing Selected Dealers Agreement. We hereby acknowledge receipt of the Prospectus. We further state that in purchasing the Shares, we have relied upon the Prospectus and upon no other statement whatsoever, whether written or oral. We hereby confirm that we are a dealer actually engaged in the investment banking or securities business and that we are either (a) a member in good standing of the National Association of Securities Dealers, Inc. (the "NASD") or (b) a dealer with its principal place of business located outside the United Sates, its territories and its possessions and not registered as a broker or dealer under the Securities Exchange Act of 1934 who hereby agrees not to make any sales within the Unites States, its territories or its possessions or to persons who are nationals thereof or resident therein. We hereby agree to comply with the provisions of NASD Rules 2420, 2730, 2740, and 2750 and, if we are a foreign dealer and not a member of the NASD, we also agree to comply with the NASD's interpretation with respect to free-riding and withholding, to comply, as though we were a member of the NASD, with the provisions of the above NASD Rules as those Rules apply to non-member foreign dealers.

Dated:____________, 1997


(Print corporate or firm name of Selected Dealer)


(Signature of authorized officer or partner)


(Print name of person signing)

Address:




[LOGO]

INCORPORATED UNDER THE LAWS OF THE STATE OF MINNESOTA

SAC TECHNOLOGIES, INC.

NUMBER SHARES


SEE REVERSE SIDE
FOR CERTAIN DEFINITIONS

CUSIP 78386P 10 4

THIS CERTIFIES THAT

IS THE OWNER OF

FULLY PAID AND NON-ASSESSABLE SHARES OF COMMON STOCK,
$.01 PAR VALUE PER SHARE, OF

SAC TECHNOLOGIES, INC.

TRANSFERABLE ON THE BOOKS OF THE CORPORATION BY THE HOLDER HEREOF IN PERSON OR BY DULY AUTHORIZED ATTORNEY UPON SURRENDER OF THIS CERTIFICATE PROPERLY ENDORSED. THIS CERTIFICATE IS NOT VALID UNLESS COUNTERSIGNED BY THE TRANSFER AGENT AND REGISTRAR.

WITNESS THE FACSIMILE SIGNATURES OF ITS DULY AUTHORIZED OFFICERS.

DATED:


/s/ Benedict A. Wittig                                     /s/ Barry Wendt
     SECRETARY                                         CHIEF EXECUTIVE OFFICER

Countersigned and Registered:
FIRSTAR TRUST COMPANY
Transfer Agent and Registrar

By
Authorized Signature


The following abbreviations, when used in the inscription on the face of this certificate, shall be construed as though they were written out in full according to applicable laws or regulations:

TEN COM - as tenants in common           UTMA - ___________ Custodian __________
                                                  (Cust)                (Minor)
TEN ENT - as tenants by entireties              under Uniform Transfer to Minors

JT TEN  - as joint tenants with right           Act ____________________________
          of survivorship and not as                         (State)
          tenants in common

Additional abbreviations may also be used though not in the above list.

FOR VALUE RECEIVED ____________ HEREBY SELL, ASSIGN AND TRANSFER UNTO

PLEASE INSERT SOCIAL SECURITY OR OTHER
IDENTIFYING NUMBER OF ASSIGNEE


PLEASE PRINT OR TYPEWRITE NAME AND ADDRESS INCLUDING POSTAL ZIP CODE OF ASSIGNEE

__________________________________________________________________ SHARES OF THE

CAPITAL STOCK REPRESENTED BY THE WITHIN CERTIFICATE, AND DO HEREBY IRREVOCABLY

CONSTITUTE AND APPOINT _________________________________________________________

_________________________________________________________ATTORNEY TO TRANSFER

THE SAID STOCK ON THE BOOKS OF THE WITHIN-NAMED CORPORATION WITH FULL POWER OF

SUBSTITUTION IN THE PREMISES.

DATED                           _______________________________________________

                                _______________________________________________

                                NOTICE: THE SIGNATURE TO THIS ASSIGNMENT MUST
                                CORRESPOND WITH THE NAME AS WRITTEN UPON THE
                                FACE OF THE CERTIFICATE IN EVERY PARTICULAR
                                WITHOUT ALTERATION OR ENLARGEMENT OR ANY CHANGE
                                WHATEVER.

SIGNATURE GUARANTEED


(612) 340-5555

January 9, 1997

EXHIBIT 5.1

SAC Technologies Inc.
4444 West 76th Street
Suite 600
Edina, Minnesota 55435

RE: REGISTRATION STATEMENT ON FORM SB-2

Ladies and Gentlemen:

We have acted on behalf of SAC Technologies, Inc., a Minnesota corporation (the "Company"), in connection with a Registration Statement on Form SB-2, File No. 333-16451, (the "Registration Statement") filed by the Company with the Securities and Exchange Commission relating to (i) 1,100,000 shares of common stock, $.01 par value, the ("Shares"), (ii) an underwriter's warrant to purchase 110,000 shares of common stock (the "Underwriter's Warrant"), and (iii) an aggregate 110,000 shares of the common stock issuable upon exercise of the Underwriter's Warrant (the "Underwriter's Warrant Shares"), all of which are to be issued by the Company. Upon examination of such corporate documents and records as we have deemed necessary or advisable for the purposes hereof and including and in reliance upon certain certificates by the Company, it is our opinion that:

1. The Company is a validly existing corporation in good standing under the laws of the State of Minnesota.

2. The Shares, Underwriter's Warrant and the Underwriter's Warrant Shares, when issued and sold as contemplated in the Regisstration Statement, will be validly issued, fully paid and non-assessable.

We hereby consent to the filing of this opinion as an exhibit to the Registration Statement.

Very truly yours,

DOHERTY RUMBLE & BUTLER
PROFESSIONAL ASSOCIATION

/s/ Stephen E. Smith
Stephen E. Smith


EXHIBIT 23.1

CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS

We have issued our report dated October 18, 1996 (except for notes E and L, as to which the date is December 18, 1996, and note G, as to which the date is January 9, 1997), accompanying the financial statements of SAC Technologies, Inc. contained in the Registration Statement and Prospectus. We consent to the use of the aforementioned report in the Registration Statement and Prospectus, and to the use of our name as it appears under the captions "Selected Financial Data" and "Experts."

/s/ DIVINE, SCHERZER & BRODY, LTD.



St. Paul, Minnesota
January 9, 1997


EXHIBIT 23.3

January 9, 1997

SAC Technologies, Inc.
4444 West 76th Street, Suite 600
Edina, MN 55435

Gentlemen:

We consent to the inclusion of our name as counsel to the Underwriter under the caption "Legal Matters" in the Company's Registration Statement No. 333-16451.

Very truly yours,

MERRITT, FURBER & TIMMER

/s/ Merritt, Furber & Timmer